cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
BRCA	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-30.75	5.21e-148	-0.87	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-30.75	5.21e-148	-0.87	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-29.54	1.55e-139	-0.86	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-29.54	1.55e-139	-0.86	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-29.54	1.55e-139	-0.86	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-29.54	1.55e-139	-0.86	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	29.19	3.96e-137	0.85	0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	29.19	3.96e-137	0.85	0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-29.15	8.13e-137	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-29.15	8.13e-137	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-29.15	8.13e-137	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-29.15	8.13e-137	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-29.01	7.81e-136	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-29.01	7.81e-136	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-28.81	1.74e-134	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-28.81	1.74e-134	-0.85	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	28.58	6.82e-133	0.84	0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	28.58	6.82e-133	0.84	0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-28.56	9.12e-133	-0.85	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-28.56	9.12e-133	-0.85	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-26.86	5.9e-121	-0.83	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-26.86	5.9e-121	-0.83	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-26.26	7.54e-117	-0.83	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-26.26	7.54e-117	-0.83	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-26.24	9.33e-117	-0.82	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-26.24	9.33e-117	-0.82	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-25.91	1.8e-114	-0.83	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-25.91	1.8e-114	-0.83	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-25.6	2.31e-112	-0.82	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-25.6	2.31e-112	-0.82	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-23.88	9.94e-101	-0.78	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-23.88	9.94e-101	-0.78	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
BRCA	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-12.15	7.84e-32	-0.62	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-12.15	7.84e-32	-0.62	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
BRCA	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	11.39	2.09e-28	0.37	0.33	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
BRCA	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	11.33	3.98e-28	0.37	0.33	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
BRCA	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	11.21	1.28e-27	0.35	0.33	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
BRCA	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	11.01	9.45e-27	0.36	0.32	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
BRCA	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	11.01	9.45e-27	0.36	0.32	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-10.58	6.61e-25	-0.34	-0.31	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	10.51	1.27e-24	0.34	0.31	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	10.41	3.25e-24	0.34	0.31	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	10.4	3.55e-24	0.34	0.31	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	10.38	4.26e-24	0.34	0.31	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	10.38	4.44e-24	0.34	0.31	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	10.38	4.53e-24	0.34	0.31	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	10.36	5.25e-24	0.34	0.31	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	10.35	5.79e-24	0.34	0.31	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	10.35	5.79e-24	0.34	0.31	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	10.35	5.79e-24	0.34	0.31	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	10.35	5.79e-24	0.34	0.31	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	10.35	5.79e-24	0.34	0.31	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	10.32	7.51e-24	0.34	0.31	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	10.29	1.01e-23	0.33	0.3	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	10.29	1.05e-23	0.33	0.3	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	10.29	1.07e-23	0.33	0.3	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	10.29	1.07e-23	0.33	0.3	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	10.29	1.07e-23	0.33	0.3	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	10.28	1.19e-23	0.34	0.3	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	10.28	1.19e-23	0.34	0.3	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	10.27	1.25e-23	0.33	0.3	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	10.27	1.26e-23	0.33	0.3	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	10.26	1.44e-23	0.33	0.3	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	10.24	1.65e-23	0.33	0.3	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	10.22	2e-23	0.33	0.3	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	10.22	2.04e-23	0.33	0.3	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	10.2	2.36e-23	0.33	0.3	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	10.19	2.72e-23	0.33	0.3	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	10.14	4.12e-23	0.33	0.3	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	10.14	4.42e-23	0.33	0.3	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	10.13	4.69e-23	0.33	0.3	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	10.13	4.69e-23	0.33	0.3	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	10.12	4.97e-23	0.33	0.3	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	10.12	4.97e-23	0.33	0.3	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	10.12	4.97e-23	0.33	0.3	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	10.11	5.55e-23	0.33	0.3	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	10.11	5.86e-23	0.33	0.3	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
BRCA	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	10.03	1.22e-22	0.55	0.3	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
BRCA	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	9.97	2.02e-22	0.32	0.3	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	9.97	2.02e-22	0.32	0.3	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	9.96	2.19e-22	0.32	0.3	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-9.96	2.32e-22	-0.33	-0.3	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	9.91	3.52e-22	0.32	0.29	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	9.64	4.09e-21	0.31	0.29	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	9.63	4.31e-21	0.31	0.29	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	9.61	5.24e-21	0.31	0.29	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-9.41	3.18e-20	-0.3	-0.28	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	9.29	8.59e-20	0.31	0.28	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	9.29	8.59e-20	0.31	0.28	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	9.26	1.19e-19	0.3	0.28	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	9.12	3.68e-19	0.31	0.27	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
BRCA	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	9.01	9.49e-19	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	9.01	9.49e-19	0.39	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
BRCA	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	8.99	1.19e-18	0.31	0.27	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-8.97	1.4e-18	-0.18	-0.27	Migraine;	chr10:103365694	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-8.97	1.4e-18	-0.18	-0.27	Migraine;	chr10:103369141	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-8.95	1.57e-18	-0.18	-0.27	Migraine;	chr10:103394332	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-8.9	2.54e-18	-0.18	-0.27	Migraine;	chr10:103415374	chr10:103394301~103394322:-
BRCA	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	8.8	5.79e-18	0.27	0.26	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
BRCA	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-8.75	8.47e-18	-0.18	-0.26	Migraine;	chr10:103338267	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	8.6	2.84e-17	0.17	0.26	Migraine;	chr10:103263177	chr10:103394301~103394322:-
BRCA	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	8.53	4.99e-17	0.26	0.26	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
BRCA	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-8.52	5.57e-17	-0.18	-0.26	Migraine;	chr10:103315955	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-8.47	8.6e-17	-0.18	-0.25	Migraine;	chr10:103295206	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-8.44	1.1e-16	-0.18	-0.25	Migraine;	chr10:103296155	chr10:103394301~103394322:-
BRCA	cis	rs754133	0.964	rs894738	MIMAT0004562	hsa-miR-196a-3p	-8.42	1.21e-16	-0.31	-0.25	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54023741	chr12:53991799~53991820:+
BRCA	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-8.42	1.23e-16	-0.17	-0.25	Migraine;	chr10:103415374	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	8.42	1.27e-16	0.3	0.25	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-8.39	1.52e-16	-0.18	-0.25	Migraine;	chr10:103286250	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-8.39	1.52e-16	-0.18	-0.25	Migraine;	chr10:103286932	chr10:103394301~103394322:-
BRCA	cis	rs754133	0.964	rs4759318	MIMAT0004562	hsa-miR-196a-3p	-8.39	1.61e-16	-0.32	-0.25	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026314	chr12:53991799~53991820:+
BRCA	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	8.39	1.62e-16	0.26	0.25	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
BRCA	cis	rs754133	0.891	rs12426399	MIMAT0004562	hsa-miR-196a-3p	-8.38	1.74e-16	-0.32	-0.25	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026126	chr12:53991799~53991820:+
BRCA	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-8.37	1.8e-16	-0.17	-0.25	Migraine;	chr10:103254113	chr10:103394301~103394322:-
BRCA	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	8.37	1.81e-16	0.17	0.25	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
BRCA	cis	rs754133	0.964	rs894737	MIMAT0004562	hsa-miR-196a-3p	-8.37	1.89e-16	-0.32	-0.25	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54024359	chr12:53991799~53991820:+
BRCA	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	8.34	2.3e-16	0.26	0.25	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
BRCA	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	8.34	2.3e-16	0.26	0.25	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
BRCA	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	8.34	2.3e-16	0.26	0.25	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
BRCA	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	8.31	2.99e-16	0.32	0.25	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
BRCA	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	8.3	3.15e-16	0.26	0.25	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
BRCA	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	8.3	3.27e-16	0.26	0.25	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
BRCA	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	8.29	3.48e-16	0.26	0.25	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
BRCA	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	8.29	3.48e-16	0.26	0.25	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
BRCA	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	8.29	3.48e-16	0.26	0.25	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
BRCA	cis	rs754133	1	rs754133	MIMAT0004562	hsa-miR-196a-3p	-8.27	4.02e-16	-0.31	-0.25	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54025136	chr12:53991799~53991820:+
BRCA	cis	rs754133	0.963	rs12319419	MIMAT0004562	hsa-miR-196a-3p	-8.27	4.19e-16	-0.32	-0.25	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026992	chr12:53991799~53991820:+
BRCA	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	8.24	5.04e-16	0.33	0.25	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	8.24	5.1e-16	0.32	0.25	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	8.24	5.2e-16	0.33	0.25	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	8.24	5.2e-16	0.33	0.25	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	8.23	5.4e-16	0.32	0.25	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	8.23	5.68e-16	0.32	0.25	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	8.23	5.68e-16	0.32	0.25	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	8.23	5.68e-16	0.32	0.25	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	8.23	5.74e-16	0.32	0.25	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	8.23	5.74e-16	0.32	0.25	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	8.2	7.15e-16	0.32	0.25	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	8.2	7.15e-16	0.32	0.25	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	8.2	7.33e-16	0.32	0.25	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	8.19	7.55e-16	0.33	0.25	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	8.17	9.26e-16	0.32	0.25	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	8.14	1.09e-15	0.32	0.25	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	8.13	1.26e-15	0.32	0.24	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	8.13	1.26e-15	0.32	0.24	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	8.12	1.35e-15	0.32	0.24	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	8.12	1.36e-15	0.32	0.24	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	8.11	1.44e-15	0.32	0.24	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	8.1	1.52e-15	0.32	0.24	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	8.07	1.87e-15	0.32	0.24	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	8.07	1.87e-15	0.32	0.24	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	8.07	1.87e-15	0.32	0.24	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	8.07	1.87e-15	0.32	0.24	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	8.07	1.98e-15	0.32	0.24	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	8.07	1.98e-15	0.32	0.24	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	8.07	1.98e-15	0.32	0.24	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	8.07	1.99e-15	0.17	0.24	Migraine;	chr10:103236031	chr10:103394301~103394322:-
BRCA	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	8.06	2.1e-15	0.32	0.24	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	8.05	2.26e-15	0.32	0.24	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	8.04	2.37e-15	0.32	0.24	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	8	3.23e-15	0.28	0.24	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	7.92	6.08e-15	0.32	0.24	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	7.89	7.41e-15	0.25	0.24	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	7.79	1.67e-14	0.25	0.24	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
BRCA	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	7.78	1.8e-14	0.3	0.24	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	7.78	1.8e-14	0.3	0.24	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	7.76	2.02e-14	0.3	0.23	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	7.75	2.25e-14	0.31	0.23	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	7.68	3.58e-14	0.3	0.23	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	7.68	3.64e-14	0.31	0.23	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	7.65	4.51e-14	0.31	0.23	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	7.65	4.73e-14	0.3	0.23	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	7.64	4.81e-14	0.2	0.23	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
BRCA	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	7.64	5.1e-14	0.3	0.23	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	7.63	5.38e-14	0.31	0.23	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	7.63	5.47e-14	0.3	0.23	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-7.62	5.64e-14	-0.16	-0.23	Migraine;	chr10:103394332	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	7.62	5.84e-14	0.2	0.23	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
BRCA	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	7.62	5.91e-14	0.3	0.23	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	7.62	5.91e-14	0.3	0.23	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	7.62	5.91e-14	0.3	0.23	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	7.62	5.91e-14	0.3	0.23	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	7.62	5.91e-14	0.3	0.23	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	7.62	5.91e-14	0.3	0.23	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	7.61	6.03e-14	0.3	0.23	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	7.61	6.04e-14	0.31	0.23	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	7.61	6.16e-14	0.2	0.23	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
BRCA	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	7.61	6.34e-14	0.3	0.23	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-7.59	6.9e-14	-0.14	-0.23	Migraine;	chr10:103284207	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-7.59	7.16e-14	-0.14	-0.23	Migraine;	chr10:103283532	chr10:103394301~103394322:-
BRCA	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	7.59	7.22e-14	0.29	0.23	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	7.59	7.22e-14	0.29	0.23	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-7.58	7.47e-14	-0.16	-0.23	Migraine;	chr10:103365694	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-7.58	7.47e-14	-0.16	-0.23	Migraine;	chr10:103369141	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	7.58	7.65e-14	0.2	0.23	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-7.58	7.67e-14	-0.14	-0.23	Migraine;	chr10:103241568	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.77	rs1061123	MIMAT0005878	hsa-miR-1287-5p	7.58	7.72e-14	0.24	0.23	Metabolite levels;	chr10:98417240	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-7.57	8.29e-14	-0.14	-0.23	Migraine;	chr10:103395309	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	7.57	8.29e-14	0.19	0.23	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	7.57	8.29e-14	0.19	0.23	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	7.57	8.29e-14	0.19	0.23	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	7.57	8.29e-14	0.19	0.23	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	7.57	8.29e-14	0.19	0.23	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.587	rs2296435	MIMAT0005878	hsa-miR-1287-5p	-7.56	8.89e-14	-0.26	-0.23	Metabolite levels;	chr10:98422528	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-7.55	9.67e-14	-0.19	-0.23	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-7.55	9.81e-14	-0.14	-0.23	Migraine;	chr10:103279822	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	7.53	1.08e-13	0.14	0.23	Migraine;	chr10:103238157	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	7.53	1.11e-13	0.19	0.23	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	7.5	1.37e-13	0.19	0.23	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	7.5	1.41e-13	0.24	0.23	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	7.46	1.82e-13	0.19	0.23	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-7.45	1.9e-13	-0.15	-0.23	Migraine;	chr10:103338267	chr10:103394341~103394361:-
BRCA	cis	rs11614913	0.509	rs12300425	MIMAT0004562	hsa-miR-196a-3p	-7.45	2.03e-13	-0.25	-0.23	Waist circumference adjusted for body mass index;	chr12:54001298	chr12:53991799~53991820:+
BRCA	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	7.44	2.08e-13	0.28	0.23	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-7.43	2.29e-13	-0.14	-0.23	Migraine;	chr10:103367951	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-7.41	2.61e-13	-0.14	-0.22	Migraine;	chr10:103395888	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	7.41	2.7e-13	0.13	0.22	Migraine;	chr10:103240612	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-7.39	3.01e-13	-0.14	-0.22	Migraine;	chr10:103273871	chr10:103394301~103394322:-
BRCA	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-7.38	3.33e-13	-0.28	-0.22	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	7.37	3.56e-13	0.19	0.22	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	7.36	3.67e-13	0.19	0.22	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	7.35	3.92e-13	0.19	0.22	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	7.35	3.94e-13	0.19	0.22	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-7.35	3.95e-13	-0.14	-0.22	Migraine;	chr10:103358705	chr10:103394301~103394322:-
BRCA	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-7.34	4.31e-13	-0.26	-0.22	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	7.33	4.53e-13	0.15	0.22	Migraine;	chr10:103263177	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-7.33	4.75e-13	-0.13	-0.22	Migraine;	chr10:103270083	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	7.32	5.08e-13	0.19	0.22	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
BRCA	cis	rs4960162	1	rs4960162	MIMAT0022472	hsa-miR-5683	7.31	5.39e-13	0.23	0.22	Night sleep phenotypes;	chr6:6065527	chr6:6169343~6169366:+
BRCA	cis	rs7072216	0.77	rs3830020	MIMAT0005878	hsa-miR-1287-5p	-7.3	5.72e-13	-0.23	-0.22	Metabolite levels;	chr10:98416858	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	7.29	6.19e-13	0.13	0.22	Migraine;	chr10:103402122	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-7.29	6.36e-13	-0.14	-0.22	Migraine;	chr10:103353944	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-7.29	6.36e-13	-0.14	-0.22	Migraine;	chr10:103356299	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-7.29	6.36e-13	-0.13	-0.22	Migraine;	chr10:103262005	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	7.28	6.62e-13	0.19	0.22	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	7.27	6.98e-13	0.19	0.22	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	7.27	6.98e-13	0.19	0.22	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	7.26	7.42e-13	0.19	0.22	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	7.25	8.11e-13	0.19	0.22	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	7.25	8.31e-13	0.19	0.22	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	7.25	8.31e-13	0.19	0.22	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	7.25	8.31e-13	0.19	0.22	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	7.24	8.58e-13	0.19	0.22	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-7.24	8.61e-13	-0.14	-0.22	Migraine;	chr10:103384531	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	7.24	8.91e-13	0.13	0.22	Migraine;	chr10:103244344	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-7.23	9.09e-13	-0.15	-0.22	Migraine;	chr10:103296155	chr10:103394341~103394361:-
BRCA	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	7.23	9.41e-13	0.29	0.22	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
BRCA	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	7.23	9.57e-13	0.29	0.22	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	7.22	9.78e-13	0.19	0.22	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	7.22	9.83e-13	0.19	0.22	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-7.22	1.02e-12	-0.15	-0.22	Migraine;	chr10:103315955	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-7.21	1.1e-12	-0.15	-0.22	Migraine;	chr10:103295206	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-7.2	1.15e-12	-0.13	-0.22	Migraine;	chr10:103367521	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	7.19	1.2e-12	0.19	0.22	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	7.19	1.2e-12	0.19	0.22	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	7.19	1.2e-12	0.19	0.22	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	7.19	1.2e-12	0.19	0.22	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	7.19	1.2e-12	0.19	0.22	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-7.18	1.31e-12	-0.13	-0.22	Migraine;	chr10:103379204	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	7.18	1.32e-12	0.19	0.22	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	7.18	1.37e-12	0.19	0.22	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	7.17	1.45e-12	0.18	0.22	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
BRCA	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-7.15	1.67e-12	-0.19	-0.22	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-7.14	1.71e-12	-0.13	-0.22	Migraine;	chr10:103375562	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	7.14	1.73e-12	0.19	0.22	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-7.14	1.73e-12	-0.13	-0.22	Migraine;	chr10:103389790	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-7.13	1.93e-12	-0.13	-0.22	Migraine;	chr10:103358719	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-7.12	2.05e-12	-0.13	-0.22	Migraine;	chr10:103299082	chr10:103394301~103394322:-
BRCA	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	7.11	2.17e-12	0.25	0.22	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	7.11	2.2e-12	0.19	0.22	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	7.1	2.24e-12	0.23	0.22	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	7.09	2.43e-12	0.13	0.22	Migraine;	chr10:103261506	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-7.08	2.7e-12	-0.13	-0.21	Migraine;	chr10:103348698	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-7.08	2.75e-12	-0.18	-0.21	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.77	rs7909131	MIMAT0005878	hsa-miR-1287-5p	7.07	2.94e-12	0.23	0.21	Metabolite levels;	chr10:98411714	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-7.06	2.95e-12	-0.15	-0.21	Migraine;	chr10:103286250	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-7.06	2.95e-12	-0.15	-0.21	Migraine;	chr10:103286932	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-7.02	3.9e-12	-0.14	-0.21	Migraine;	chr10:103254113	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-7.02	4.1e-12	-0.13	-0.21	Migraine;	chr10:103386935	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	7.01	4.28e-12	0.18	0.21	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	7.01	4.28e-12	0.18	0.21	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	7.01	4.39e-12	0.18	0.21	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	6.99	4.77e-12	0.13	0.21	Migraine;	chr10:103367830	chr10:103394301~103394322:-
BRCA	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	6.98	5.16e-12	0.24	0.21	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	6.98	5.19e-12	0.14	0.21	Migraine;	chr10:103236031	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	6.98	5.25e-12	0.18	0.21	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	6.98	5.38e-12	0.18	0.21	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.77	rs942810	MIMAT0005878	hsa-miR-1287-5p	6.97	5.48e-12	0.23	0.21	Metabolite levels;	chr10:98408103	chr10:98395271~98395292:-
BRCA	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	6.97	5.53e-12	0.14	0.21	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	6.97	5.64e-12	0.18	0.21	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
BRCA	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-6.96	5.85e-12	-0.29	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-6.96	5.85e-12	-0.29	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
BRCA	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	6.96	6.17e-12	0.32	0.21	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
BRCA	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-6.96	6.23e-12	-0.33	-0.21	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
BRCA	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	6.93	7.3e-12	0.18	0.21	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	6.92	7.83e-12	0.12	0.21	Migraine;	chr10:103242040	chr10:103394301~103394322:-
BRCA	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-6.91	8.23e-12	-0.25	-0.21	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-6.91	8.65e-12	-0.13	-0.21	Migraine;	chr10:103317367	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-6.91	8.65e-12	-0.13	-0.21	Migraine;	chr10:103319682	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-6.9	9.34e-12	-0.13	-0.21	Migraine;	chr10:103292867	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-6.9	9.34e-12	-0.13	-0.21	Migraine;	chr10:103293183	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-6.89	9.72e-12	-0.13	-0.21	Migraine;	chr10:103293219	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-6.88	1.04e-11	-0.13	-0.21	Migraine;	chr10:103289348	chr10:103394301~103394322:-
BRCA	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-6.85	1.25e-11	-0.12	-0.21	Migraine;	chr10:103273985	chr10:103394301~103394322:-
BRCA	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-6.84	1.38e-11	-0.32	-0.21	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
BRCA	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-6.83	1.41e-11	-0.29	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-6.83	1.41e-11	-0.29	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
BRCA	cis	rs7072216	0.77	rs7896828	MIMAT0005878	hsa-miR-1287-5p	6.83	1.45e-11	0.22	0.21	Metabolite levels;	chr10:98410750	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	6.82	1.53e-11	0.17	0.21	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
BRCA	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-6.78	2.02e-11	-0.28	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-6.78	2.02e-11	-0.28	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
BRCA	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-6.76	2.24e-11	-0.12	-0.21	Migraine;	chr10:103305652	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	6.76	2.28e-11	0.19	0.21	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
BRCA	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-6.75	2.39e-11	-0.32	-0.21	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
BRCA	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-6.74	2.67e-11	-0.12	-0.21	Migraine;	chr10:103279291	chr10:103394301~103394322:-
BRCA	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-6.73	2.75e-11	-0.32	-0.2	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
BRCA	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	6.73	2.89e-11	0.22	0.2	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-6.72	2.9e-11	-0.12	-0.2	Migraine;	chr10:103309363	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.666	rs11598689	MIMAT0005878	hsa-miR-1287-5p	6.72	2.93e-11	0.24	0.2	Metabolite levels;	chr10:98396270	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	6.7	3.34e-11	0.12	0.2	Migraine;	chr10:103237257	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-6.7	3.39e-11	-0.12	-0.2	Migraine;	chr10:103278698	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	6.7	3.44e-11	0.12	0.2	Migraine;	chr10:103347713	chr10:103394301~103394322:-
BRCA	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-6.69	3.55e-11	-0.12	-0.2	Migraine;	chr10:103273258	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-6.65	4.68e-11	-0.12	-0.2	Migraine;	chr10:103299551	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-6.65	4.77e-11	-0.17	-0.2	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
BRCA	cis	rs453301	0.653	rs7016139	MIMAT0019728	hsa-miR-4660	-6.64	4.93e-11	-0.25	-0.2	Joint mobility (Beighton score);	chr8:9037960	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	6.64	5.14e-11	0.17	0.2	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
BRCA	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	6.64	5.14e-11	0.17	0.2	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
BRCA	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-6.62	5.63e-11	-0.24	-0.2	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-6.6	6.54e-11	-0.12	-0.2	Migraine;	chr10:103284400	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	6.6	6.74e-11	0.12	0.2	Migraine;	chr10:103248169	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	6.6	6.74e-11	0.12	0.2	Migraine;	chr10:103249329	chr10:103394301~103394322:-
BRCA	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-6.57	7.76e-11	-0.23	-0.2	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
BRCA	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-6.57	7.92e-11	-0.23	-0.2	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	6.54	9.87e-11	0.12	0.2	Migraine;	chr10:103241753	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-6.51	1.17e-10	-0.12	-0.2	Migraine;	chr10:103241568	chr10:103394341~103394361:-
BRCA	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-6.46	1.61e-10	-0.23	-0.2	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
BRCA	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-6.46	1.64e-10	-0.23	-0.2	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
BRCA	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-6.43	1.95e-10	-0.23	-0.2	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
BRCA	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-6.43	1.99e-10	-0.27	-0.2	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
BRCA	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	6.41	2.18e-10	0.16	0.2	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-6.41	2.21e-10	-0.12	-0.2	Migraine;	chr10:103307280	chr10:103394301~103394322:-
BRCA	cis	rs1045529	0.524	rs34251783	MIMAT0019728	hsa-miR-4660	-6.38	2.63e-10	-0.24	-0.19	Myopia (pathological);Myopia;	chr8:9033866	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.666	rs11189592	MIMAT0005878	hsa-miR-1287-5p	6.37	2.87e-10	0.22	0.19	Metabolite levels;	chr10:98395885	chr10:98395271~98395292:-
BRCA	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-6.36	2.95e-10	-0.27	-0.19	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
BRCA	cis	rs453301	0.686	rs6748	MIMAT0019728	hsa-miR-4660	-6.36	2.95e-10	-0.24	-0.19	Joint mobility (Beighton score);	chr8:9033292	chr8:9048453~9048475:+
BRCA	cis	rs453301	0.658	rs13271797	MIMAT0019728	hsa-miR-4660	-6.36	3.03e-10	-0.24	-0.19	Joint mobility (Beighton score);	chr8:9028444	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	6.35	3.18e-10	0.12	0.19	Migraine;	chr10:103238157	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-6.33	3.65e-10	-0.17	-0.19	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.922	rs4488133	MIMAT0005878	hsa-miR-1287-5p	-6.33	3.7e-10	-0.2	-0.19	Metabolite levels;	chr10:98399379	chr10:98395271~98395292:-
BRCA	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-6.32	3.95e-10	-0.22	-0.19	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-6.29	4.68e-10	-0.12	-0.19	Migraine;	chr10:103279822	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-6.29	4.82e-10	-0.12	-0.19	Migraine;	chr10:103284207	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-6.28	5.1e-10	-0.12	-0.19	Migraine;	chr10:103283532	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-6.23	6.73e-10	-0.11	-0.19	Migraine;	chr10:103273871	chr10:103394341~103394361:-
BRCA	cis	rs453301	0.686	rs1045527	MIMAT0019728	hsa-miR-4660	-6.22	7.38e-10	-0.23	-0.19	Joint mobility (Beighton score);	chr8:9032531	chr8:9048453~9048475:+
BRCA	cis	rs75358501	0.551	rs13394079	MIMAT0014995	hsa-miR-3130-5p	-6.21	7.79e-10	-0.26	-0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.551	rs13394079	MIMAT0014995_1	hsa-miR-3130-5p	-6.21	7.79e-10	-0.26	-0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783246~206783266:+
BRCA	cis	rs453301	0.719	rs34004903	MIMAT0019728	hsa-miR-4660	-6.17	9.84e-10	-0.23	-0.19	Joint mobility (Beighton score);	chr8:9035094	chr8:9048453~9048475:+
BRCA	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.07e-09	-0.16	-0.19	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	6.15	1.12e-09	0.16	0.19	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.686	rs2409120	MIMAT0019728	hsa-miR-4660	-6.14	1.15e-09	-0.23	-0.19	Joint mobility (Beighton score);	chr8:9025061	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.809	rs7655987	MIMAT0003242	hsa-miR-577	6.13	1.22e-09	0.16	0.19	Optic disc area;	chr4:114596146	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	6.12	1.31e-09	0.16	0.19	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
BRCA	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-6.12	1.34e-09	-0.16	-0.19	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-6.12	1.35e-09	-0.16	-0.19	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-6.11	1.42e-09	-0.16	-0.19	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
BRCA	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-6.11	1.43e-09	-0.11	-0.19	Migraine;	chr10:103297804	chr10:103394301~103394322:-
BRCA	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-6.1	1.5e-09	-0.16	-0.19	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-6.1	1.5e-09	-0.16	-0.19	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	6.08	1.73e-09	0.16	0.19	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
BRCA	cis	rs453301	0.686	rs6987107	MIMAT0019728	hsa-miR-4660	-6.07	1.77e-09	-0.23	-0.19	Joint mobility (Beighton score);	chr8:9036071	chr8:9048453~9048475:+
BRCA	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	6.07	1.83e-09	0.23	0.19	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.782	rs2388975	MIMAT0003242	hsa-miR-577	6.06	1.91e-09	0.16	0.19	Optic disc area;	chr4:114592899	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.782	rs7437569	MIMAT0003242	hsa-miR-577	-6.06	1.95e-09	-0.16	-0.19	Optic disc area;	chr4:114595431	chr4:114656774~114656794:+
BRCA	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-6.03	2.28e-09	-0.16	-0.18	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-6.03	2.28e-09	-0.16	-0.18	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.686	rs11785634	MIMAT0019728	hsa-miR-4660	-6.02	2.41e-09	-0.23	-0.18	Joint mobility (Beighton score);	chr8:9035087	chr8:9048453~9048475:+
BRCA	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-6.02	2.44e-09	-0.16	-0.18	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
BRCA	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	6.02	2.45e-09	0.11	0.18	Migraine;	chr10:103367830	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-6.01	2.63e-09	-0.16	-0.18	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-5.97	3.18e-09	-0.16	-0.18	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-5.97	3.21e-09	-0.2	-0.18	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.809	rs35733223	MIMAT0003242	hsa-miR-577	5.96	3.44e-09	0.16	0.18	Optic disc area;	chr4:114566454	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-5.96	3.55e-09	-0.11	-0.18	Migraine;	chr10:103395309	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-5.95	3.58e-09	-0.16	-0.18	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
BRCA	cis	rs7072216	1	rs7072216	MIMAT0005878	hsa-miR-1287-5p	5.95	3.68e-09	0.19	0.18	Metabolite levels;	chr10:98397096	chr10:98395271~98395292:-
BRCA	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-5.95	3.74e-09	-0.16	-0.18	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-5.95	3.74e-09	-0.16	-0.18	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
BRCA	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-5.94	3.83e-09	-0.11	-0.18	Migraine;	chr10:103395888	chr10:103394341~103394361:-
BRCA	cis	rs4921799	0.686	rs7459632	MIMAT0015020	hsa-miR-548v	5.94	3.91e-09	0.23	0.18	Lung cancer;Adenocarcinoma;	chr8:17678579	chr8:17681588~17681609:-
BRCA	cis	rs453301	0.686	rs10217044	MIMAT0019728	hsa-miR-4660	-5.94	3.91e-09	-0.22	-0.18	Joint mobility (Beighton score);	chr8:9037242	chr8:9048453~9048475:+
BRCA	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-5.92	4.36e-09	-0.16	-0.18	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.658	rs3855900	MIMAT0019728	hsa-miR-4660	-5.91	4.52e-09	-0.22	-0.18	Joint mobility (Beighton score);	chr8:9044411	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-5.91	4.55e-09	-0.11	-0.18	Migraine;	chr10:103299082	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-5.91	4.61e-09	-0.16	-0.18	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.658	rs6986044	MIMAT0019728	hsa-miR-4660	-5.91	4.72e-09	-0.22	-0.18	Joint mobility (Beighton score);	chr8:9017276	chr8:9048453~9048475:+
BRCA	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-5.9	4.86e-09	-0.16	-0.18	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
BRCA	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-5.9	4.94e-09	-0.11	-0.18	Migraine;	chr10:103367951	chr10:103394341~103394361:-
BRCA	cis	rs7829975	0.742	rs1533058	MIMAT0019728	hsa-miR-4660	5.89	5.13e-09	0.22	0.18	Mood instability;	chr8:8827680	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	5.89	5.24e-09	0.16	0.18	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
BRCA	cis	rs453301	0.606	rs6601279	MIMAT0019728	hsa-miR-4660	-5.88	5.38e-09	-0.22	-0.18	Joint mobility (Beighton score);	chr8:9050721	chr8:9048453~9048475:+
BRCA	cis	rs453301	0.606	rs6981060	MIMAT0019728	hsa-miR-4660	-5.88	5.38e-09	-0.22	-0.18	Joint mobility (Beighton score);	chr8:9050725	chr8:9048453~9048475:+
BRCA	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	5.88	5.56e-09	0.16	0.18	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	5.88	5.6e-09	0.22	0.18	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.922	rs10786415	MIMAT0005878	hsa-miR-1287-5p	5.87	5.73e-09	0.19	0.18	Metabolite levels;	chr10:98391509	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.922	rs942814	MIMAT0005878	hsa-miR-1287-5p	5.87	5.73e-09	0.19	0.18	Metabolite levels;	chr10:98391548	chr10:98395271~98395292:-
BRCA	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-5.86	6.32e-09	-0.15	-0.18	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.658	rs12114954	MIMAT0019728	hsa-miR-4660	-5.86	6.35e-09	-0.22	-0.18	Joint mobility (Beighton score);	chr8:9047352	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-5.85	6.59e-09	-0.11	-0.18	Migraine;	chr10:103358705	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.922	rs6584191	MIMAT0005878	hsa-miR-1287-5p	5.85	6.69e-09	0.19	0.18	Metabolite levels;	chr10:98392298	chr10:98395271~98395292:-
BRCA	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-5.84	6.85e-09	-0.16	-0.18	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-5.84	6.85e-09	-0.16	-0.18	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-5.84	6.85e-09	-0.16	-0.18	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
BRCA	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	5.84	6.98e-09	0.22	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	5.84	6.98e-09	0.22	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
BRCA	cis	rs7072216	0.587	rs2296435	MIMAT0026738	hsa-miR-1287-3p	-5.83	7.36e-09	-0.16	-0.18	Metabolite levels;	chr10:98422528	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	5.83	7.45e-09	0.1	0.18	Migraine;	chr10:103402122	chr10:103394341~103394361:-
BRCA	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-5.83	7.45e-09	-0.2	-0.18	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.922	rs59667296	MIMAT0005878	hsa-miR-1287-5p	5.83	7.49e-09	0.19	0.18	Metabolite levels;	chr10:98386556	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-5.82	7.71e-09	-0.11	-0.18	Migraine;	chr10:103367521	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
BRCA	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-5.82	7.77e-09	-0.15	-0.18	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-5.81	8.3e-09	-0.15	-0.18	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
BRCA	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-5.81	8.3e-09	-0.11	-0.18	Migraine;	chr10:103353944	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-5.81	8.3e-09	-0.11	-0.18	Migraine;	chr10:103356299	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-5.8	8.67e-09	-0.15	-0.18	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-5.8	8.76e-09	-0.19	-0.18	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
BRCA	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-5.79	9.24e-09	-0.15	-0.18	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-5.79	9.24e-09	-0.15	-0.18	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-5.79	9.24e-09	-0.15	-0.18	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-5.79	9.24e-09	-0.15	-0.18	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.867	rs12507591	MIMAT0003242	hsa-miR-577	5.79	9.6e-09	0.15	0.18	Optic disc area;	chr4:114574339	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-5.77	1.02e-08	-0.11	-0.18	Migraine;	chr10:103358719	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.04e-08	-0.15	-0.18	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.922	rs4539242	MIMAT0005878	hsa-miR-1287-5p	5.77	1.06e-08	0.19	0.18	Metabolite levels;	chr10:98388301	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.881	rs2147896	MIMAT0005878	hsa-miR-1287-5p	5.77	1.06e-08	0.19	0.18	Metabolite levels;	chr10:98388419	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-5.77	1.06e-08	-0.1	-0.18	Migraine;	chr10:103389790	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-5.76	1.14e-08	-0.1	-0.18	Migraine;	chr10:103375562	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-5.74	1.22e-08	-0.11	-0.18	Migraine;	chr10:103384531	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-5.74	1.22e-08	-0.15	-0.18	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-5.74	1.23e-08	-0.19	-0.18	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-5.74	1.26e-08	-0.19	-0.18	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
BRCA	cis	rs453301	0.658	rs6983877	MIMAT0019728	hsa-miR-4660	-5.73	1.31e-08	-0.21	-0.18	Joint mobility (Beighton score);	chr8:9047129	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-5.73	1.32e-08	-0.11	-0.18	Migraine;	chr10:103348698	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-5.72	1.39e-08	-0.11	-0.18	Migraine;	chr10:103379204	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-5.7	1.54e-08	-0.15	-0.17	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
BRCA	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	5.7	1.55e-08	0.21	0.17	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.735	rs9995962	MIMAT0003242	hsa-miR-577	5.69	1.63e-08	0.15	0.17	Optic disc area;	chr4:114551671	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.688	rs7827182	MIMAT0019728	hsa-miR-4660	5.69	1.69e-08	0.21	0.17	Mood instability;	chr8:8522961	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.744	rs2388976	MIMAT0003242	hsa-miR-577	5.67	1.84e-08	0.15	0.17	Optic disc area;	chr4:114581250	chr4:114656774~114656794:+
BRCA	cis	rs2980436	1	rs2980436	MIMAT0019728	hsa-miR-4660	-5.66	1.92e-08	-0.22	-0.17	Schizophrenia;	chr8:8234503	chr8:9048453~9048475:+
BRCA	cis	rs2277912	1	rs56243714	MIMAT0014995	hsa-miR-3130-5p	5.64	2.22e-08	0.26	0.17	Height;	chr2:206776345	chr2:206783276~206783296:-
BRCA	cis	rs2277912	1	rs56243714	MIMAT0014995_1	hsa-miR-3130-5p	5.64	2.22e-08	0.26	0.17	Height;	chr2:206776345	chr2:206783246~206783266:+
BRCA	cis	rs7072216	0.666	rs2274248	MIMAT0005878	hsa-miR-1287-5p	5.63	2.38e-08	0.19	0.17	Metabolite levels;	chr10:98388785	chr10:98395271~98395292:-
BRCA	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	5.62	2.45e-08	0.15	0.17	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
BRCA	cis	rs2277912	1	rs2277912	MIMAT0014995	hsa-miR-3130-5p	5.62	2.48e-08	0.26	0.17	Height;	chr2:206769512	chr2:206783276~206783296:-
BRCA	cis	rs2277912	1	rs2277912	MIMAT0014995_1	hsa-miR-3130-5p	5.62	2.48e-08	0.26	0.17	Height;	chr2:206769512	chr2:206783246~206783266:+
BRCA	cis	rs7829975	0.688	rs6601703	MIMAT0019728	hsa-miR-4660	5.61	2.61e-08	0.21	0.17	Mood instability;	chr8:8522714	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.809	rs9884212	MIMAT0003242	hsa-miR-577	5.61	2.62e-08	0.15	0.17	Optic disc area;	chr4:114580888	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-5.6	2.75e-08	-0.1	-0.17	Migraine;	chr10:103386935	chr10:103394341~103394361:-
BRCA	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-5.59	2.93e-08	-0.1	-0.17	Migraine;	chr10:103279291	chr10:103394341~103394361:-
BRCA	cis	rs2066940	0.54	rs2045562	MIMAT0000510	hsa-miR-320a-3p	5.59	2.97e-08	0.21	0.17	Sitting height ratio;	chr8:21350726	chr8:22244975~22244996:-
BRCA	cis	rs10021731	0.756	rs28787070	MIMAT0003242	hsa-miR-577	-5.57	3.19e-08	-0.15	-0.17	Optic disc area;	chr4:114556918	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-5.56	3.36e-08	-0.11	-0.17	Migraine;	chr10:103293219	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-5.56	3.36e-08	-0.11	-0.17	Migraine;	chr10:103292867	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-5.56	3.36e-08	-0.11	-0.17	Migraine;	chr10:103293183	chr10:103394341~103394361:-
BRCA	cis	rs453301	0.606	rs7462373	MIMAT0019728	hsa-miR-4660	-5.56	3.45e-08	-0.21	-0.17	Joint mobility (Beighton score);	chr8:9041808	chr8:9048453~9048475:+
BRCA	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-5.55	3.56e-08	-0.17	-0.17	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
BRCA	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-5.54	3.92e-08	-0.15	-0.17	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.756	rs35235288	MIMAT0003242	hsa-miR-577	-5.53	4.11e-08	-0.15	-0.17	Optic disc area;	chr4:114547620	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-5.52	4.35e-08	-0.1	-0.17	Migraine;	chr10:103289348	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.666	rs11598689	MIMAT0026738	hsa-miR-1287-3p	5.51	4.54e-08	0.15	0.17	Metabolite levels;	chr10:98396270	chr10:98395232~98395253:-
BRCA	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-5.5	4.85e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-5.5	4.85e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
BRCA	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-5.5	4.89e-08	-0.1	-0.17	Migraine;	chr10:103273985	chr10:103394341~103394361:-
BRCA	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-5.49	4.97e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-5.47	5.59e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-5.47	5.61e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-5.47	5.79e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
BRCA	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-5.46	6.07e-08	-0.19	-0.17	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
BRCA	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-5.46	6.11e-08	-0.19	-0.17	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-5.45	6.17e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-5.45	6.17e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
BRCA	cis	rs7594645	0.59	rs61258471	MIMAT0014995	hsa-miR-3130-5p	5.45	6.21e-08	0.3	0.17	Episodic memory;	chr2:206751133	chr2:206783276~206783296:-
BRCA	cis	rs7594645	0.59	rs61258471	MIMAT0014995_1	hsa-miR-3130-5p	5.45	6.21e-08	0.3	0.17	Episodic memory;	chr2:206751133	chr2:206783246~206783266:+
BRCA	cis	rs2277912	1	rs12620432	MIMAT0014995	hsa-miR-3130-5p	5.45	6.38e-08	0.25	0.17	Height;	chr2:206771794	chr2:206783276~206783296:-
BRCA	cis	rs2277912	1	rs12620432	MIMAT0014995_1	hsa-miR-3130-5p	5.45	6.38e-08	0.25	0.17	Height;	chr2:206771794	chr2:206783246~206783266:+
BRCA	cis	rs10021731	0.718	rs1460772	MIMAT0003242	hsa-miR-577	-5.41	7.85e-08	-0.14	-0.17	Optic disc area;	chr4:114487028	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.688	rs7817376	MIMAT0019728	hsa-miR-4660	-5.41	8.01e-08	-0.2	-0.17	Mood instability;	chr8:8523020	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	5.4	8.06e-08	0.1	0.17	Migraine;	chr10:103237257	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-5.4	8.28e-08	-0.14	-0.17	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-5.4	8.38e-08	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-5.4	8.47e-08	-0.1	-0.17	Migraine;	chr10:103278698	chr10:103394341~103394361:-
BRCA	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-5.4	8.49e-08	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.688	rs7837587	MIMAT0019728	hsa-miR-4660	5.39	8.55e-08	0.2	0.17	Mood instability;	chr8:8521482	chr8:9048453~9048475:+
BRCA	cis	rs5749696	1	rs5749696	MIMAT0000691	hsa-miR-130b-3p	5.39	8.66e-08	0.13	0.17	Schizophrenia;	chr22:21709048	chr22:21653354~21653375:+
BRCA	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-5.39	8.7e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-5.39	8.7e-08	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
BRCA	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	5.39	8.74e-08	0.19	0.17	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
BRCA	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-5.39	8.77e-08	-0.1	-0.17	Migraine;	chr10:103273258	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	5.38	9.02e-08	0.1	0.17	Migraine;	chr10:103240612	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.692	rs10516602	MIMAT0003242	hsa-miR-577	-5.38	9.39e-08	-0.14	-0.16	Optic disc area;	chr4:114486174	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-5.38	9.41e-08	-0.1	-0.16	Migraine;	chr10:103270083	chr10:103394341~103394361:-
BRCA	cis	rs2277912	1	rs3762567	MIMAT0014995	hsa-miR-3130-5p	5.37	9.51e-08	0.25	0.16	Height;	chr2:206765614	chr2:206783276~206783296:-
BRCA	cis	rs2277912	1	rs3762567	MIMAT0014995_1	hsa-miR-3130-5p	5.37	9.51e-08	0.25	0.16	Height;	chr2:206765614	chr2:206783246~206783266:+
BRCA	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-5.37	9.76e-08	-0.16	-0.16	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
BRCA	cis	rs7829975	0.688	rs7826654	MIMAT0019728	hsa-miR-4660	5.37	9.77e-08	0.2	0.16	Mood instability;	chr8:8521596	chr8:9048453~9048475:+
BRCA	cis	rs7829975	0.688	rs7826660	MIMAT0019728	hsa-miR-4660	5.37	9.77e-08	0.2	0.16	Mood instability;	chr8:8521597	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.718	rs7655989	MIMAT0003242	hsa-miR-577	-5.37	9.88e-08	-0.14	-0.16	Optic disc area;	chr4:114528134	chr4:114656774~114656794:+
BRCA	cis	rs79387448	0.638	rs116055209	MIMAT0019926	hsa-miR-4772-5p	-5.37	9.92e-08	-0.25	-0.16	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432300~102432321:+
BRCA	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	5.36	1.01e-07	0.1	0.16	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-5.35	1.06e-07	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	5.35	1.07e-07	0.18	0.16	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
BRCA	cis	rs2980439	0.525	rs2980508	MIMAT0019728	hsa-miR-4660	5.35	1.08e-07	0.19	0.16	Neuroticism;	chr8:8314210	chr8:9048453~9048475:+
BRCA	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-5.34	1.12e-07	-0.24	-0.16	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
BRCA	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	5.34	1.14e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-5.34	1.14e-07	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.843	rs4400721	MIMAT0026738	hsa-miR-1287-3p	5.34	1.15e-07	0.14	0.16	Metabolite levels;	chr10:98387340	chr10:98395232~98395253:-
BRCA	cis	rs7829975	0.711	rs12682352	MIMAT0019728	hsa-miR-4660	5.34	1.15e-07	0.19	0.16	Mood instability;	chr8:8788736	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	5.34	1.16e-07	0.1	0.16	Migraine;	chr10:103241753	chr10:103394341~103394361:-
BRCA	cis	rs453301	0.658	rs9329175	MIMAT0019728	hsa-miR-4660	-5.34	1.17e-07	-0.19	-0.16	Joint mobility (Beighton score);	chr8:9009151	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-5.33	1.23e-07	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-5.32	1.25e-07	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-5.32	1.25e-07	-0.1	-0.16	Migraine;	chr10:103284400	chr10:103394341~103394361:-
BRCA	cis	rs7594645	0.59	rs879472	MIMAT0014995	hsa-miR-3130-5p	-5.32	1.28e-07	-0.29	-0.16	Episodic memory;	chr2:206787058	chr2:206783276~206783296:-
BRCA	cis	rs7594645	0.59	rs879472	MIMAT0014995_1	hsa-miR-3130-5p	-5.32	1.28e-07	-0.29	-0.16	Episodic memory;	chr2:206787058	chr2:206783246~206783266:+
BRCA	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-5.32	1.29e-07	-0.16	-0.16	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
BRCA	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	5.32	1.3e-07	0.19	0.16	Asthma;	chr2:102344364	chr2:102432300~102432321:+
BRCA	cis	rs7829975	0.688	rs13270194	MIMAT0019728	hsa-miR-4660	5.31	1.32e-07	0.2	0.16	Mood instability;	chr8:8520592	chr8:9048453~9048475:+
BRCA	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	5.31	1.32e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
BRCA	cis	rs2277912	1	rs72957112	MIMAT0014995	hsa-miR-3130-5p	5.31	1.33e-07	0.24	0.16	Height;	chr2:206830729	chr2:206783276~206783296:-
BRCA	cis	rs2277912	1	rs72957112	MIMAT0014995_1	hsa-miR-3130-5p	5.31	1.33e-07	0.24	0.16	Height;	chr2:206830729	chr2:206783246~206783266:+
BRCA	cis	rs7829975	0.624	rs7823056	MIMAT0019728	hsa-miR-4660	5.3	1.4e-07	0.19	0.16	Mood instability;	chr8:8525195	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	5.3	1.43e-07	0.09	0.16	Migraine;	chr10:103244344	chr10:103394341~103394361:-
BRCA	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	5.29	1.47e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.718	rs2126028	MIMAT0003242	hsa-miR-577	-5.29	1.48e-07	-0.14	-0.16	Optic disc area;	chr4:114533453	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.54	rs2976909	MIMAT0019728	hsa-miR-4660	-5.29	1.48e-07	-0.21	-0.16	Mood instability;	chr8:8489180	chr8:9048453~9048475:+
BRCA	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	5.29	1.49e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.881	rs2274247	MIMAT0005878	hsa-miR-1287-5p	5.28	1.59e-07	0.17	0.16	Metabolite levels;	chr10:98390391	chr10:98395271~98395292:-
BRCA	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	5.27	1.64e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
BRCA	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	5.27	1.66e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
BRCA	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	5.27	1.66e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.718	rs2100782	MIMAT0003242	hsa-miR-577	5.27	1.67e-07	0.14	0.16	Optic disc area;	chr4:114530452	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs6834235	MIMAT0003242	hsa-miR-577	-5.27	1.7e-07	-0.14	-0.16	Optic disc area;	chr4:114531582	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs1599320	MIMAT0003242	hsa-miR-577	-5.27	1.7e-07	-0.14	-0.16	Optic disc area;	chr4:114532227	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs1824490	MIMAT0003242	hsa-miR-577	5.27	1.7e-07	0.14	0.16	Optic disc area;	chr4:114529766	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs1824489	MIMAT0003242	hsa-miR-577	5.27	1.7e-07	0.14	0.16	Optic disc area;	chr4:114529776	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7669767	MIMAT0003242	hsa-miR-577	5.27	1.7e-07	0.14	0.16	Optic disc area;	chr4:114530264	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs12508960	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114531061	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.681	rs11098254	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114531300	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs11098255	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114531393	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7683270	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114532438	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13103719	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114532620	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.681	rs13109008	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114532769	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13109803	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114532837	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7440658	MIMAT0003242	hsa-miR-577	5.26	1.74e-07	0.14	0.16	Optic disc area;	chr4:114533303	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.674	rs2121051	MIMAT0014979	hsa-miR-3117-3p	-5.25	1.89e-07	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66551494	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.623	rs10092965	MIMAT0019728	hsa-miR-4660	5.24	1.94e-07	0.2	0.16	Mood instability;	chr8:8515975	chr8:9048453~9048475:+
BRCA	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	5.24	1.95e-07	0.09	0.16	Migraine;	chr10:103261506	chr10:103394341~103394361:-
BRCA	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.24	1.97e-07	-0.16	-0.16	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
BRCA	cis	rs9527	0.518	rs4633383	MIMAT0005951	hsa-miR-1307-3p	5.24	1.98e-07	0.14	0.16	Arsenic metabolism;	chr10:103035966	chr10:103394301~103394322:-
BRCA	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	5.24	1.99e-07	0.09	0.16	Migraine;	chr10:103347713	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.881	rs11189591	MIMAT0005878	hsa-miR-1287-5p	5.23	2.01e-07	0.16	0.16	Metabolite levels;	chr10:98395539	chr10:98395271~98395292:-
BRCA	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-5.23	2.01e-07	-0.09	-0.16	Migraine;	chr10:103262005	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.718	rs2199312	MIMAT0003242	hsa-miR-577	-5.23	2.02e-07	-0.14	-0.16	Optic disc area;	chr4:114513322	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs10028232	MIMAT0003242	hsa-miR-577	-5.23	2.05e-07	-0.14	-0.16	Optic disc area;	chr4:114487644	chr4:114656774~114656794:+
BRCA	cis	rs453301	0.624	rs330049	MIMAT0019728	hsa-miR-4660	5.23	2.05e-07	0.19	0.16	Joint mobility (Beighton score);	chr8:9229789	chr8:9048453~9048475:+
BRCA	cis	rs2921036	0.529	rs2979192	MIMAT0019728	hsa-miR-4660	5.23	2.08e-07	0.21	0.16	Neuroticism;	chr8:8480637	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.718	rs2219591	MIMAT0003242	hsa-miR-577	-5.22	2.21e-07	-0.14	-0.16	Optic disc area;	chr4:114491902	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs2199310	MIMAT0003242	hsa-miR-577	-5.22	2.21e-07	-0.14	-0.16	Optic disc area;	chr4:114492246	chr4:114656774~114656794:+
BRCA	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-5.21	2.24e-07	-0.09	-0.16	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.718	rs958771	MIMAT0003242	hsa-miR-577	-5.21	2.24e-07	-0.14	-0.16	Optic disc area;	chr4:114514506	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs10857031	MIMAT0003242	hsa-miR-577	-5.21	2.33e-07	-0.14	-0.16	Optic disc area;	chr4:114527690	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	5.2	2.43e-07	0.09	0.16	Migraine;	chr10:103248169	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	5.2	2.43e-07	0.09	0.16	Migraine;	chr10:103249329	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.718	rs1460771	MIMAT0003242	hsa-miR-577	5.2	2.45e-07	0.14	0.16	Optic disc area;	chr4:114486755	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7698790	MIMAT0003242	hsa-miR-577	5.18	2.61e-07	0.14	0.16	Optic disc area;	chr4:114492647	chr4:114656774~114656794:+
BRCA	cis	rs1018697	0.966	rs10748832	MIMAT0005951	hsa-miR-1307-3p	5.18	2.63e-07	0.1	0.16	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394301~103394322:-
BRCA	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-5.18	2.64e-07	-0.18	-0.16	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs1585447	MIMAT0003242	hsa-miR-577	-5.18	2.65e-07	-0.14	-0.16	Optic disc area;	chr4:114490912	chr4:114656774~114656794:+
BRCA	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	5.18	2.67e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.692	rs1585448	MIMAT0003242	hsa-miR-577	-5.18	2.67e-07	-0.14	-0.16	Optic disc area;	chr4:114491050	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs1870655	MIMAT0003242	hsa-miR-577	-5.18	2.67e-07	-0.14	-0.16	Optic disc area;	chr4:114491625	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7671026	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114487736	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs10031142	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114488433	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs17678686	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114489100	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs28766989	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114489752	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs11722125	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114490374	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs11722162	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114490460	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.668	rs11722201	MIMAT0003242	hsa-miR-577	-5.18	2.71e-07	-0.14	-0.16	Optic disc area;	chr4:114490577	chr4:114656774~114656794:+
BRCA	cis	rs10021731	1	rs13104222	MIMAT0003242	hsa-miR-577	5.18	2.71e-07	0.14	0.16	Optic disc area;	chr4:114549757	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-5.18	2.73e-07	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
BRCA	cis	rs4921799	0.662	rs7465342	MIMAT0015020	hsa-miR-548v	5.17	2.78e-07	0.2	0.16	Lung cancer;Adenocarcinoma;	chr8:17679039	chr8:17681588~17681609:-
BRCA	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	5.17	2.82e-07	0.28	0.16	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
BRCA	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	5.17	2.86e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
BRCA	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-5.17	2.86e-07	-0.19	-0.16	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
BRCA	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-5.17	2.86e-07	-0.19	-0.16	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
BRCA	cis	rs79387448	0.638	rs7600961	MIMAT0019926	hsa-miR-4772-5p	-5.17	2.87e-07	-0.23	-0.16	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432300~102432321:+
BRCA	cis	rs6681460	0.674	rs7543607	MIMAT0014979	hsa-miR-3117-3p	-5.16	2.94e-07	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66546909	chr1:66628485~66628505:+
BRCA	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-5.16	2.94e-07	-0.09	-0.16	Migraine;	chr10:103305652	chr10:103394341~103394361:-
BRCA	cis	rs7594645	1	rs73070048	MIMAT0014995	hsa-miR-3130-5p	5.16	2.96e-07	0.29	0.16	Episodic memory;	chr2:206776670	chr2:206783276~206783296:-
BRCA	cis	rs7594645	1	rs73070048	MIMAT0014995_1	hsa-miR-3130-5p	5.16	2.96e-07	0.29	0.16	Episodic memory;	chr2:206776670	chr2:206783246~206783266:+
BRCA	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-5.16	3.03e-07	-0.19	-0.16	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
BRCA	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	5.15	3.04e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
BRCA	cis	rs7829975	0.688	rs6995407	MIMAT0019728	hsa-miR-4660	5.15	3.08e-07	0.19	0.16	Mood instability;	chr8:8527137	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.666	rs11189592	MIMAT0026738	hsa-miR-1287-3p	5.15	3.14e-07	0.14	0.16	Metabolite levels;	chr10:98395885	chr10:98395232~98395253:-
BRCA	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-5.14	3.22e-07	-0.09	-0.16	Migraine;	chr10:103299551	chr10:103394341~103394361:-
BRCA	cis	rs79387448	0.638	rs11465670	MIMAT0019926	hsa-miR-4772-5p	-5.14	3.23e-07	-0.23	-0.16	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432300~102432321:+
BRCA	cis	rs10021731	0.668	rs7698363	MIMAT0003242	hsa-miR-577	-5.14	3.26e-07	-0.14	-0.16	Optic disc area;	chr4:114492418	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.645	rs7698524	MIMAT0003242	hsa-miR-577	-5.14	3.28e-07	-0.14	-0.16	Optic disc area;	chr4:114492417	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs4409025	MIMAT0003242	hsa-miR-577	-5.14	3.32e-07	-0.14	-0.16	Optic disc area;	chr4:114511785	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs4409026	MIMAT0003242	hsa-miR-577	-5.14	3.32e-07	-0.14	-0.16	Optic disc area;	chr4:114511787	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.668	rs66482879	MIMAT0003242	hsa-miR-577	-5.13	3.4e-07	-0.14	-0.16	Optic disc area;	chr4:114517522	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs28657376	MIMAT0003242	hsa-miR-577	-5.13	3.4e-07	-0.14	-0.16	Optic disc area;	chr4:114517650	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs4409027	MIMAT0003242	hsa-miR-577	-5.13	3.44e-07	-0.14	-0.16	Optic disc area;	chr4:114511985	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs4413472	MIMAT0003242	hsa-miR-577	-5.13	3.44e-07	-0.14	-0.16	Optic disc area;	chr4:114512090	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs11936113	MIMAT0003242	hsa-miR-577	-5.13	3.44e-07	-0.14	-0.16	Optic disc area;	chr4:114512224	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs2199314	MIMAT0003242	hsa-miR-577	-5.13	3.44e-07	-0.14	-0.16	Optic disc area;	chr4:114513555	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs993460	MIMAT0003242	hsa-miR-577	-5.13	3.44e-07	-0.14	-0.16	Optic disc area;	chr4:114510521	chr4:114656774~114656794:+
BRCA	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	5.13	3.46e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
BRCA	cis	rs7826238	0.539	rs2945891	MIMAT0019728	hsa-miR-4660	5.13	3.48e-07	0.19	0.16	Systolic blood pressure;	chr8:8297953	chr8:9048453~9048475:+
BRCA	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	5.13	3.49e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.631	rs11098253	MIMAT0003242	hsa-miR-577	-5.13	3.49e-07	-0.14	-0.16	Optic disc area;	chr4:114527990	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs4295329	MIMAT0003242	hsa-miR-577	-5.12	3.58e-07	-0.14	-0.16	Optic disc area;	chr4:114511945	chr4:114656774~114656794:+
BRCA	cis	rs7594645	0.59	rs2359724	MIMAT0014995	hsa-miR-3130-5p	-5.12	3.58e-07	-0.27	-0.16	Episodic memory;	chr2:206750798	chr2:206783276~206783296:-
BRCA	cis	rs7594645	0.59	rs2359724	MIMAT0014995_1	hsa-miR-3130-5p	-5.12	3.58e-07	-0.27	-0.16	Episodic memory;	chr2:206750798	chr2:206783246~206783266:+
BRCA	cis	rs189798	0.592	rs10111263	MIMAT0019728	hsa-miR-4660	-5.12	3.59e-07	-0.21	-0.16	Myopia (pathological);	chr8:9111923	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.693	rs7686100	MIMAT0003242	hsa-miR-577	-5.12	3.59e-07	-0.14	-0.16	Optic disc area;	chr4:114511670	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs11936150	MIMAT0003242	hsa-miR-577	-5.12	3.65e-07	-0.14	-0.16	Optic disc area;	chr4:114512391	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.881	rs755126	MIMAT0005878	hsa-miR-1287-5p	5.11	3.78e-07	0.16	0.16	Metabolite levels;	chr10:98389194	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.881	rs7916469	MIMAT0005878	hsa-miR-1287-5p	5.11	3.79e-07	0.16	0.16	Metabolite levels;	chr10:98388896	chr10:98395271~98395292:-
BRCA	cis	rs7829975	0.742	rs1533059	MIMAT0019728	hsa-miR-4660	-5.11	3.86e-07	-0.19	-0.16	Mood instability;	chr8:8827443	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.718	rs28736894	MIMAT0003242	hsa-miR-577	-5.11	3.87e-07	-0.14	-0.16	Optic disc area;	chr4:114514184	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs17622270	MIMAT0003242	hsa-miR-577	-5.11	3.87e-07	-0.14	-0.16	Optic disc area;	chr4:114514205	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.687	rs10883085	MIMAT0005878	hsa-miR-1287-5p	5.11	3.89e-07	0.16	0.16	Metabolite levels;	chr10:98395856	chr10:98395271~98395292:-
BRCA	cis	rs10021731	0.668	rs12512563	MIMAT0003242	hsa-miR-577	-5.11	3.9e-07	-0.14	-0.16	Optic disc area;	chr4:114493973	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.6	rs12504927	MIMAT0003242	hsa-miR-577	-5.11	3.9e-07	-0.14	-0.16	Optic disc area;	chr4:114493975	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.645	rs13147121	MIMAT0003242	hsa-miR-577	-5.11	3.9e-07	-0.14	-0.16	Optic disc area;	chr4:114493994	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.668	rs7684322	MIMAT0003242	hsa-miR-577	-5.1	3.97e-07	-0.14	-0.16	Optic disc area;	chr4:114519788	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs12108520	MIMAT0003242	hsa-miR-577	-5.1	3.97e-07	-0.14	-0.16	Optic disc area;	chr4:114522087	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-5.1	3.98e-07	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
BRCA	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-5.1	3.99e-07	-0.18	-0.16	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
BRCA	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-5.1	4.01e-07	-0.18	-0.16	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.744	rs6814022	MIMAT0003242	hsa-miR-577	-5.1	4.05e-07	-0.14	-0.16	Optic disc area;	chr4:114528667	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-5.1	4.11e-07	-0.09	-0.16	Migraine;	chr10:103307280	chr10:103394341~103394361:-
BRCA	cis	rs7072216	0.881	rs2147895	MIMAT0005878	hsa-miR-1287-5p	5.1	4.14e-07	0.16	0.16	Metabolite levels;	chr10:98388551	chr10:98395271~98395292:-
BRCA	cis	rs2948294	0.588	rs4840913	MIMAT0019728	hsa-miR-4660	5.09	4.17e-07	0.21	0.16	Red cell distribution width;	chr8:8259384	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.718	rs13104081	MIMAT0003242	hsa-miR-577	-5.09	4.21e-07	-0.14	-0.16	Optic disc area;	chr4:114532641	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	5.09	4.22e-07	0.18	0.16	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs13117126	MIMAT0003242	hsa-miR-577	-5.09	4.24e-07	-0.13	-0.16	Optic disc area;	chr4:114526758	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-5.09	4.36e-07	-0.09	-0.16	Migraine;	chr10:103317367	chr10:103394341~103394361:-
BRCA	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-5.09	4.36e-07	-0.09	-0.16	Migraine;	chr10:103319682	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.692	rs28361366	MIMAT0003242	hsa-miR-577	-5.08	4.37e-07	-0.14	-0.16	Optic disc area;	chr4:114512809	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs28656197	MIMAT0003242	hsa-miR-577	-5.08	4.37e-07	-0.14	-0.16	Optic disc area;	chr4:114512821	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.922	rs7097824	MIMAT0005878	hsa-miR-1287-5p	5.08	4.41e-07	0.16	0.16	Metabolite levels;	chr10:98392042	chr10:98395271~98395292:-
BRCA	cis	rs10021731	0.692	rs7662125	MIMAT0003242	hsa-miR-577	-5.08	4.41e-07	-0.14	-0.16	Optic disc area;	chr4:114495706	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs2054303	MIMAT0003242	hsa-miR-577	-5.08	4.41e-07	-0.14	-0.16	Optic disc area;	chr4:114495803	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13102706	MIMAT0003242	hsa-miR-577	-5.08	4.41e-07	-0.14	-0.16	Optic disc area;	chr4:114492998	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13102910	MIMAT0003242	hsa-miR-577	-5.08	4.41e-07	-0.14	-0.16	Optic disc area;	chr4:114493049	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13127839	MIMAT0003242	hsa-miR-577	-5.08	4.41e-07	-0.14	-0.16	Optic disc area;	chr4:114493059	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.881	rs6584192	MIMAT0005878	hsa-miR-1287-5p	5.08	4.42e-07	0.16	0.16	Metabolite levels;	chr10:98392616	chr10:98395271~98395292:-
BRCA	cis	rs10021731	0.718	rs10857032	MIMAT0003242	hsa-miR-577	-5.08	4.46e-07	-0.13	-0.16	Optic disc area;	chr4:114527831	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs7690858	MIMAT0003242	hsa-miR-577	-5.07	4.65e-07	-0.14	-0.16	Optic disc area;	chr4:114511804	chr4:114656774~114656794:+
BRCA	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	5.07	4.73e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.881	rs1079179	MIMAT0005878	hsa-miR-1287-5p	5.06	4.91e-07	0.16	0.16	Metabolite levels;	chr10:98389589	chr10:98395271~98395292:-
BRCA	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	5.06	4.93e-07	0.17	0.16	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.881	rs10883084	MIMAT0005878	hsa-miR-1287-5p	5.06	4.94e-07	0.16	0.16	Metabolite levels;	chr10:98391432	chr10:98395271~98395292:-
BRCA	cis	rs9527	0.518	rs11191487	MIMAT0005951	hsa-miR-1307-3p	5.05	5.13e-07	0.14	0.16	Arsenic metabolism;	chr10:102974866	chr10:103394301~103394322:-
BRCA	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-5.05	5.16e-07	-0.19	-0.16	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
BRCA	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-5.05	5.16e-07	-0.19	-0.16	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
BRCA	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	5.05	5.24e-07	0.09	0.16	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.649	rs6691033	MIMAT0014979	hsa-miR-3117-3p	-5.04	5.36e-07	-0.19	-0.15	Presence of antiphospholipid antibodies;	chr1:66541746	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.692	rs13103833	MIMAT0003242	hsa-miR-577	-5.04	5.41e-07	-0.13	-0.15	Optic disc area;	chr4:114495414	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.881	rs2182168	MIMAT0005878	hsa-miR-1287-5p	5.04	5.42e-07	0.16	0.15	Metabolite levels;	chr10:98388596	chr10:98395271~98395292:-
BRCA	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	5.04	5.42e-07	0.09	0.15	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.668	rs55968476	MIMAT0003242	hsa-miR-577	-5.04	5.45e-07	-0.14	-0.15	Optic disc area;	chr4:114532478	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.668	rs1599322	MIMAT0003242	hsa-miR-577	-5.04	5.49e-07	-0.14	-0.15	Optic disc area;	chr4:114531895	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs2035059	MIMAT0003242	hsa-miR-577	-5.04	5.53e-07	-0.13	-0.15	Optic disc area;	chr4:114496530	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs2054306	MIMAT0003242	hsa-miR-577	-5.04	5.57e-07	-0.13	-0.15	Optic disc area;	chr4:114496204	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-5.04	5.59e-07	-0.09	-0.15	Migraine;	chr10:103309363	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.521	rs116635794	MIMAT0003242	hsa-miR-577	-5.03	5.66e-07	-0.14	-0.15	Optic disc area;	chr4:114520865	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.806	rs2428	MIMAT0019728	hsa-miR-4660	5.03	5.73e-07	0.18	0.15	Mood instability;	chr8:8783635	chr8:9048453~9048475:+
BRCA	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	5.02	5.94e-07	0.09	0.15	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.668	rs13103537	MIMAT0003242	hsa-miR-577	-5.02	5.94e-07	-0.14	-0.15	Optic disc area;	chr4:114495092	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs4833458	MIMAT0003242	hsa-miR-577	-5.02	5.97e-07	-0.13	-0.15	Optic disc area;	chr4:114493571	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs4833459	MIMAT0003242	hsa-miR-577	-5.02	5.97e-07	-0.13	-0.15	Optic disc area;	chr4:114493734	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs12501292	MIMAT0003242	hsa-miR-577	-5.02	5.97e-07	-0.13	-0.15	Optic disc area;	chr4:114493876	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.622	rs12711027	MIMAT0003242	hsa-miR-577	-5.02	5.97e-07	-0.13	-0.15	Optic disc area;	chr4:114494204	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13103158	MIMAT0003242	hsa-miR-577	-5.02	5.98e-07	-0.13	-0.15	Optic disc area;	chr4:114493188	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs13127680	MIMAT0003242	hsa-miR-577	-5.02	5.98e-07	-0.13	-0.15	Optic disc area;	chr4:114493217	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.693	rs4834415	MIMAT0003242	hsa-miR-577	-5.02	5.98e-07	-0.13	-0.15	Optic disc area;	chr4:114493245	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs13104693	MIMAT0003242	hsa-miR-577	-5.02	5.99e-07	-0.13	-0.15	Optic disc area;	chr4:114495600	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs13104685	MIMAT0003242	hsa-miR-577	-5.02	6.01e-07	-0.13	-0.15	Optic disc area;	chr4:114495590	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs13148430	MIMAT0003242	hsa-miR-577	-5.02	6.03e-07	-0.13	-0.15	Optic disc area;	chr4:114494469	chr4:114656774~114656794:+
BRCA	cis	rs2980439	0.818	rs2948294	MIMAT0019728	hsa-miR-4660	5.02	6.05e-07	0.19	0.15	Neuroticism;	chr8:8237439	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.692	rs13147488	MIMAT0003242	hsa-miR-577	-5.02	6.11e-07	-0.13	-0.15	Optic disc area;	chr4:114494051	chr4:114656774~114656794:+
BRCA	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	5.02	6.15e-07	0.09	0.15	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-5.02	6.2e-07	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-5.01	6.43e-07	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.693	rs114243292	MIMAT0003242	hsa-miR-577	-5	6.56e-07	-0.13	-0.15	Optic disc area;	chr4:114516751	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.742	rs12547493	MIMAT0019728	hsa-miR-4660	-5	6.58e-07	-0.19	-0.15	Mood instability;	chr8:8804024	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.692	rs6840798	MIMAT0003242	hsa-miR-577	-5	6.82e-07	-0.13	-0.15	Optic disc area;	chr4:114495078	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs6817762	MIMAT0003242	hsa-miR-577	-5	6.82e-07	-0.13	-0.15	Optic disc area;	chr4:114495098	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.644	rs7665675	MIMAT0003242	hsa-miR-577	-4.99	6.98e-07	-0.13	-0.15	Optic disc area;	chr4:114480704	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7692571	MIMAT0003242	hsa-miR-577	-4.99	6.98e-07	-0.13	-0.15	Optic disc area;	chr4:114480792	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-4.99	7e-07	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs13104656	MIMAT0003242	hsa-miR-577	-4.99	7.01e-07	-0.13	-0.15	Optic disc area;	chr4:114495547	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.687	rs4551689	MIMAT0005878	hsa-miR-1287-5p	-4.99	7.09e-07	-0.16	-0.15	Metabolite levels;	chr10:98397836	chr10:98395271~98395292:-
BRCA	cis	rs10021731	0.668	rs62309894	MIMAT0003242	hsa-miR-577	-4.99	7.18e-07	-0.14	-0.15	Optic disc area;	chr4:114504575	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.706	rs1380931	MIMAT0003242	hsa-miR-577	-4.99	7.18e-07	-0.14	-0.15	Optic disc area;	chr4:114506853	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs11724674	MIMAT0003242	hsa-miR-577	-4.99	7.24e-07	-0.13	-0.15	Optic disc area;	chr4:114482175	chr4:114656774~114656794:+
BRCA	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	4.98	7.29e-07	0.09	0.15	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
BRCA	cis	rs189798	0.807	rs9949	MIMAT0019728	hsa-miR-4660	4.98	7.3e-07	0.22	0.15	Myopia (pathological);	chr8:9137002	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.518	rs7899608	MIMAT0005951	hsa-miR-1307-3p	4.98	7.37e-07	0.13	0.15	Arsenic metabolism;	chr10:102967547	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.518	rs12771834	MIMAT0005951	hsa-miR-1307-3p	4.98	7.55e-07	0.13	0.15	Arsenic metabolism;	chr10:102895662	chr10:103394301~103394322:-
BRCA	cis	rs4921799	0.711	rs2269698	MIMAT0015020	hsa-miR-548v	4.98	7.58e-07	0.18	0.15	Lung cancer;Adenocarcinoma;	chr8:17675064	chr8:17681588~17681609:-
BRCA	cis	rs10021731	0.668	rs2199313	MIMAT0003242	hsa-miR-577	-4.96	8.07e-07	-0.14	-0.15	Optic disc area;	chr4:114513488	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-4.96	8.11e-07	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
BRCA	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	4.96	8.33e-07	0.09	0.15	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.634	rs994396	MIMAT0014979	hsa-miR-3117-3p	-4.95	8.59e-07	-0.19	-0.15	Presence of antiphospholipid antibodies;	chr1:66546553	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.674	rs4134135	MIMAT0014979	hsa-miR-3117-3p	-4.95	8.59e-07	-0.19	-0.15	Presence of antiphospholipid antibodies;	chr1:66547045	chr1:66628485~66628505:+
BRCA	cis	rs7826238	0.72	rs12546760	MIMAT0019728	hsa-miR-4660	-4.95	8.67e-07	-0.18	-0.15	Systolic blood pressure;	chr8:8517326	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.881	rs2182169	MIMAT0005878	hsa-miR-1287-5p	4.95	8.68e-07	0.16	0.15	Metabolite levels;	chr10:98388247	chr10:98395271~98395292:-
BRCA	cis	rs6681460	1	rs1562217	MIMAT0014979	hsa-miR-3117-3p	4.95	8.72e-07	0.17	0.15	Presence of antiphospholipid antibodies;	chr1:66607883	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-4.94	8.89e-07	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
BRCA	cis	rs453301	0.686	rs3989373	MIMAT0019728	hsa-miR-4660	-4.94	9.06e-07	-0.18	-0.15	Joint mobility (Beighton score);	chr8:9053798	chr8:9048453~9048475:+
BRCA	cis	rs754133	0.507	rs10876531	MIMAT0004562	hsa-miR-196a-3p	-4.94	9.15e-07	-0.19	-0.15	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54049934	chr12:53991799~53991820:+
BRCA	cis	rs6681460	0.649	rs967325	MIMAT0014979	hsa-miR-3117-3p	-4.93	9.46e-07	-0.19	-0.15	Presence of antiphospholipid antibodies;	chr1:66538039	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.634	rs4142763	MIMAT0014979	hsa-miR-3117-3p	-4.93	9.56e-07	-0.19	-0.15	Presence of antiphospholipid antibodies;	chr1:66532353	chr1:66628485~66628505:+
BRCA	cis	rs10021731	1	rs11098258	MIMAT0003242	hsa-miR-577	4.93	9.75e-07	0.13	0.15	Optic disc area;	chr4:114564528	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-4.92	1e-06	-0.09	-0.15	Migraine;	chr10:103297804	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.692	rs13105714	MIMAT0003242	hsa-miR-577	-4.92	1.01e-06	-0.13	-0.15	Optic disc area;	chr4:114511171	chr4:114656774~114656794:+
BRCA	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	4.91	1.04e-06	0.09	0.15	Migraine;	chr10:103242040	chr10:103394341~103394361:-
BRCA	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-4.91	1.06e-06	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.667	rs1877119	MIMAT0019728	hsa-miR-4660	4.91	1.06e-06	0.18	0.15	Mood instability;	chr8:8849687	chr8:9048453~9048475:+
BRCA	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	4.9	1.09e-06	0.09	0.15	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.718	rs10002657	MIMAT0003242	hsa-miR-577	-4.9	1.1e-06	-0.13	-0.15	Optic disc area;	chr4:114483120	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.582	rs6982832	MIMAT0019728	hsa-miR-4660	-4.9	1.12e-06	-0.18	-0.15	Mood instability;	chr8:8934707	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.718	rs2054305	MIMAT0003242	hsa-miR-577	-4.89	1.15e-06	-0.13	-0.15	Optic disc area;	chr4:114496175	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7686774	MIMAT0003242	hsa-miR-577	-4.89	1.16e-06	-0.13	-0.15	Optic disc area;	chr4:114480357	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7687413	MIMAT0003242	hsa-miR-577	-4.89	1.16e-06	-0.13	-0.15	Optic disc area;	chr4:114480417	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-4.89	1.17e-06	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.659	rs4382480	MIMAT0019728	hsa-miR-4660	4.89	1.17e-06	0.18	0.15	Mood instability;	chr8:8863963	chr8:9048453~9048475:+
BRCA	cis	rs10021731	1	rs6533801	MIMAT0003242	hsa-miR-577	4.88	1.22e-06	0.13	0.15	Optic disc area;	chr4:114553199	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-4.87	1.27e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.582	rs6983150	MIMAT0019728	hsa-miR-4660	-4.87	1.28e-06	-0.18	-0.15	Mood instability;	chr8:8934916	chr8:9048453~9048475:+
BRCA	cis	rs7829975	0.686	rs907180	MIMAT0019728	hsa-miR-4660	4.87	1.28e-06	0.17	0.15	Mood instability;	chr8:8845317	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.718	rs6839599	MIMAT0003242	hsa-miR-577	-4.87	1.28e-06	-0.13	-0.15	Optic disc area;	chr4:114494754	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7689158	MIMAT0003242	hsa-miR-577	-4.87	1.28e-06	-0.13	-0.15	Optic disc area;	chr4:114495770	chr4:114656774~114656794:+
BRCA	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-4.87	1.29e-06	-0.18	-0.15	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
BRCA	cis	rs10021731	0.718	rs2054304	MIMAT0003242	hsa-miR-577	-4.86	1.33e-06	-0.13	-0.15	Optic disc area;	chr4:114495902	chr4:114656774~114656794:+
BRCA	cis	rs10021731	1	rs1599323	MIMAT0003242	hsa-miR-577	4.86	1.34e-06	0.13	0.15	Optic disc area;	chr4:114549176	chr4:114656774~114656794:+
BRCA	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-4.86	1.35e-06	-0.18	-0.15	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
BRCA	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-4.86	1.35e-06	-0.18	-0.15	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
BRCA	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-4.86	1.35e-06	-0.18	-0.15	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
BRCA	cis	rs10021731	0.668	rs13112732	MIMAT0003242	hsa-miR-577	-4.86	1.35e-06	-0.13	-0.15	Optic disc area;	chr4:114483845	chr4:114656774~114656794:+
BRCA	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-4.86	1.36e-06	-0.18	-0.15	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
BRCA	cis	rs75358501	0.551	rs10171736	MIMAT0014995	hsa-miR-3130-5p	-4.86	1.39e-06	-0.18	-0.15	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783276~206783296:-
BRCA	cis	rs75358501	0.551	rs10171736	MIMAT0014995_1	hsa-miR-3130-5p	-4.86	1.39e-06	-0.18	-0.15	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783246~206783266:+
BRCA	cis	rs17710780	0.803	rs10515631	MIMAT0000732	hsa-miR-378a-3p	-4.85	1.4e-06	-0.18	-0.15	Major depressive disorder;	chr5:149723097	chr5:149732867~149732888:+
BRCA	cis	rs6681460	0.966	rs7542924	MIMAT0014979	hsa-miR-3117-3p	-4.85	1.44e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66677372	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs1460779	MIMAT0003242	hsa-miR-577	4.84	1.47e-06	0.13	0.15	Optic disc area;	chr4:114528894	chr4:114656774~114656794:+
BRCA	cis	rs7594645	0.59	rs73068058	MIMAT0014995	hsa-miR-3130-5p	4.84	1.47e-06	0.27	0.15	Episodic memory;	chr2:206752613	chr2:206783276~206783296:-
BRCA	cis	rs7594645	0.59	rs73068058	MIMAT0014995_1	hsa-miR-3130-5p	4.84	1.47e-06	0.27	0.15	Episodic memory;	chr2:206752613	chr2:206783246~206783266:+
BRCA	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-4.84	1.49e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.623	rs10087493	MIMAT0019728	hsa-miR-4660	-4.84	1.49e-06	-0.18	-0.15	Mood instability;	chr8:8516047	chr8:9048453~9048475:+
BRCA	cis	rs10021731	1	rs4834419	MIMAT0003242	hsa-miR-577	4.84	1.5e-06	0.13	0.15	Optic disc area;	chr4:114548870	chr4:114656774~114656794:+
BRCA	cis	rs9527	0.518	rs12776863	MIMAT0005951	hsa-miR-1307-3p	4.83	1.57e-06	0.13	0.15	Arsenic metabolism;	chr10:102881922	chr10:103394301~103394322:-
BRCA	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-4.83	1.58e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs11724670	MIMAT0003242	hsa-miR-577	-4.82	1.67e-06	-0.13	-0.15	Optic disc area;	chr4:114482122	chr4:114656774~114656794:+
BRCA	cis	rs7826238	0.623	rs2976893	MIMAT0019728	hsa-miR-4660	-4.82	1.68e-06	-0.18	-0.15	Systolic blood pressure;	chr8:8480709	chr8:9048453~9048475:+
BRCA	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-4.81	1.69e-06	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
BRCA	cis	rs17710780	1	rs17710855	MIMAT0000732	hsa-miR-378a-3p	-4.81	1.7e-06	-0.2	-0.15	Major depressive disorder;	chr5:149686294	chr5:149732867~149732888:+
BRCA	cis	rs10021731	0.668	rs2199311	MIMAT0003242	hsa-miR-577	-4.8	1.81e-06	-0.13	-0.15	Optic disc area;	chr4:114492288	chr4:114656774~114656794:+
BRCA	cis	rs453301	0.686	rs13252797	MIMAT0019728	hsa-miR-4660	4.8	1.86e-06	0.18	0.15	Joint mobility (Beighton score);	chr8:9003920	chr8:9048453~9048475:+
BRCA	cis	rs1867631	0.585	rs12062570	MIMAT0014979	hsa-miR-3117-3p	-4.78	2e-06	-0.16	-0.15	Menopause (age at onset);	chr1:66620602	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-4.78	2.02e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs62309866	MIMAT0003242	hsa-miR-577	-4.78	2.03e-06	-0.13	-0.15	Optic disc area;	chr4:114479583	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.718	rs7685549	MIMAT0003242	hsa-miR-577	-4.78	2.03e-06	-0.13	-0.15	Optic disc area;	chr4:114479772	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.793	rs12650568	MIMAT0003242	hsa-miR-577	4.78	2.04e-06	0.14	0.15	Optic disc area;	chr4:114578461	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-4.78	2.05e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs6710528	MIMAT0019927	hsa-miR-4772-3p	4.77	2.06e-06	0.12	0.15	Asthma;	chr2:102399682	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.649	rs1415984	MIMAT0014979	hsa-miR-3117-3p	-4.77	2.07e-06	-0.18	-0.15	Presence of antiphospholipid antibodies;	chr1:66536434	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.606	rs891570	MIMAT0019728	hsa-miR-4660	-4.77	2.11e-06	-0.18	-0.15	Mood instability;	chr8:8936944	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.666	rs2274248	MIMAT0026738	hsa-miR-1287-3p	4.77	2.13e-06	0.13	0.15	Metabolite levels;	chr10:98388785	chr10:98395232~98395253:-
BRCA	cis	rs10021731	1	rs10021731	MIMAT0003242	hsa-miR-577	4.77	2.14e-06	0.13	0.15	Optic disc area;	chr4:114560759	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-4.77	2.15e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs1585446	MIMAT0003242	hsa-miR-577	-4.76	2.17e-06	-0.13	-0.15	Optic disc area;	chr4:114490871	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.692	rs1599316	MIMAT0003242	hsa-miR-577	-4.76	2.2e-06	-0.13	-0.15	Optic disc area;	chr4:114490702	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-4.76	2.22e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.692	rs62309904	MIMAT0003242	hsa-miR-577	-4.76	2.25e-06	-0.13	-0.15	Optic disc area;	chr4:114514011	chr4:114656774~114656794:+
BRCA	cis	rs17710780	0.803	rs11749341	MIMAT0000732	hsa-miR-378a-3p	-4.75	2.37e-06	-0.18	-0.15	Major depressive disorder;	chr5:149723346	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs62382267	MIMAT0000732	hsa-miR-378a-3p	-4.75	2.37e-06	-0.18	-0.15	Major depressive disorder;	chr5:149723764	chr5:149732867~149732888:+
BRCA	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-4.74	2.49e-06	-0.17	-0.15	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.718	rs12505597	MIMAT0003242	hsa-miR-577	-4.73	2.52e-06	-0.13	-0.15	Optic disc area;	chr4:114527954	chr4:114656774~114656794:+
BRCA	cis	rs7461897	0.511	rs1383916	MIMAT0027587	hsa-miR-6842-3p	4.73	2.52e-06	0.23	0.15	Epilepsy and lamotrigine-induced maculopapular eruptions;	chr8:26967728	chr8:27433413~27433434:+
BRCA	cis	rs10021731	0.692	rs10021252	MIMAT0003242	hsa-miR-577	-4.72	2.66e-06	-0.13	-0.15	Optic disc area;	chr4:114515190	chr4:114656774~114656794:+
BRCA	cis	rs17710780	0.803	rs72828357	MIMAT0000732	hsa-miR-378a-3p	-4.71	2.77e-06	-0.18	-0.15	Major depressive disorder;	chr5:149693110	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs1001778	MIMAT0000732	hsa-miR-378a-3p	-4.71	2.84e-06	-0.18	-0.14	Major depressive disorder;	chr5:149695209	chr5:149732867~149732888:+
BRCA	cis	rs10021731	0.692	rs12108281	MIMAT0003242	hsa-miR-577	-4.7	3e-06	-0.13	-0.14	Optic disc area;	chr4:114522147	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.881	rs7082192	MIMAT0005878	hsa-miR-1287-5p	4.7	3e-06	0.15	0.14	Metabolite levels;	chr10:98392087	chr10:98395271~98395292:-
BRCA	cis	rs9527	0.518	rs10883802	MIMAT0005951	hsa-miR-1307-3p	-4.69	3.04e-06	-0.12	-0.14	Arsenic metabolism;	chr10:102920605	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.718	rs13127822	MIMAT0003242	hsa-miR-577	-4.69	3.06e-06	-0.13	-0.14	Optic disc area;	chr4:114493024	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.606	rs6422352	MIMAT0019728	hsa-miR-4660	-4.68	3.2e-06	-0.17	-0.14	Mood instability;	chr8:8936683	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.649	rs1415974	MIMAT0014979	hsa-miR-3117-3p	4.68	3.32e-06	0.17	0.14	Presence of antiphospholipid antibodies;	chr1:66539820	chr1:66628485~66628505:+
BRCA	cis	rs17710780	0.803	rs1001779	MIMAT0000732	hsa-miR-378a-3p	-4.68	3.32e-06	-0.18	-0.14	Major depressive disorder;	chr5:149695294	chr5:149732867~149732888:+
BRCA	cis	rs615632	0.53	rs10092464	MIMAT0019728	hsa-miR-4660	-4.67	3.36e-06	-0.19	-0.14	Neuroticism;	chr8:9946675	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs17654872	MIMAT0000732	hsa-miR-378a-3p	-4.67	3.38e-06	-0.18	-0.14	Major depressive disorder;	chr5:149735588	chr5:149732867~149732888:+
BRCA	cis	rs10021731	0.668	rs28651771	MIMAT0003242	hsa-miR-577	-4.66	3.51e-06	-0.13	-0.14	Optic disc area;	chr4:114501291	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.634	rs12143964	MIMAT0014979	hsa-miR-3117-3p	-4.66	3.55e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66544583	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.502	rs7820738	MIMAT0019728	hsa-miR-4660	-4.66	3.64e-06	-0.17	-0.14	Mood instability;	chr8:8845097	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.881	rs2147897	MIMAT0005878	hsa-miR-1287-5p	-4.66	3.66e-06	-0.15	-0.14	Metabolite levels;	chr10:98388056	chr10:98395271~98395292:-
BRCA	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-4.65	3.67e-06	-0.16	-0.14	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-4.65	3.67e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.668	rs1599317	MIMAT0003242	hsa-miR-577	-4.64	3.85e-06	-0.12	-0.14	Optic disc area;	chr4:114503010	chr4:114656774~114656794:+
BRCA	cis	rs7072216	0.687	rs10786417	MIMAT0005878	hsa-miR-1287-5p	4.64	3.89e-06	0.15	0.14	Metabolite levels;	chr10:98394147	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.687	rs11597425	MIMAT0005878	hsa-miR-1287-5p	4.64	3.89e-06	0.15	0.14	Metabolite levels;	chr10:98394445	chr10:98395271~98395292:-
BRCA	cis	rs4921799	0.662	rs13262658	MIMAT0015020	hsa-miR-548v	4.64	4.01e-06	0.17	0.14	Lung cancer;Adenocarcinoma;	chr8:17666270	chr8:17681588~17681609:-
BRCA	cis	rs7072216	0.881	rs4345897	MIMAT0005878	hsa-miR-1287-5p	4.63	4.09e-06	0.15	0.14	Metabolite levels;	chr10:98387303	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.687	rs7924303	MIMAT0005878	hsa-miR-1287-5p	-4.63	4.15e-06	-0.15	-0.14	Metabolite levels;	chr10:98396206	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.687	rs11597428	MIMAT0005878	hsa-miR-1287-5p	4.63	4.19e-06	0.15	0.14	Metabolite levels;	chr10:98394490	chr10:98395271~98395292:-
BRCA	cis	rs10021731	0.83	rs17622401	MIMAT0003242	hsa-miR-577	4.62	4.23e-06	0.13	0.14	Optic disc area;	chr4:114571551	chr4:114656774~114656794:+
BRCA	cis	rs1884537	1	rs1884537	MIMAT0003332	hsa-miR-656-3p	-4.62	4.26e-06	-0.15	-0.14	Optic nerve measurement (disc area);	chr14:100785652	chr14:101066766~101066786:+
BRCA	cis	rs10021731	0.798	rs34581144	MIMAT0003242	hsa-miR-577	4.62	4.27e-06	0.13	0.14	Optic disc area;	chr4:114583571	chr4:114656774~114656794:+
BRCA	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	4.62	4.32e-06	0.16	0.14	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-4.62	4.37e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
BRCA	cis	rs9527	0.545	rs35756290	MIMAT0005951	hsa-miR-1307-3p	4.62	4.42e-06	0.1	0.14	Arsenic metabolism;	chr10:102825815	chr10:103394301~103394322:-
BRCA	cis	rs17710780	0.57	rs7379457	MIMAT0000732	hsa-miR-378a-3p	-4.61	4.45e-06	-0.18	-0.14	Major depressive disorder;	chr5:149729316	chr5:149732867~149732888:+
BRCA	cis	rs10021731	0.83	rs4834421	MIMAT0003242	hsa-miR-577	4.61	4.48e-06	0.13	0.14	Optic disc area;	chr4:114572686	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-4.61	4.5e-06	-0.16	-0.14	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
BRCA	cis	rs7829975	0.617	rs4841072	MIMAT0019728	hsa-miR-4660	-4.61	4.53e-06	-0.17	-0.14	Mood instability;	chr8:8933743	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.83	rs1460785	MIMAT0003242	hsa-miR-577	4.6	4.7e-06	0.13	0.14	Optic disc area;	chr4:114545757	chr4:114656774~114656794:+
BRCA	cis	rs9807989	0.729	rs10170583	MIMAT0019927	hsa-miR-4772-3p	-4.6	4.76e-06	-0.12	-0.14	Asthma;	chr2:102358304	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	4.6	4.78e-06	0.12	0.14	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
BRCA	cis	rs7829975	0.617	rs4841071	MIMAT0019728	hsa-miR-4660	4.6	4.8e-06	0.17	0.14	Mood instability;	chr8:8933634	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-4.6	4.82e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.649	rs7540195	MIMAT0014979	hsa-miR-3117-3p	4.6	4.86e-06	0.17	0.14	Presence of antiphospholipid antibodies;	chr1:66536723	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-4.59	4.95e-06	-0.11	-0.14	Asthma;	chr2:102402540	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-4.59	4.95e-06	-0.11	-0.14	Asthma;	chr2:102402571	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs1420105	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.02e-06	-0.11	-0.14	Asthma;	chr2:102418659	chr2:102432336~102432357:+
BRCA	cis	rs7829975	0.522	rs6601689	MIMAT0019728	hsa-miR-4660	4.58	5.25e-06	0.17	0.14	Mood instability;	chr8:8314761	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.668	rs7676684	MIMAT0003242	hsa-miR-577	4.58	5.25e-06	0.12	0.14	Optic disc area;	chr4:114492371	chr4:114656774~114656794:+
BRCA	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-4.57	5.34e-06	-0.11	-0.14	Asthma;	chr2:102431747	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-4.57	5.34e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-4.57	5.34e-06	-0.11	-0.14	Asthma;	chr2:102432120	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-4.57	5.34e-06	-0.11	-0.14	Asthma;	chr2:102432614	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-4.57	5.34e-06	-0.11	-0.14	Asthma;	chr2:102433405	chr2:102432336~102432357:+
BRCA	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-4.57	5.39e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-4.57	5.39e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.922	rs2296438	MIMAT0005878	hsa-miR-1287-5p	4.57	5.5e-06	0.14	0.14	Metabolite levels;	chr10:98387138	chr10:98395271~98395292:-
BRCA	cis	rs7829975	0.626	rs907183	MIMAT0019728	hsa-miR-4660	-4.57	5.51e-06	-0.17	-0.14	Mood instability;	chr8:8872251	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.649	rs4655494	MIMAT0014979	hsa-miR-3117-3p	-4.56	5.68e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66537193	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	4.56	5.68e-06	0.11	0.14	Asthma;	chr2:102374909	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.649	rs967322	MIMAT0014979	hsa-miR-3117-3p	-4.56	5.73e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66537763	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-4.55	5.94e-06	-0.16	-0.14	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-4.55	6.12e-06	-0.11	-0.14	Asthma;	chr2:102374753	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.649	rs1856315	MIMAT0014979	hsa-miR-3117-3p	-4.54	6.22e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66539546	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.77	rs3830020	MIMAT0026738	hsa-miR-1287-3p	-4.53	6.48e-06	-0.11	-0.14	Metabolite levels;	chr10:98416858	chr10:98395232~98395253:-
BRCA	cis	rs4988958	0.565	rs10206291	MIMAT0019927	hsa-miR-4772-3p	-4.53	6.57e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102422403	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-4.53	6.62e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-4.53	6.62e-06	-0.11	-0.14	Asthma;	chr2:102427407	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-4.53	6.62e-06	-0.11	-0.14	Asthma;	chr2:102427715	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-4.53	6.62e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-4.53	6.62e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-4.53	6.69e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	4.52	6.84e-06	0.11	0.14	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
BRCA	cis	rs6681460	0.649	rs1947083	MIMAT0014979	hsa-miR-3117-3p	-4.52	6.9e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66539118	chr1:66628485~66628505:+
BRCA	cis	rs1558648	1	rs1558648	MIMAT0019926	hsa-miR-4772-5p	4.51	7.1e-06	0.2	0.14	Serum protein levels (sST2);	chr2:102193708	chr2:102432300~102432321:+
BRCA	cis	rs17710780	0.803	rs17654705	MIMAT0000732	hsa-miR-378a-3p	-4.51	7.11e-06	-0.18	-0.14	Major depressive disorder;	chr5:149721453	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs11167477	MIMAT0000732	hsa-miR-378a-3p	-4.51	7.12e-06	-0.16	-0.14	Major depressive disorder;	chr5:149723392	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs11740140	MIMAT0000732	hsa-miR-378a-3p	-4.51	7.12e-06	-0.16	-0.14	Major depressive disorder;	chr5:149723602	chr5:149732867~149732888:+
BRCA	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-4.51	7.13e-06	-0.17	-0.14	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-4.51	7.35e-06	-0.11	-0.14	Asthma;	chr2:102423717	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.524	rs6759479	MIMAT0019927	hsa-miR-4772-3p	-4.51	7.39e-06	-0.11	-0.14	Asthma;	chr2:102423587	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.608	rs10889624	MIMAT0014979	hsa-miR-3117-3p	-4.5	7.41e-06	-0.16	-0.14	Presence of antiphospholipid antibodies;	chr1:66540124	chr1:66628485~66628505:+
BRCA	cis	rs4988958	0.565	rs3771154	MIMAT0019927	hsa-miR-4772-3p	-4.5	7.43e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102422900	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs11745896	MIMAT0000732	hsa-miR-378a-3p	-4.5	7.53e-06	-0.16	-0.14	Major depressive disorder;	chr5:149723334	chr5:149732867~149732888:+
BRCA	cis	rs6681460	0.649	rs1338184	MIMAT0014979	hsa-miR-3117-3p	4.5	7.59e-06	0.16	0.14	Presence of antiphospholipid antibodies;	chr1:66539389	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.839	rs7603730	MIMAT0019927	hsa-miR-4772-3p	-4.5	7.67e-06	-0.11	-0.14	Asthma;	chr2:102357911	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs62380631	MIMAT0000732	hsa-miR-378a-3p	-4.49	7.78e-06	-0.18	-0.14	Major depressive disorder;	chr5:149702913	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-4.49	7.8e-06	-0.11	-0.14	Asthma;	chr2:102403325	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-4.49	7.82e-06	-0.11	-0.14	Asthma;	chr2:102404807	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-4.49	7.82e-06	-0.11	-0.14	Asthma;	chr2:102407218	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-4.49	7.83e-06	-0.11	-0.14	Asthma;	chr2:102403679	chr2:102432336~102432357:+
BRCA	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	4.49	8.04e-06	0.17	0.14	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-4.49	8.04e-06	-0.11	-0.14	Asthma;	chr2:102426252	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.83	rs12648883	MIMAT0003242	hsa-miR-577	-4.49	8.06e-06	-0.13	-0.14	Optic disc area;	chr4:114576504	chr4:114656774~114656794:+
BRCA	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	4.48	8.25e-06	0.11	0.14	Asthma;	chr2:102374328	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.801	rs10173193	MIMAT0019927	hsa-miR-4772-3p	-4.48	8.29e-06	-0.11	-0.14	Asthma;	chr2:102358590	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.801	rs10176664	MIMAT0019927	hsa-miR-4772-3p	-4.48	8.29e-06	-0.11	-0.14	Asthma;	chr2:102359712	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs6543123	MIMAT0019927	hsa-miR-4772-3p	-4.48	8.29e-06	-0.11	-0.14	Asthma;	chr2:102360736	chr2:102432336~102432357:+
BRCA	cis	rs9527	0.59	rs1475642	MIMAT0005951	hsa-miR-1307-3p	-4.48	8.37e-06	-0.09	-0.14	Arsenic metabolism;	chr10:102786426	chr10:103394301~103394322:-
BRCA	cis	rs7072216	0.687	rs7924209	MIMAT0005878	hsa-miR-1287-5p	4.48	8.4e-06	0.14	0.14	Metabolite levels;	chr10:98396170	chr10:98395271~98395292:-
BRCA	cis	rs17710780	0.614	rs115403966	MIMAT0000732	hsa-miR-378a-3p	-4.47	8.5e-06	-0.18	-0.14	Major depressive disorder;	chr5:149698057	chr5:149732867~149732888:+
BRCA	cis	rs7829975	0.606	rs11776838	MIMAT0019728	hsa-miR-4660	-4.47	8.62e-06	-0.16	-0.14	Mood instability;	chr8:8937291	chr8:9048453~9048475:+
BRCA	cis	rs9807989	0.839	rs1974675	MIMAT0019927	hsa-miR-4772-3p	-4.47	8.75e-06	-0.11	-0.14	Asthma;	chr2:102369915	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-4.46	9.07e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-4.46	9.09e-06	-0.11	-0.14	Asthma;	chr2:102415289	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs17710942	MIMAT0000732	hsa-miR-378a-3p	-4.45	9.32e-06	-0.18	-0.14	Major depressive disorder;	chr5:149699521	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-4.45	9.39e-06	-0.11	-0.14	Asthma;	chr2:102399227	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs3771166	MIMAT0019927	hsa-miR-4772-3p	-4.45	9.46e-06	-0.11	-0.14	Asthma;	chr2:102369762	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.687	rs10883086	MIMAT0005878	hsa-miR-1287-5p	4.45	9.46e-06	0.14	0.14	Metabolite levels;	chr10:98395986	chr10:98395271~98395292:-
BRCA	cis	rs9807989	0.801	rs11123925	MIMAT0019927	hsa-miR-4772-3p	-4.44	9.75e-06	-0.11	-0.14	Asthma;	chr2:102361051	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs10204837	MIMAT0019927	hsa-miR-4772-3p	-4.44	9.75e-06	-0.11	-0.14	Asthma;	chr2:102361270	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs3755276	MIMAT0019927	hsa-miR-4772-3p	-4.44	9.75e-06	-0.11	-0.14	Asthma;	chr2:102361999	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs9308857	MIMAT0019927	hsa-miR-4772-3p	-4.44	9.75e-06	-0.11	-0.14	Asthma;	chr2:102363164	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs1420099	MIMAT0019927	hsa-miR-4772-3p	-4.44	9.75e-06	-0.11	-0.14	Asthma;	chr2:102364083	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.83	rs28870381	MIMAT0003242	hsa-miR-577	4.44	9.82e-06	0.13	0.14	Optic disc area;	chr4:114557343	chr4:114656774~114656794:+
BRCA	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-4.44	9.88e-06	-0.11	-0.14	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.687	rs7908310	MIMAT0005878	hsa-miR-1287-5p	4.44	9.96e-06	0.14	0.14	Metabolite levels;	chr10:98396470	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.687	rs10883087	MIMAT0005878	hsa-miR-1287-5p	4.44	1e-05	0.14	0.14	Metabolite levels;	chr10:98397233	chr10:98395271~98395292:-
BRCA	cis	rs9527	0.662	rs4919686	MIMAT0005951	hsa-miR-1307-3p	4.43	1.02e-05	0.09	0.14	Arsenic metabolism;	chr10:102832492	chr10:103394301~103394322:-
BRCA	cis	rs13256369	0.708	rs10903310	MIMAT0019728	hsa-miR-4660	-4.43	1.06e-05	-0.19	-0.14	Obesity-related traits;	chr8:8732177	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.687	rs11189586	MIMAT0005878	hsa-miR-1287-5p	4.43	1.06e-05	0.14	0.14	Metabolite levels;	chr10:98394339	chr10:98395271~98395292:-
BRCA	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.07e-05	-0.11	-0.14	Asthma;	chr2:102370999	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.527	rs3771155	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.07e-05	-0.11	-0.14	Asthma (childhood onset);	chr2:102421366	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.687	rs11189590	MIMAT0005878	hsa-miR-1287-5p	4.42	1.08e-05	0.14	0.14	Metabolite levels;	chr10:98394848	chr10:98395271~98395292:-
BRCA	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.09e-05	-0.11	-0.14	Asthma;	chr2:102418383	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.565	rs885088	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.09e-05	-0.11	-0.14	Asthma (childhood onset);	chr2:102422584	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs2293224	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.1e-05	-0.11	-0.14	Asthma;	chr2:102419319	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs6743516	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.1e-05	-0.11	-0.14	Asthma;	chr2:102419875	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.565	rs1420100	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.1e-05	-0.11	-0.14	Asthma (childhood onset);	chr2:102420542	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs10182710	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.11e-05	-0.11	-0.14	Asthma;	chr2:102364846	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs13392100	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.11e-05	-0.11	-0.14	Asthma;	chr2:102365634	chr2:102432336~102432357:+
BRCA	cis	rs7829975	0.658	rs907181	MIMAT0019728	hsa-miR-4660	4.41	1.13e-05	0.16	0.14	Mood instability;	chr8:8845365	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.16e-05	-0.16	-0.14	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.16e-05	-0.16	-0.14	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	4.4	1.18e-05	0.11	0.14	Asthma;	chr2:102377873	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.21e-05	-0.11	-0.14	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.687	rs10786418	MIMAT0005878	hsa-miR-1287-5p	4.4	1.22e-05	0.14	0.14	Metabolite levels;	chr10:98397611	chr10:98395271~98395292:-
BRCA	cis	rs17710780	0.803	rs56073703	MIMAT0000732	hsa-miR-378a-3p	-4.39	1.24e-05	-0.18	-0.14	Major depressive disorder;	chr5:149705665	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs4705083	MIMAT0000732	hsa-miR-378a-3p	-4.39	1.24e-05	-0.18	-0.14	Major depressive disorder;	chr5:149705876	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.24e-05	-0.11	-0.14	Asthma;	chr2:102411180	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.24e-05	-0.11	-0.14	Asthma;	chr2:102411191	chr2:102432336~102432357:+
BRCA	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-4.39	1.26e-05	-0.15	-0.14	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
BRCA	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-4.39	1.26e-05	-0.15	-0.14	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
BRCA	cis	rs7072216	0.687	rs7097625	MIMAT0005878	hsa-miR-1287-5p	4.39	1.27e-05	0.14	0.14	Metabolite levels;	chr10:98399165	chr10:98395271~98395292:-
BRCA	cis	rs7829975	0.572	rs7005000	MIMAT0019728	hsa-miR-4660	-4.39	1.27e-05	-0.16	-0.14	Mood instability;	chr8:8939092	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.73	rs62382305	MIMAT0000732	hsa-miR-378a-3p	-4.39	1.28e-05	-0.17	-0.14	Major depressive disorder;	chr5:149772623	chr5:149732867~149732888:+
BRCA	cis	rs7072216	0.687	rs11189587	MIMAT0005878	hsa-miR-1287-5p	4.38	1.28e-05	0.14	0.14	Metabolite levels;	chr10:98394788	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.687	rs11189588	MIMAT0005878	hsa-miR-1287-5p	4.38	1.28e-05	0.14	0.14	Metabolite levels;	chr10:98394794	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.687	rs11189589	MIMAT0005878	hsa-miR-1287-5p	4.38	1.28e-05	0.14	0.14	Metabolite levels;	chr10:98394808	chr10:98395271~98395292:-
BRCA	cis	rs7072216	0.77	rs1737	MIMAT0026738	hsa-miR-1287-3p	4.38	1.32e-05	0.11	0.13	Metabolite levels;	chr10:98416609	chr10:98395232~98395253:-
BRCA	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-4.38	1.32e-05	-0.11	-0.13	Asthma;	chr2:102394452	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-4.38	1.32e-05	-0.11	-0.13	Asthma;	chr2:102350776	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-4.38	1.33e-05	-0.16	-0.13	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
BRCA	cis	rs2302612	0.687	rs3755285	MIMAT0019926	hsa-miR-4772-5p	4.38	1.33e-05	0.14	0.13	Serum protein levels (sST2);	chr2:102227560	chr2:102432300~102432321:+
BRCA	cis	rs7829975	0.714	rs11784052	MIMAT0019728	hsa-miR-4660	4.38	1.33e-05	0.16	0.13	Mood instability;	chr8:8814452	chr8:9048453~9048475:+
BRCA	cis	rs1884537	0.966	rs11160605	MIMAT0003332	hsa-miR-656-3p	-4.37	1.34e-05	-0.14	-0.13	Optic nerve measurement (disc area);	chr14:100786079	chr14:101066766~101066786:+
BRCA	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-4.37	1.34e-05	-0.11	-0.13	Asthma;	chr2:102351751	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-4.37	1.34e-05	-0.11	-0.13	Asthma;	chr2:102351752	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.83	rs1460784	MIMAT0003242	hsa-miR-577	4.37	1.35e-05	0.12	0.13	Optic disc area;	chr4:114541947	chr4:114656774~114656794:+
BRCA	cis	rs10949834	0.793	rs810532	MIMAT0003258	hsa-miR-590-5p	-4.36	1.41e-05	-0.11	-0.13	Verbal memory performance (residualized delayed recall change);	chr7:74090858	chr7:74191213~74191234:+
BRCA	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-4.35	1.47e-05	-0.11	-0.13	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
BRCA	cis	rs10949834	0.793	rs810534	MIMAT0003258	hsa-miR-590-5p	4.35	1.47e-05	0.11	0.13	Verbal memory performance (residualized delayed recall change);	chr7:74090715	chr7:74191213~74191234:+
BRCA	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-4.35	1.48e-05	-0.11	-0.13	Asthma;	chr2:102412435	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-4.35	1.48e-05	-0.11	-0.13	Asthma;	chr2:102412461	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-4.35	1.48e-05	-0.11	-0.13	Asthma;	chr2:102412524	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-4.35	1.48e-05	-0.11	-0.13	Asthma;	chr2:102415109	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-4.35	1.48e-05	-0.11	-0.13	Asthma;	chr2:102417501	chr2:102432336~102432357:+
BRCA	cis	rs453301	0.631	rs17700611	MIMAT0019728	hsa-miR-4660	-4.35	1.48e-05	-0.17	-0.13	Joint mobility (Beighton score);	chr8:8936144	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs72828366	MIMAT0000732	hsa-miR-378a-3p	-4.35	1.49e-05	-0.16	-0.13	Major depressive disorder;	chr5:149697605	chr5:149732867~149732888:+
BRCA	cis	rs6011674	1	rs75824619	MIMAT0016888	hsa-miR-4326	-4.35	1.5e-05	-0.3	-0.13	Response to cytadine analogues (cytosine arabinoside);	chr20:63225119	chr20:63286818~63286837:+
BRCA	cis	rs17710780	0.685	rs62382279	MIMAT0000732	hsa-miR-378a-3p	-4.34	1.55e-05	-0.17	-0.13	Major depressive disorder;	chr5:149757891	chr5:149732867~149732888:+
BRCA	cis	rs6011674	1	rs6011674	MIMAT0016888	hsa-miR-4326	4.34	1.55e-05	0.21	0.13	Response to cytadine analogues (cytosine arabinoside);	chr20:63223100	chr20:63286818~63286837:+
BRCA	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	4.34	1.59e-05	0.11	0.13	Asthma;	chr2:102393077	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs55954911	MIMAT0000732	hsa-miR-378a-3p	-4.33	1.61e-05	-0.17	-0.13	Major depressive disorder;	chr5:149760120	chr5:149732867~149732888:+
BRCA	cis	rs7829975	0.582	rs448231	MIMAT0019728	hsa-miR-4660	-4.33	1.61e-05	-0.16	-0.13	Mood instability;	chr8:8932549	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs55636314	MIMAT0000732	hsa-miR-378a-3p	-4.33	1.61e-05	-0.18	-0.13	Major depressive disorder;	chr5:149710154	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.62e-05	-0.11	-0.13	Asthma;	chr2:102381819	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.62e-05	-0.11	-0.13	Asthma;	chr2:102382514	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.62e-05	-0.11	-0.13	Asthma;	chr2:102382943	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.62e-05	-0.11	-0.13	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.62e-05	-0.11	-0.13	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.63e-05	-0.11	-0.13	Asthma;	chr2:102379885	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs62382266	MIMAT0000732	hsa-miR-378a-3p	-4.33	1.66e-05	-0.16	-0.13	Major depressive disorder;	chr5:149722518	chr5:149732867~149732888:+
BRCA	cis	rs7072216	0.687	rs7907555	MIMAT0005878	hsa-miR-1287-5p	-4.32	1.73e-05	-0.14	-0.13	Metabolite levels;	chr10:98396053	chr10:98395271~98395292:-
BRCA	cis	rs7829975	0.606	rs10112585	MIMAT0019728	hsa-miR-4660	-4.31	1.75e-05	-0.16	-0.13	Mood instability;	chr8:8937520	chr8:9048453~9048475:+
BRCA	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-4.31	1.75e-05	-0.11	-0.13	Asthma;	chr2:102351825	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-4.31	1.75e-05	-0.11	-0.13	Asthma;	chr2:102351896	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-4.31	1.75e-05	-0.11	-0.13	Asthma;	chr2:102351902	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-4.31	1.76e-05	-0.15	-0.13	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-4.31	1.8e-05	-0.11	-0.13	Asthma;	chr2:102351547	chr2:102432336~102432357:+
BRCA	cis	rs10021731	0.546	rs7668023	MIMAT0003242	hsa-miR-577	-4.31	1.82e-05	-0.12	-0.13	Optic disc area;	chr4:114535366	chr4:114656774~114656794:+
BRCA	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-4.31	1.82e-05	-0.11	-0.13	Asthma;	chr2:102446780	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.839	rs1362348	MIMAT0019927	hsa-miR-4772-3p	-4.3	1.89e-05	-0.11	-0.13	Asthma;	chr2:102368164	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs72828384	MIMAT0000732	hsa-miR-378a-3p	-4.3	1.89e-05	-0.16	-0.13	Major depressive disorder;	chr5:149714172	chr5:149732867~149732888:+
BRCA	cis	rs6681460	0.649	rs10889625	MIMAT0014979	hsa-miR-3117-3p	-4.3	1.91e-05	-0.16	-0.13	Presence of antiphospholipid antibodies;	chr1:66541552	chr1:66628485~66628505:+
BRCA	cis	rs9527	1	rs12416687	MIMAT0005951	hsa-miR-1307-3p	4.29	1.94e-05	0.09	0.13	Arsenic metabolism;	chr10:102869254	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.546	rs12503437	MIMAT0003242	hsa-miR-577	-4.29	1.94e-05	-0.12	-0.13	Optic disc area;	chr4:114534955	chr4:114656774~114656794:+
BRCA	cis	rs10021731	0.546	rs12503481	MIMAT0003242	hsa-miR-577	-4.29	1.94e-05	-0.12	-0.13	Optic disc area;	chr4:114535080	chr4:114656774~114656794:+
BRCA	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-4.29	1.97e-05	-0.14	-0.13	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
BRCA	cis	rs10021731	0.83	rs28734840	MIMAT0003242	hsa-miR-577	4.28	2.06e-05	0.12	0.13	Optic disc area;	chr4:114575934	chr4:114656774~114656794:+
BRCA	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	4.28	2.08e-05	0.13	0.13	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
BRCA	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-4.26	2.23e-05	-0.11	-0.13	Asthma;	chr2:102410644	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-4.25	2.33e-05	-0.1	-0.13	Asthma;	chr2:102381261	chr2:102432336~102432357:+
BRCA	cis	rs2980439	0.846	rs2980437	MIMAT0019728	hsa-miR-4660	-4.25	2.34e-05	-0.16	-0.13	Neuroticism;	chr8:8237241	chr8:9048453~9048475:+
BRCA	cis	rs7594645	0.59	rs10164949	MIMAT0014995	hsa-miR-3130-5p	4.25	2.34e-05	0.24	0.13	Episodic memory;	chr2:206816281	chr2:206783276~206783296:-
BRCA	cis	rs7594645	0.59	rs10164949	MIMAT0014995_1	hsa-miR-3130-5p	4.25	2.34e-05	0.24	0.13	Episodic memory;	chr2:206816281	chr2:206783246~206783266:+
BRCA	cis	rs9807989	0.839	rs4988957	MIMAT0019927	hsa-miR-4772-3p	4.25	2.38e-05	0.11	0.13	Asthma;	chr2:102351615	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs11745024	MIMAT0000732	hsa-miR-378a-3p	-4.24	2.46e-05	-0.16	-0.13	Major depressive disorder;	chr5:149713345	chr5:149732867~149732888:+
BRCA	cis	rs17710780	1	rs72828383	MIMAT0000732	hsa-miR-378a-3p	-4.24	2.46e-05	-0.16	-0.13	Major depressive disorder;	chr5:149713586	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs11745748	MIMAT0000732	hsa-miR-378a-3p	-4.24	2.46e-05	-0.16	-0.13	Major depressive disorder;	chr5:149713609	chr5:149732867~149732888:+
BRCA	cis	rs7829975	0.564	rs2976855	MIMAT0019728	hsa-miR-4660	4.24	2.46e-05	0.16	0.13	Mood instability;	chr8:8444284	chr8:9048453~9048475:+
BRCA	cis	rs4988958	0.565	rs3755265	MIMAT0019927	hsa-miR-4772-3p	-4.24	2.47e-05	-0.1	-0.13	Asthma (childhood onset);	chr2:102436356	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	4.23	2.5e-05	0.1	0.13	Asthma;	chr2:102394777	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.77	rs7909131	MIMAT0026738	hsa-miR-1287-3p	4.23	2.51e-05	0.11	0.13	Metabolite levels;	chr10:98411714	chr10:98395232~98395253:-
BRCA	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-4.23	2.53e-05	-0.1	-0.13	Asthma;	chr2:102389644	chr2:102432336~102432357:+
BRCA	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-4.23	2.53e-05	-0.1	-0.13	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-4.23	2.53e-05	-0.1	-0.13	Asthma;	chr2:102388870	chr2:102432336~102432357:+
BRCA	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-4.23	2.53e-05	-0.1	-0.13	Asthma;	chr2:102389988	chr2:102432336~102432357:+
BRCA	cis	rs7829975	0.593	rs2921061	MIMAT0019728	hsa-miR-4660	4.23	2.58e-05	0.16	0.13	Mood instability;	chr8:8460105	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-4.22	2.67e-05	-0.16	-0.13	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
BRCA	cis	rs732716	0.504	rs9352	MIMAT0019880	hsa-miR-4746-5p	4.22	2.68e-05	0.14	0.13	Mean corpuscular volume;	chr19:4442339	chr19:4445987~4446009:+
BRCA	cis	rs9527	1	rs4919690	MIMAT0005951	hsa-miR-1307-3p	-4.21	2.76e-05	-0.09	-0.13	Arsenic metabolism;	chr10:102856743	chr10:103394301~103394322:-
BRCA	cis	rs9807989	0.507	rs3732124	MIMAT0019927	hsa-miR-4772-3p	4.21	2.78e-05	0.1	0.13	Asthma;	chr2:102401592	chr2:102432336~102432357:+
BRCA	cis	rs7072216	0.77	rs1739	MIMAT0026738	hsa-miR-1287-3p	4.21	2.83e-05	0.11	0.13	Metabolite levels;	chr10:98416582	chr10:98395232~98395253:-
BRCA	cis	rs74233809	0.605	rs999867	MIMAT0005951	hsa-miR-1307-3p	-4.2	2.85e-05	-0.12	-0.13	Birth weight;	chr10:102744807	chr10:103394301~103394322:-
BRCA	cis	rs7829975	0.573	rs7842359	MIMAT0019728	hsa-miR-4660	-4.2	2.85e-05	-0.16	-0.13	Mood instability;	chr8:8939568	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.548	rs7917547	MIMAT0005951	hsa-miR-1307-3p	4.2	2.92e-05	0.09	0.13	Schizophrenia;	chr10:103052295	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.866	rs996123	MIMAT0014979	hsa-miR-3117-3p	-4.19	2.97e-05	-0.16	-0.13	Presence of antiphospholipid antibodies;	chr1:66559660	chr1:66628485~66628505:+
BRCA	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	4.19	3e-05	0.15	0.13	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs4479442	MIMAT0019927	hsa-miR-4772-3p	-4.19	3.06e-05	-0.1	-0.13	Asthma;	chr2:102437614	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs11740002	MIMAT0000732	hsa-miR-378a-3p	-4.18	3.17e-05	-0.17	-0.13	Major depressive disorder;	chr5:149699066	chr5:149732867~149732888:+
BRCA	cis	rs263063	0.834	rs710957	MIMAT0019880	hsa-miR-4746-5p	-4.18	3.17e-05	-0.21	-0.13	Periodontitis (CDC/AAP);	chr19:5054334	chr19:4445987~4446009:+
BRCA	cis	rs1558648	0.858	rs12996377	MIMAT0019926	hsa-miR-4772-5p	4.17	3.25e-05	0.18	0.13	Serum protein levels (sST2);	chr2:102214018	chr2:102432300~102432321:+
BRCA	cis	rs7829975	0.56	rs17154599	MIMAT0019728	hsa-miR-4660	-4.17	3.25e-05	-0.16	-0.13	Mood instability;	chr8:8693908	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.685	rs56007731	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.31e-05	-0.15	-0.13	Major depressive disorder;	chr5:149712814	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.32e-05	-0.1	-0.13	Asthma;	chr2:102446466	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs17711388	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.32e-05	-0.16	-0.13	Major depressive disorder;	chr5:149760246	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs2058659	MIMAT0019927	hsa-miR-4772-3p	4.17	3.34e-05	0.1	0.13	Asthma;	chr2:102438096	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs4705080	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149716781	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.685	rs62380642	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149717583	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs62380643	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149717781	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs34172303	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149718602	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs62382262	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149718893	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.772	rs62382263	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149719055	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs17654687	MIMAT0000732	hsa-miR-378a-3p	-4.17	3.35e-05	-0.15	-0.13	Major depressive disorder;	chr5:149719226	chr5:149732867~149732888:+
BRCA	cis	rs4851551	0.543	rs62156407	MIMAT0019926	hsa-miR-4772-5p	4.16	3.38e-05	0.27	0.13	Blood protein levels;	chr2:102208162	chr2:102432300~102432321:+
BRCA	cis	rs7829975	0.593	rs2921077	MIMAT0019728	hsa-miR-4660	4.16	3.39e-05	0.15	0.13	Mood instability;	chr8:8446992	chr8:9048453~9048475:+
BRCA	cis	rs7829975	0.567	rs6601273	MIMAT0019728	hsa-miR-4660	-4.16	3.42e-05	-0.15	-0.13	Mood instability;	chr8:8939009	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs17711074	MIMAT0000732	hsa-miR-378a-3p	-4.16	3.51e-05	-0.15	-0.13	Major depressive disorder;	chr5:149721379	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs72828399	MIMAT0000732	hsa-miR-378a-3p	-4.16	3.51e-05	-0.15	-0.13	Major depressive disorder;	chr5:149721509	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs17711098	MIMAT0000732	hsa-miR-378a-3p	-4.16	3.51e-05	-0.15	-0.13	Major depressive disorder;	chr5:149721807	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs17654717	MIMAT0000732	hsa-miR-378a-3p	-4.16	3.51e-05	-0.15	-0.13	Major depressive disorder;	chr5:149722011	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs10515633	MIMAT0000732	hsa-miR-378a-3p	-4.16	3.51e-05	-0.15	-0.13	Major depressive disorder;	chr5:149722247	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs4705361	MIMAT0000732	hsa-miR-378a-3p	-4.16	3.51e-05	-0.15	-0.13	Major depressive disorder;	chr5:149716913	chr5:149732867~149732888:+
BRCA	cis	rs9527	0.615	rs4919685	MIMAT0005951	hsa-miR-1307-3p	4.15	3.56e-05	0.09	0.13	Arsenic metabolism;	chr10:102827605	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.61	rs12570528	MIMAT0005951	hsa-miR-1307-3p	4.15	3.65e-05	0.09	0.13	Schizophrenia;	chr10:103070453	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	4.14	3.68e-05	0.14	0.13	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
BRCA	cis	rs17710780	0.803	rs4705081	MIMAT0000732	hsa-miR-378a-3p	-4.14	3.75e-05	-0.15	-0.13	Major depressive disorder;	chr5:149711066	chr5:149732867~149732888:+
BRCA	cis	rs9807989	0.507	rs13021177	MIMAT0019927	hsa-miR-4772-3p	-4.13	3.85e-05	-0.1	-0.13	Asthma;	chr2:102440033	chr2:102432336~102432357:+
BRCA	cis	rs7829975	0.606	rs7819827	MIMAT0019728	hsa-miR-4660	-4.13	3.9e-05	-0.15	-0.13	Mood instability;	chr8:8939545	chr8:9048453~9048475:+
BRCA	cis	rs453301	0.571	rs330048	MIMAT0019728	hsa-miR-4660	-4.13	3.91e-05	-0.15	-0.13	Joint mobility (Beighton score);	chr8:9229768	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs17711038	MIMAT0000732	hsa-miR-378a-3p	4.13	3.91e-05	0.15	0.13	Major depressive disorder;	chr5:149714883	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs62380635	MIMAT0000732	hsa-miR-378a-3p	-4.13	3.97e-05	-0.16	-0.13	Major depressive disorder;	chr5:149707536	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs113501980	MIMAT0000732	hsa-miR-378a-3p	-4.13	4e-05	-0.15	-0.13	Major depressive disorder;	chr5:149716259	chr5:149732867~149732888:+
BRCA	cis	rs7829975	0.509	rs7838674	MIMAT0019728	hsa-miR-4660	-4.12	4.07e-05	-0.15	-0.13	Mood instability;	chr8:8939563	chr8:9048453~9048475:+
BRCA	cis	rs7829975	0.682	rs7013471	MIMAT0019728	hsa-miR-4660	-4.12	4.12e-05	-0.15	-0.13	Mood instability;	chr8:8829815	chr8:9048453~9048475:+
BRCA	cis	rs4711336	1	rs764752	MIMAT0022975	hsa-miR-3934-3p	-4.12	4.16e-05	-0.15	-0.13	Height;	chr6:33690289	chr6:33698191~33698212:+
BRCA	cis	rs4711336	1	rs764754	MIMAT0022975	hsa-miR-3934-3p	-4.12	4.16e-05	-0.15	-0.13	Height;	chr6:33690533	chr6:33698191~33698212:+
BRCA	cis	rs10949834	0.715	rs710968	MIMAT0003258	hsa-miR-590-5p	4.11	4.35e-05	0.1	0.13	Verbal memory performance (residualized delayed recall change);	chr7:74083398	chr7:74191213~74191234:+
BRCA	cis	rs6681460	0.576	rs6588203	MIMAT0014979	hsa-miR-3117-3p	-4.1	4.38e-05	-0.16	-0.13	Presence of antiphospholipid antibodies;	chr1:66525168	chr1:66628485~66628505:+
BRCA	cis	rs9807989	0.507	rs1420097	MIMAT0019927	hsa-miR-4772-3p	4.1	4.43e-05	0.1	0.13	Asthma;	chr2:102392894	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.535	rs6588204	MIMAT0014979	hsa-miR-3117-3p	-4.1	4.51e-05	-0.15	-0.13	Presence of antiphospholipid antibodies;	chr1:66525325	chr1:66628485~66628505:+
BRCA	cis	rs4713675	0.565	rs4713659	MIMAT0022975	hsa-miR-3934-3p	-4.09	4.6e-05	-0.15	-0.13	Plateletcrit;	chr6:33700062	chr6:33698191~33698212:+
BRCA	cis	rs7072216	0.77	rs942810	MIMAT0026738	hsa-miR-1287-3p	4.09	4.61e-05	0.1	0.13	Metabolite levels;	chr10:98408103	chr10:98395232~98395253:-
BRCA	cis	rs263063	0.834	rs11673509	MIMAT0019880	hsa-miR-4746-5p	4.09	4.61e-05	0.24	0.13	Periodontitis (CDC/AAP);	chr19:5080636	chr19:4445987~4446009:+
BRCA	cis	rs4711336	1	rs4711336	MIMAT0022975	hsa-miR-3934-3p	4.09	4.65e-05	0.15	0.13	Height;	chr6:33691269	chr6:33698191~33698212:+
BRCA	cis	rs7829975	0.572	rs28730413	MIMAT0019728	hsa-miR-4660	-4.08	4.81e-05	-0.15	-0.13	Mood instability;	chr8:8937937	chr8:9048453~9048475:+
BRCA	cis	rs9987353	0.566	rs13260067	MIMAT0019728	hsa-miR-4660	-4.08	4.86e-05	-0.16	-0.13	Recombination measurement;	chr8:9213523	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs1926029	MIMAT0005951	hsa-miR-1307-3p	4.08	4.87e-05	0.08	0.13	Arsenic metabolism;	chr10:103095913	chr10:103394301~103394322:-
BRCA	cis	rs17710780	0.803	rs4705082	MIMAT0000732	hsa-miR-378a-3p	-4.07	4.98e-05	-0.15	-0.13	Major depressive disorder;	chr5:149710929	chr5:149732867~149732888:+
BRCA	cis	rs1558648	0.858	rs13014004	MIMAT0019926	hsa-miR-4772-5p	4.06	5.23e-05	0.18	0.13	Serum protein levels (sST2);	chr2:102224207	chr2:102432300~102432321:+
BRCA	cis	rs17710780	0.803	rs72830211	MIMAT0000732	hsa-miR-378a-3p	-4.06	5.26e-05	-0.16	-0.13	Major depressive disorder;	chr5:149747117	chr5:149732867~149732888:+
BRCA	cis	rs263063	0.764	rs2291149	MIMAT0019880	hsa-miR-4746-5p	-4.06	5.32e-05	-0.23	-0.13	Periodontitis (CDC/AAP);	chr19:5077325	chr19:4445987~4446009:+
BRCA	cis	rs17710780	0.803	rs17711318	MIMAT0000732	hsa-miR-378a-3p	-4.06	5.37e-05	-0.16	-0.13	Major depressive disorder;	chr5:149746158	chr5:149732867~149732888:+
BRCA	cis	rs79387448	0.808	rs77518775	MIMAT0019926	hsa-miR-4772-5p	-4.05	5.46e-05	-0.19	-0.13	Gut microbiota (bacterial taxa);	chr2:102621183	chr2:102432300~102432321:+
BRCA	cis	rs17710780	0.803	rs4705367	MIMAT0000732	hsa-miR-378a-3p	-4.05	5.48e-05	-0.16	-0.12	Major depressive disorder;	chr5:149745432	chr5:149732867~149732888:+
BRCA	cis	rs6601327	0.613	rs4612345	MIMAT0019728	hsa-miR-4660	-4.05	5.49e-05	-0.15	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9722491	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs56200554	MIMAT0000732	hsa-miR-378a-3p	-4.05	5.5e-05	-0.16	-0.12	Major depressive disorder;	chr5:149749440	chr5:149732867~149732888:+
BRCA	cis	rs6681460	0.932	rs603750	MIMAT0014979	hsa-miR-3117-3p	-4.05	5.57e-05	-0.14	-0.12	Presence of antiphospholipid antibodies;	chr1:66711805	chr1:66628485~66628505:+
BRCA	cis	rs9527	0.83	rs10883790	MIMAT0005951	hsa-miR-1307-3p	4.04	5.73e-05	0.08	0.12	Arsenic metabolism;	chr10:102881198	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.83	rs11191440	MIMAT0005951	hsa-miR-1307-3p	4.04	5.73e-05	0.08	0.12	Arsenic metabolism;	chr10:102881754	chr10:103394301~103394322:-
BRCA	cis	rs7894407	0.76	rs1163072	MIMAT0022727	hsa-miR-1307-5p	4.04	5.78e-05	0.07	0.12	White matter hyperintensity burden;	chr10:103264621	chr10:103394341~103394361:-
BRCA	cis	rs17604090	0.756	rs113829432	MIMAT0004800	hsa-miR-550a-5p	4.03	5.88e-05	0.18	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29685453	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.756	rs113829432	MIMAT0004800_1	hsa-miR-550a-5p	4.03	5.88e-05	0.18	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29685453	chr7:32733002~32733024:+
BRCA	cis	rs9527	0.545	rs12247514	MIMAT0005951	hsa-miR-1307-3p	4.02	6.17e-05	0.08	0.12	Arsenic metabolism;	chr10:103198309	chr10:103394301~103394322:-
BRCA	cis	rs13256369	0.826	rs7846050	MIMAT0019728	hsa-miR-4660	4.02	6.17e-05	0.17	0.12	Obesity-related traits;	chr8:8718159	chr8:9048453~9048475:+
BRCA	cis	rs17604090	0.938	rs850029	MIMAT0004800	hsa-miR-550a-5p	4.02	6.18e-05	0.19	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29638471	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs850029	MIMAT0004800_1	hsa-miR-550a-5p	4.02	6.18e-05	0.19	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29638471	chr7:32733002~32733024:+
BRCA	cis	rs7897654	0.61	rs7916476	MIMAT0005951	hsa-miR-1307-3p	4.02	6.21e-05	0.09	0.12	Schizophrenia;	chr10:103055511	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs7910900	MIMAT0005951	hsa-miR-1307-3p	4.02	6.27e-05	0.08	0.12	Arsenic metabolism;	chr10:103070141	chr10:103394301~103394322:-
BRCA	cis	rs10949834	0.73	rs2237503	MIMAT0003258	hsa-miR-590-5p	-4.02	6.27e-05	-0.1	-0.12	Verbal memory performance (residualized delayed recall change);	chr7:74094996	chr7:74191213~74191234:+
BRCA	cis	rs9527	0.83	rs11191442	MIMAT0005951	hsa-miR-1307-3p	4.02	6.29e-05	0.08	0.12	Arsenic metabolism;	chr10:102883839	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.545	rs11191602	MIMAT0005951	hsa-miR-1307-3p	4.02	6.34e-05	0.08	0.12	Arsenic metabolism;	chr10:103194462	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.545	rs7095304	MIMAT0005951	hsa-miR-1307-3p	4.02	6.34e-05	0.08	0.12	Arsenic metabolism;	chr10:103195038	chr10:103394301~103394322:-
BRCA	cis	rs4851551	0.619	rs34722443	MIMAT0019926	hsa-miR-4772-5p	4.01	6.39e-05	0.26	0.12	Blood protein levels;	chr2:102223859	chr2:102432300~102432321:+
BRCA	cis	rs7829975	0.593	rs2979241	MIMAT0019728	hsa-miR-4660	4.01	6.51e-05	0.15	0.12	Mood instability;	chr8:8445843	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs11191540	MIMAT0005951	hsa-miR-1307-3p	4	6.69e-05	0.08	0.12	Arsenic metabolism;	chr10:103063052	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs7092029	MIMAT0005951	hsa-miR-1307-3p	4	6.69e-05	0.08	0.12	Arsenic metabolism;	chr10:103064152	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs943039	MIMAT0005951	hsa-miR-1307-3p	4	6.69e-05	0.08	0.12	Arsenic metabolism;	chr10:103065375	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.641	rs4919684	MIMAT0005951	hsa-miR-1307-3p	3.99	6.99e-05	0.08	0.12	Arsenic metabolism;	chr10:102827267	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.544	rs11191549	MIMAT0005951	hsa-miR-1307-3p	3.99	7.05e-05	0.08	0.12	Arsenic metabolism;	chr10:103087040	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.662	rs4919687	MIMAT0005951	hsa-miR-1307-3p	3.99	7.06e-05	0.08	0.12	Arsenic metabolism;	chr10:102835491	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.545	rs7100369	MIMAT0005951	hsa-miR-1307-3p	3.99	7.07e-05	0.08	0.12	Arsenic metabolism;	chr10:103196461	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.545	rs12784384	MIMAT0005951	hsa-miR-1307-3p	3.99	7.07e-05	0.08	0.12	Arsenic metabolism;	chr10:103197837	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.545	rs10883847	MIMAT0005951	hsa-miR-1307-3p	3.99	7.07e-05	0.08	0.12	Arsenic metabolism;	chr10:103198527	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.518	rs11191530	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.13e-05	-0.1	-0.12	Arsenic metabolism;	chr10:103040287	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs10883781	MIMAT0005951	hsa-miR-1307-3p	3.99	7.13e-05	0.08	0.12	Arsenic metabolism;	chr10:102821373	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.544	rs1572578	MIMAT0005951	hsa-miR-1307-3p	3.99	7.18e-05	0.08	0.12	Arsenic metabolism;	chr10:103062674	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-3.99	7.21e-05	-0.14	-0.12	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
BRCA	cis	rs17867775	0.623	rs10487472	MIMAT0003260	hsa-miR-592	-3.98	7.25e-05	-0.28	-0.12	Anti-saccade response;	chr7:127225983	chr7:127058148~127058169:-
BRCA	cis	rs9527	0.83	rs12249194	MIMAT0005951	hsa-miR-1307-3p	3.98	7.39e-05	0.08	0.12	Arsenic metabolism;	chr10:102883941	chr10:103394301~103394322:-
BRCA	cis	rs61008539	0.893	rs11765528	MIMAT0004702	hsa-miR-339-3p	-3.98	7.4e-05	-0.11	-0.12	Perceived unattractiveness to mosquitoes;	chr7:822315	chr7:1022955~1022977:-
BRCA	cis	rs11142387	0.528	rs10868825	MIMAT0000265	hsa-miR-204-5p	-3.97	7.6e-05	-0.11	-0.12	Body mass index (SNP x SNP interaction);Intelligence (multi-trait analysis);Body mass index;	chr9:70416149	chr9:70810031~70810052:-
BRCA	cis	rs17710780	0.803	rs11743128	MIMAT0000732	hsa-miR-378a-3p	-3.97	7.68e-05	-0.15	-0.12	Major depressive disorder;	chr5:149744542	chr5:149732867~149732888:+
BRCA	cis	rs17710780	0.803	rs17654574	MIMAT0000732	hsa-miR-378a-3p	3.96	7.88e-05	0.17	0.12	Major depressive disorder;	chr5:149699659	chr5:149732867~149732888:+
BRCA	cis	rs12497850	0.931	rs6442130	MIMAT0000440	hsa-miR-191-5p	3.96	8.17e-05	0.09	0.12	Parkinson's disease;	chr3:48740594	chr3:49020672~49020694:-
BRCA	cis	rs1864585	0.806	rs17778223	MIMAT0003266	hsa-miR-598-3p	3.95	8.3e-05	0.17	0.12	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10872182	chr8:11035221~11035242:-
BRCA	cis	rs2400997	0.967	rs2226074	MIMAT0022923	hsa-miR-376b-5p	-3.95	8.45e-05	-0.12	-0.12	Prostate cancer (SNP x SNP interaction);	chr14:101274577	chr14:101040459~101040480:+
BRCA	cis	rs17710780	0.803	rs11738167	MIMAT0000732	hsa-miR-378a-3p	-3.95	8.48e-05	-0.15	-0.12	Major depressive disorder;	chr5:149755482	chr5:149732867~149732888:+
BRCA	cis	rs9527	0.545	rs7894588	MIMAT0005951	hsa-miR-1307-3p	3.94	8.65e-05	0.08	0.12	Arsenic metabolism;	chr10:102996273	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs11191544	MIMAT0005951	hsa-miR-1307-3p	3.94	8.68e-05	0.08	0.12	Arsenic metabolism;	chr10:103067441	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs7085854	MIMAT0005951	hsa-miR-1307-3p	3.94	8.71e-05	0.09	0.12	Schizophrenia;	chr10:102890494	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs12780134	MIMAT0005951	hsa-miR-1307-3p	3.93	8.99e-05	0.09	0.12	Schizophrenia;	chr10:102886686	chr10:103394301~103394322:-
BRCA	cis	rs1355223	0.506	rs7130678	MIMAT0019776	hsa-miR-1343-3p	3.93	9.06e-05	0.12	0.12	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34847634	chr11:34941888~34941909:+
BRCA	cis	rs4851551	0.867	rs3917299	MIMAT0019926	hsa-miR-4772-5p	3.93	9.09e-05	0.24	0.12	Blood protein levels;	chr2:102169626	chr2:102432300~102432321:+
BRCA	cis	rs9527	1	rs9527	MIMAT0005951	hsa-miR-1307-3p	3.93	9.11e-05	0.08	0.12	Arsenic metabolism;	chr10:102863821	chr10:103394301~103394322:-
BRCA	cis	rs7894407	0.76	rs4917386	MIMAT0022727	hsa-miR-1307-5p	3.91	9.71e-05	0.07	0.12	White matter hyperintensity burden;	chr10:103247771	chr10:103394341~103394361:-
BRCA	cis	rs6601327	0.606	rs4841203	MIMAT0019728	hsa-miR-4660	-3.91	9.73e-05	-0.15	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9725220	chr8:9048453~9048475:+
BRCA	cis	rs2284367	0.505	rs4755374	MIMAT0019776	hsa-miR-1343-3p	-3.91	9.91e-05	-0.18	-0.12	Blood protein levels;	chr11:34465057	chr11:34941888~34941909:+
BRCA	cis	rs9807989	0.839	rs4988955	MIMAT0019927	hsa-miR-4772-3p	-3.91	9.95e-05	-0.1	-0.12	Asthma;	chr2:102351468	chr2:102432336~102432357:+
BRCA	cis	rs2284932	0.533	rs918282	MIMAT0016895	hsa-miR-2355-5p	3.91	9.99e-05	0.14	0.12	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207127274	chr2:207110043~207110063:-
BRCA	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	3.9	1e-04	0.09	0.12	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
BRCA	cis	rs9527	0.59	rs763914	MIMAT0005951	hsa-miR-1307-3p	3.9	0.000102	0.08	0.12	Arsenic metabolism;	chr10:103081830	chr10:103394301~103394322:-
BRCA	cis	rs263063	0.749	rs11085111	MIMAT0019880	hsa-miR-4746-5p	-3.9	0.000102	-0.22	-0.12	Periodontitis (CDC/AAP);	chr19:5069250	chr19:4445987~4446009:+
BRCA	cis	rs2284932	0.556	rs2014766	MIMAT0016895	hsa-miR-2355-5p	3.9	0.000102	0.14	0.12	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207126660	chr2:207110043~207110063:-
BRCA	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	3.9	0.000103	0.13	0.12	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
BRCA	cis	rs9527	0.59	rs7901197	MIMAT0005951	hsa-miR-1307-3p	3.9	0.000104	0.08	0.12	Arsenic metabolism;	chr10:103080676	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.662	rs743575	MIMAT0005951	hsa-miR-1307-3p	3.9	0.000104	0.08	0.12	Arsenic metabolism;	chr10:102835149	chr10:103394301~103394322:-
BRCA	cis	rs4851551	0.543	rs17026757	MIMAT0019926	hsa-miR-4772-5p	3.89	0.000105	0.2	0.12	Blood protein levels;	chr2:102197452	chr2:102432300~102432321:+
BRCA	cis	rs6601327	0.606	rs13268319	MIMAT0019728	hsa-miR-4660	-3.89	0.000105	-0.15	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9721739	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.61	rs10883819	MIMAT0005951	hsa-miR-1307-3p	3.89	0.000106	0.08	0.12	Schizophrenia;	chr10:103003551	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.761	rs115923387	MIMAT0004800	hsa-miR-550a-5p	3.89	0.000106	0.19	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29681086	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.761	rs115923387	MIMAT0004800_1	hsa-miR-550a-5p	3.89	0.000106	0.19	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29681086	chr7:32733002~32733024:+
BRCA	cis	rs56235845	0.694	rs11749830	MIMAT0005796	hsa-miR-1271-5p	-3.89	0.000106	-0.12	-0.12	Hematocrit;Hemoglobin concentration;	chr5:177339546	chr5:176367960~176367981:+
BRCA	cis	rs263063	0.764	rs12979556	MIMAT0019880	hsa-miR-4746-5p	-3.89	0.000107	-0.22	-0.12	Periodontitis (CDC/AAP);	chr19:5076845	chr19:4445987~4446009:+
BRCA	cis	rs7147503	1	rs7147503	MIMAT0003163	hsa-miR-539-5p	-3.89	0.000107	-0.07	-0.12	Corneal astigmatism;	chr14:101073047	chr14:101047329~101047350:+
BRCA	cis	rs7897654	0.61	rs12764154	MIMAT0005951	hsa-miR-1307-3p	3.89	0.000107	0.08	0.12	Schizophrenia;	chr10:102997952	chr10:103394301~103394322:-
BRCA	cis	rs250677	0.687	rs250679	MIMAT0003249	hsa-miR-584-5p	-3.89	0.000107	-0.14	-0.12	Breast cancer;	chr5:149055389	chr5:149062373~149062394:-
BRCA	cis	rs2302612	0.58	rs11123912	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000109	0.13	0.12	Serum protein levels (sST2);	chr2:102200076	chr2:102432300~102432321:+
BRCA	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-3.88	0.00011	-0.14	-0.12	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.8	rs539014	MIMAT0014979	hsa-miR-3117-3p	3.88	0.00011	0.14	0.12	Presence of antiphospholipid antibodies;	chr1:66746204	chr1:66628485~66628505:+
BRCA	cis	rs4851551	1	rs4851551	MIMAT0019926	hsa-miR-4772-5p	3.88	0.00011	0.24	0.12	Blood protein levels;	chr2:102183770	chr2:102432300~102432321:+
BRCA	cis	rs74233809	0.748	rs10786736	MIMAT0022727	hsa-miR-1307-5p	-3.87	0.000114	-0.11	-0.12	Birth weight;	chr10:103089359	chr10:103394341~103394361:-
BRCA	cis	rs13256369	1	rs13256369	MIMAT0019728	hsa-miR-4660	3.87	0.000114	0.16	0.12	Obesity-related traits;	chr8:8719869	chr8:9048453~9048475:+
BRCA	cis	rs9693857	0.52	rs7814570	MIMAT0019728	hsa-miR-4660	3.87	0.000114	0.16	0.12	Systolic blood pressure;	chr8:9508802	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs726010	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000115	0.07	0.12	Arsenic metabolism;	chr10:103082220	chr10:103394301~103394322:-
BRCA	cis	rs6717918	0.887	rs6746834	MIMAT0019935	hsa-miR-4777-3p	-3.87	0.000116	-0.15	-0.12	Height;	chr2:232294107	chr2:231362764~231362785:+
BRCA	cis	rs7829975	0.711	rs4841051	MIMAT0019728	hsa-miR-4660	-3.87	0.000116	-0.14	-0.12	Mood instability;	chr8:8828136	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.729	rs17047190	MIMAT0003242	hsa-miR-577	3.87	0.000116	0.11	0.12	Optic disc area;	chr4:114536699	chr4:114656774~114656794:+
BRCA	cis	rs2302612	0.718	rs6742931	MIMAT0019926	hsa-miR-4772-5p	3.87	0.000116	0.12	0.12	Serum protein levels (sST2);	chr2:102234783	chr2:102432300~102432321:+
BRCA	cis	rs74233809	1	rs943037	MIMAT0005951	hsa-miR-1307-3p	-3.87	0.000117	-0.12	-0.12	Birth weight;	chr10:103076162	chr10:103394301~103394322:-
BRCA	cis	rs6700896	0.522	rs10158937	MIMAT0004513	hsa-miR-101-5p	3.87	0.000117	0.13	0.12	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65679193	chr1:65058477~65058498:-
BRCA	cis	rs10256972	0.647	rs10233430	MIMAT0004702	hsa-miR-339-3p	3.87	0.000117	0.1	0.12	Endometriosis;Longevity;	chr7:1012028	chr7:1022955~1022977:-
BRCA	cis	rs7829975	0.577	rs940030	MIMAT0019728	hsa-miR-4660	-3.86	0.000118	-0.15	-0.12	Mood instability;	chr8:8689418	chr8:9048453~9048475:+
BRCA	cis	rs4713675	0.584	rs3818527	MIMAT0022975	hsa-miR-3934-3p	3.86	0.000118	0.14	0.12	Plateletcrit;	chr6:33693258	chr6:33698191~33698212:+
BRCA	cis	rs9527	0.59	rs7917650	MIMAT0005951	hsa-miR-1307-3p	3.86	0.000119	0.07	0.12	Arsenic metabolism;	chr10:103177343	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.83	rs3740392	MIMAT0005951	hsa-miR-1307-3p	3.86	0.000119	0.08	0.12	Arsenic metabolism;	chr10:102877098	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.54	rs6982148	MIMAT0019728	hsa-miR-4660	-3.86	0.000119	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9723560	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.61	rs12780440	MIMAT0005951	hsa-miR-1307-3p	3.86	0.00012	0.08	0.12	Schizophrenia;	chr10:103032491	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.61	rs7091889	MIMAT0005951	hsa-miR-1307-3p	3.86	0.00012	0.08	0.12	Schizophrenia;	chr10:103033966	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-3.86	0.00012	-0.13	-0.12	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
BRCA	cis	rs9527	0.615	rs11191401	MIMAT0005951	hsa-miR-1307-3p	3.86	0.000121	0.08	0.12	Arsenic metabolism;	chr10:102813646	chr10:103394301~103394322:-
BRCA	cis	rs7226408	0.842	rs1609425	MIMAT0000262	hsa-miR-187-3p	-3.86	0.000121	-0.22	-0.12	Obesity-related traits;	chr18:36765721	chr18:35904835~35904856:-
BRCA	cis	rs6601327	1	rs6601327	MIMAT0019728	hsa-miR-4660	-3.86	0.000122	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9538022	chr8:9048453~9048475:+
BRCA	cis	rs9868809	0.772	rs13070798	MIMAT0000440	hsa-miR-191-5p	3.86	0.000122	0.12	0.12	Inflammatory bowel disease;Crohn's disease;Ulcerative colitis;	chr3:48668501	chr3:49020672~49020694:-
BRCA	cis	rs9527	0.59	rs10883829	MIMAT0005951	hsa-miR-1307-3p	3.85	0.000123	0.07	0.12	Arsenic metabolism;	chr10:103080878	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.545	rs10218853	MIMAT0005951	hsa-miR-1307-3p	3.85	0.000125	0.07	0.12	Arsenic metabolism;	chr10:103037030	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.59	rs7093470	MIMAT0005951	hsa-miR-1307-3p	3.85	0.000127	0.08	0.12	Schizophrenia;	chr10:102911111	chr10:103394301~103394322:-
BRCA	cis	rs10256972	0.669	rs10229964	MIMAT0004702	hsa-miR-339-3p	3.84	0.000128	0.1	0.12	Endometriosis;Longevity;	chr7:1012140	chr7:1022955~1022977:-
BRCA	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-3.84	0.000129	-0.14	-0.12	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
BRCA	cis	rs74233809	1	rs11191454	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.000129	-0.12	-0.12	Birth weight;	chr10:102900247	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs7087040	MIMAT0005951	hsa-miR-1307-3p	3.84	0.00013	0.07	0.12	Arsenic metabolism;	chr10:103039911	chr10:103394301~103394322:-
BRCA	cis	rs1867631	0.565	rs10749764	MIMAT0014979	hsa-miR-3117-3p	-3.84	0.000132	-0.13	-0.12	Menopause (age at onset);	chr1:66684023	chr1:66628485~66628505:+
BRCA	cis	rs9527	0.662	rs10883783	MIMAT0005951	hsa-miR-1307-3p	3.84	0.000132	0.08	0.12	Arsenic metabolism;	chr10:102831395	chr10:103394301~103394322:-
BRCA	cis	rs7894407	0.892	rs10883859	MIMAT0022727	hsa-miR-1307-5p	3.84	0.000132	0.07	0.12	White matter hyperintensity burden;	chr10:103368377	chr10:103394341~103394361:-
BRCA	cis	rs2031532	0.589	rs4941643	MIMAT0017990	hsa-miR-3613-5p	3.84	0.000132	0.1	0.12	Cardiac hypertrophy;	chr13:49494251	chr13:49996465~49996486:-
BRCA	cis	rs7897654	0.651	rs7924072	MIMAT0005951	hsa-miR-1307-3p	3.84	0.000133	0.08	0.12	Schizophrenia;	chr10:102914601	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs6584532	MIMAT0005951	hsa-miR-1307-3p	3.84	0.000133	0.08	0.12	Schizophrenia;	chr10:102914759	chr10:103394301~103394322:-
BRCA	cis	rs7894407	0.76	rs1163085	MIMAT0022727	hsa-miR-1307-5p	-3.83	0.000133	-0.07	-0.12	White matter hyperintensity burden;	chr10:103279484	chr10:103394341~103394361:-
BRCA	cis	rs2284932	0.533	rs16839275	MIMAT0016895	hsa-miR-2355-5p	3.83	0.000134	0.14	0.12	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207127431	chr2:207110043~207110063:-
BRCA	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	3.83	0.000135	0.14	0.12	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
BRCA	cis	rs4851551	0.543	rs1997503	MIMAT0019926	hsa-miR-4772-5p	3.83	0.000135	0.19	0.12	Blood protein levels;	chr2:102192775	chr2:102432300~102432321:+
BRCA	cis	rs17710780	0.803	rs7713668	MIMAT0000732	hsa-miR-378a-3p	-3.83	0.000138	-0.14	-0.12	Major depressive disorder;	chr5:149697294	chr5:149732867~149732888:+
BRCA	cis	rs61008539	0.893	rs4719460	MIMAT0004702	hsa-miR-339-3p	3.82	0.000139	0.1	0.12	Perceived unattractiveness to mosquitoes;	chr7:819973	chr7:1022955~1022977:-
BRCA	cis	rs6601327	0.607	rs13276086	MIMAT0019728	hsa-miR-4660	-3.82	0.00014	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9721472	chr8:9048453~9048475:+
BRCA	cis	rs9693857	0.518	rs35589912	MIMAT0019728	hsa-miR-4660	-3.82	0.000141	-0.16	-0.12	Systolic blood pressure;	chr8:9420478	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.641	rs11780399	MIMAT0019728	hsa-miR-4660	-3.82	0.000141	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9731657	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	3.82	0.000142	0.13	0.12	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
BRCA	cis	rs7897654	0.651	rs34572965	MIMAT0005951	hsa-miR-1307-3p	3.82	0.000143	0.08	0.12	Schizophrenia;	chr10:102925780	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs1046411	MIMAT0005951	hsa-miR-1307-3p	3.82	0.000144	0.07	0.12	Arsenic metabolism;	chr10:103078059	chr10:103394301~103394322:-
BRCA	cis	rs4851551	0.543	rs35918372	MIMAT0019926	hsa-miR-4772-5p	3.81	0.000145	0.23	0.12	Blood protein levels;	chr2:102202803	chr2:102432300~102432321:+
BRCA	cis	rs74233809	1	rs11191454	MIMAT0022727	hsa-miR-1307-5p	-3.81	0.000145	-0.12	-0.12	Birth weight;	chr10:102900247	chr10:103394341~103394361:-
BRCA	cis	rs1355223	0.545	rs7106831	MIMAT0019776	hsa-miR-1343-3p	3.81	0.000147	0.12	0.12	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34857995	chr11:34941888~34941909:+
BRCA	cis	rs9527	0.59	rs7894959	MIMAT0005951	hsa-miR-1307-3p	3.81	0.000148	0.07	0.12	Arsenic metabolism;	chr10:102996425	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs10786744	MIMAT0005951	hsa-miR-1307-3p	-3.81	0.000148	-0.07	-0.12	Arsenic metabolism;	chr10:103185271	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs11191465	MIMAT0005951	hsa-miR-1307-3p	3.8	0.000151	0.08	0.12	Schizophrenia;	chr10:102925346	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs10883818	MIMAT0005951	hsa-miR-1307-3p	3.79	0.000157	0.07	0.12	Arsenic metabolism;	chr10:102999829	chr10:103394301~103394322:-
BRCA	cis	rs250677	0.522	rs1432798	MIMAT0003249	hsa-miR-584-5p	3.79	0.000158	0.13	0.12	Breast cancer;	chr5:149003782	chr5:149062373~149062394:-
BRCA	cis	rs4713675	0.584	rs7739505	MIMAT0022975	hsa-miR-3934-3p	-3.79	0.00016	-0.14	-0.12	Plateletcrit;	chr6:33702593	chr6:33698191~33698212:+
BRCA	cis	rs4851551	1	rs3917329	MIMAT0019926	hsa-miR-4772-5p	-3.78	0.000163	-0.23	-0.12	Blood protein levels;	chr2:102179403	chr2:102432300~102432321:+
BRCA	cis	rs4711336	1	rs764752	MIMAT0018349	hsa-miR-3934-5p	-3.78	0.000164	-0.13	-0.12	Height;	chr6:33690289	chr6:33698152~33698173:+
BRCA	cis	rs4711336	1	rs764754	MIMAT0018349	hsa-miR-3934-5p	-3.78	0.000164	-0.13	-0.12	Height;	chr6:33690533	chr6:33698152~33698173:+
BRCA	cis	rs10021731	0.725	rs1551742	MIMAT0003242	hsa-miR-577	3.78	0.000164	0.11	0.12	Optic disc area;	chr4:114485894	chr4:114656774~114656794:+
BRCA	cis	rs7829975	0.539	rs940031	MIMAT0019728	hsa-miR-4660	-3.78	0.000164	-0.14	-0.12	Mood instability;	chr8:8689338	chr8:9048453~9048475:+
BRCA	cis	rs17604090	0.756	rs10249388	MIMAT0004800	hsa-miR-550a-5p	3.78	0.000165	0.16	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29689519	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.756	rs10249388	MIMAT0004800_1	hsa-miR-550a-5p	3.78	0.000165	0.16	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29689519	chr7:32733002~32733024:+
BRCA	cis	rs9527	0.64	rs6584541	MIMAT0005951	hsa-miR-1307-3p	3.78	0.000165	0.07	0.12	Arsenic metabolism;	chr10:103169367	chr10:103394301~103394322:-
BRCA	cis	rs2400997	0.967	rs8008153	MIMAT0022923	hsa-miR-376b-5p	3.78	0.000168	0.11	0.12	Prostate cancer (SNP x SNP interaction);	chr14:101273343	chr14:101040459~101040480:+
BRCA	cis	rs1355223	0.525	rs7129517	MIMAT0019776	hsa-miR-1343-3p	3.78	0.000169	0.12	0.12	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34850689	chr11:34941888~34941909:+
BRCA	cis	rs1018697	1	rs7088711	MIMAT0022727	hsa-miR-1307-5p	-3.78	0.000169	-0.07	-0.12	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394341~103394361:-
BRCA	cis	rs7829975	0.84	rs572366	MIMAT0019728	hsa-miR-4660	3.77	0.00017	0.14	0.12	Mood instability;	chr8:8721284	chr8:9048453~9048475:+
BRCA	cis	rs4711336	1	rs2296740	MIMAT0022975	hsa-miR-3934-3p	-3.77	0.000171	-0.14	-0.12	Height;	chr6:33691759	chr6:33698191~33698212:+
BRCA	cis	rs6681460	0.834	rs2916	MIMAT0014979	hsa-miR-3117-3p	3.77	0.000172	0.13	0.12	Presence of antiphospholipid antibodies;	chr1:66751014	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.834	rs1280310	MIMAT0014979	hsa-miR-3117-3p	3.77	0.000172	0.13	0.12	Presence of antiphospholipid antibodies;	chr1:66751140	chr1:66628485~66628505:+
BRCA	cis	rs7897654	0.651	rs11191457	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000172	0.08	0.12	Schizophrenia;	chr10:102901951	chr10:103394301~103394322:-
BRCA	cis	rs56235845	0.694	rs36102285	MIMAT0005796	hsa-miR-1271-5p	-3.77	0.000173	-0.11	-0.12	Hematocrit;Hemoglobin concentration;	chr5:177347017	chr5:176367960~176367981:+
BRCA	cis	rs56235845	0.694	rs4532376	MIMAT0005796	hsa-miR-1271-5p	-3.77	0.000173	-0.11	-0.12	Hematocrit;Hemoglobin concentration;	chr5:177347402	chr5:176367960~176367981:+
BRCA	cis	rs10949834	0.652	rs2269082	MIMAT0003258	hsa-miR-590-5p	-3.77	0.000173	-0.09	-0.12	Verbal memory performance (residualized delayed recall change);	chr7:74105545	chr7:74191213~74191234:+
BRCA	cis	rs9527	0.59	rs7087459	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000174	0.07	0.12	Arsenic metabolism;	chr10:103031242	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs7088200	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000174	0.07	0.12	Arsenic metabolism;	chr10:103033478	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.641	rs11782886	MIMAT0019728	hsa-miR-4660	-3.77	0.000175	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9730381	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.651	rs7922349	MIMAT0005951	hsa-miR-1307-3p	3.76	0.000176	0.08	0.12	Schizophrenia;	chr10:102929701	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs12416441	MIMAT0005951	hsa-miR-1307-3p	3.76	0.000176	0.08	0.12	Schizophrenia;	chr10:102930233	chr10:103394301~103394322:-
BRCA	cis	rs7929679	0.875	rs11032874	MIMAT0019776	hsa-miR-1343-3p	3.76	0.000177	0.11	0.12	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34785060	chr11:34941888~34941909:+
BRCA	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-3.76	0.000177	-0.14	-0.12	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
BRCA	cis	rs4713675	0.584	rs9380375	MIMAT0022975	hsa-miR-3934-3p	-3.76	0.000178	-0.14	-0.12	Plateletcrit;	chr6:33714614	chr6:33698191~33698212:+
BRCA	cis	rs4676380	0.927	rs1583259	MIMAT0000450	hsa-miR-149-5p	3.76	0.000179	0.12	0.12	Response to metformin (IC50);	chr2:240705517	chr2:240456015~240456037:+
BRCA	cis	rs9527	0.59	rs7920868	MIMAT0005951	hsa-miR-1307-3p	3.76	0.000181	0.07	0.12	Arsenic metabolism;	chr10:103035652	chr10:103394301~103394322:-
BRCA	cis	rs35275482	0.646	rs8031153	MIMAT0011161	hsa-miR-2116-3p	3.76	0.000182	0.14	0.12	Gut microbiota (bacterial taxa);	chr15:59834292	chr15:59171192~59171212:-
BRCA	cis	rs2302612	0.58	rs11123913	MIMAT0019926	hsa-miR-4772-5p	3.75	0.000184	0.12	0.12	Serum protein levels (sST2);	chr2:102209019	chr2:102432300~102432321:+
BRCA	cis	rs1018697	0.897	rs2150929	MIMAT0022727	hsa-miR-1307-5p	3.75	0.000185	0.07	0.12	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394341~103394361:-
BRCA	cis	rs7594645	0.59	rs7605735	MIMAT0014995	hsa-miR-3130-5p	3.75	0.000185	0.21	0.12	Episodic memory;	chr2:206820890	chr2:206783276~206783296:-
BRCA	cis	rs7594645	0.59	rs7605735	MIMAT0014995_1	hsa-miR-3130-5p	3.75	0.000185	0.21	0.12	Episodic memory;	chr2:206820890	chr2:206783246~206783266:+
BRCA	cis	rs1018697	1	rs7086400	MIMAT0022727	hsa-miR-1307-5p	3.75	0.000186	0.07	0.12	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394341~103394361:-
BRCA	cis	rs9527	0.641	rs10786732	MIMAT0005951	hsa-miR-1307-3p	3.75	0.000187	0.07	0.12	Arsenic metabolism;	chr10:103002778	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.606	rs9644707	MIMAT0019728	hsa-miR-4660	-3.75	0.000188	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9732606	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.61	rs10883822	MIMAT0005951	hsa-miR-1307-3p	3.75	0.000188	0.08	0.12	Schizophrenia;	chr10:103036895	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs12415388	MIMAT0005951	hsa-miR-1307-3p	3.75	0.000188	0.07	0.12	Arsenic metabolism;	chr10:103036588	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.834	rs544258	MIMAT0014979	hsa-miR-3117-3p	3.74	0.000191	0.14	0.12	Presence of antiphospholipid antibodies;	chr1:66753526	chr1:66628485~66628505:+
BRCA	cis	rs6601327	0.641	rs7014663	MIMAT0019728	hsa-miR-4660	-3.74	0.000191	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9729765	chr8:9048453~9048475:+
BRCA	cis	rs2400997	0.967	rs2226074	MIMAT0022861	hsa-miR-376c-5p	-3.74	0.000192	-0.11	-0.12	Prostate cancer (SNP x SNP interaction);	chr14:101274577	chr14:101039694~101039714:+
BRCA	cis	rs7829975	0.533	rs13274028	MIMAT0019728	hsa-miR-4660	3.74	0.000192	0.14	0.12	Mood instability;	chr8:8871683	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-3.74	0.000194	-0.13	-0.12	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
BRCA	cis	rs61008539	0.893	rs7783487	MIMAT0004702	hsa-miR-339-3p	-3.74	0.000195	-0.1	-0.12	Perceived unattractiveness to mosquitoes;	chr7:820523	chr7:1022955~1022977:-
BRCA	cis	rs7894407	1	rs7894407	MIMAT0022727	hsa-miR-1307-5p	3.74	0.000195	0.07	0.12	White matter hyperintensity burden;	chr10:103416422	chr10:103394341~103394361:-
BRCA	cis	rs9527	0.662	rs10786714	MIMAT0005951	hsa-miR-1307-3p	3.74	0.000195	0.08	0.12	Arsenic metabolism;	chr10:102838849	chr10:103394301~103394322:-
BRCA	cis	rs263063	0.92	rs2240678	MIMAT0019880	hsa-miR-4746-5p	-3.74	0.000196	-0.21	-0.12	Periodontitis (CDC/AAP);	chr19:5041167	chr19:4445987~4446009:+
BRCA	cis	rs79387448	1	rs79387448	MIMAT0019926	hsa-miR-4772-5p	-3.74	0.000196	-0.18	-0.12	Gut microbiota (bacterial taxa);	chr2:102598951	chr2:102432300~102432321:+
BRCA	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	3.74	0.000196	0.13	0.12	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
BRCA	cis	rs6601327	0.551	rs13272424	MIMAT0019728	hsa-miR-4660	-3.74	0.000196	-0.14	-0.12	Multiple myeloma (hyperdiploidy);	chr8:9717809	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs3781285	MIMAT0005951	hsa-miR-1307-3p	-3.74	0.000197	-0.12	-0.12	Birth weight;	chr10:103065908	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.878	rs4000284	MIMAT0004800	hsa-miR-550a-5p	3.74	0.000197	0.16	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29687301	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.878	rs4000284	MIMAT0004800_1	hsa-miR-550a-5p	3.74	0.000197	0.16	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29687301	chr7:32733002~32733024:+
BRCA	cis	rs4711336	1	rs4711336	MIMAT0018349	hsa-miR-3934-5p	3.74	0.000198	0.13	0.12	Height;	chr6:33691269	chr6:33698152~33698173:+
BRCA	cis	rs17604090	0.938	rs68158127	MIMAT0004800	hsa-miR-550a-5p	3.73	0.000198	0.17	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645082	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs68158127	MIMAT0004800_1	hsa-miR-550a-5p	3.73	0.000198	0.17	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645082	chr7:32733002~32733024:+
BRCA	cis	rs6681460	0.866	rs485521	MIMAT0014979	hsa-miR-3117-3p	3.73	0.000198	0.13	0.12	Presence of antiphospholipid antibodies;	chr1:66743879	chr1:66628485~66628505:+
BRCA	cis	rs17604090	0.938	rs10276157	MIMAT0004800	hsa-miR-550a-5p	3.73	2e-04	0.19	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29625400	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs10276157	MIMAT0004800_1	hsa-miR-550a-5p	3.73	2e-04	0.19	0.12	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29625400	chr7:32733002~32733024:+
BRCA	cis	rs2284932	0.591	rs2269078	MIMAT0016895	hsa-miR-2355-5p	3.73	0.000201	0.14	0.12	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207121339	chr2:207110043~207110063:-
BRCA	cis	rs7897654	0.61	rs12569364	MIMAT0005951	hsa-miR-1307-3p	3.73	0.000203	0.08	0.12	Schizophrenia;	chr10:102993750	chr10:103394301~103394322:-
BRCA	cis	rs56235845	0.694	rs12055081	MIMAT0005796	hsa-miR-1271-5p	-3.73	0.000205	-0.11	-0.12	Hematocrit;Hemoglobin concentration;	chr5:177330190	chr5:176367960~176367981:+
BRCA	cis	rs9527	0.59	rs4917992	MIMAT0005951	hsa-miR-1307-3p	3.72	0.000206	0.07	0.12	Arsenic metabolism;	chr10:103026556	chr10:103394301~103394322:-
BRCA	cis	rs12682352	0.602	rs635594	MIMAT0019728	hsa-miR-4660	-3.72	0.000206	-0.14	-0.12	Neuroticism;	chr8:8755877	chr8:9048453~9048475:+
BRCA	cis	rs1950626	0.623	rs4402490	MIMAT0022698	hsa-miR-345-3p	3.72	0.000207	0.14	0.12	Pelvic organ prolapse (moderate/severe);	chr14:100979116	chr14:100307912~100307933:+
BRCA	cis	rs7829975	0.533	rs1039917	MIMAT0019728	hsa-miR-4660	3.72	0.000209	0.14	0.11	Mood instability;	chr8:8861340	chr8:9048453~9048475:+
BRCA	cis	rs7072216	0.77	rs7896828	MIMAT0026738	hsa-miR-1287-3p	3.72	0.00021	0.1	0.11	Metabolite levels;	chr10:98410750	chr10:98395232~98395253:-
BRCA	cis	rs74233809	1	rs79668541	MIMAT0005951	hsa-miR-1307-3p	-3.72	0.000213	-0.12	-0.11	Birth weight;	chr10:103034147	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs7073323	MIMAT0005951	hsa-miR-1307-3p	3.72	0.000213	0.07	0.11	Arsenic metabolism;	chr10:103037666	chr10:103394301~103394322:-
BRCA	cis	rs17710780	1	rs17710855	MIMAT0000731	hsa-miR-378a-5p	-3.72	0.000213	-0.15	-0.11	Major depressive disorder;	chr5:149686294	chr5:149732829~149732850:+
BRCA	cis	rs7226408	0.842	rs62083203	MIMAT0000262	hsa-miR-187-3p	3.72	0.000214	0.23	0.11	Obesity-related traits;	chr18:36772544	chr18:35904835~35904856:-
BRCA	cis	rs7929679	0.875	rs11032867	MIMAT0019776	hsa-miR-1343-3p	3.71	0.000215	0.11	0.11	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34782001	chr11:34941888~34941909:+
BRCA	cis	rs1018697	1	rs4919677	MIMAT0022727	hsa-miR-1307-5p	3.71	0.000219	0.07	0.11	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394341~103394361:-
BRCA	cis	rs1018697	1	rs7073114	MIMAT0022727	hsa-miR-1307-5p	3.71	0.000221	0.07	0.11	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394341~103394361:-
BRCA	cis	rs56235845	0.694	rs6876677	MIMAT0005796	hsa-miR-1271-5p	-3.71	0.000221	-0.11	-0.11	Hematocrit;Hemoglobin concentration;	chr5:177328341	chr5:176367960~176367981:+
BRCA	cis	rs13256369	1	rs13266699	MIMAT0019728	hsa-miR-4660	-3.71	0.000222	-0.16	-0.11	Obesity-related traits;	chr8:8712803	chr8:9048453~9048475:+
BRCA	cis	rs13256369	0.802	rs11249884	MIMAT0019728	hsa-miR-4660	-3.7	0.000223	-0.16	-0.11	Obesity-related traits;	chr8:8704042	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.641	rs11778555	MIMAT0019728	hsa-miR-4660	-3.7	0.000226	-0.14	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9730064	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.641	rs11785923	MIMAT0019728	hsa-miR-4660	-3.7	0.000226	-0.14	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9730164	chr8:9048453~9048475:+
BRCA	cis	rs4713675	0.565	rs9469566	MIMAT0022975	hsa-miR-3934-3p	-3.7	0.000226	-0.14	-0.11	Plateletcrit;	chr6:33699828	chr6:33698191~33698212:+
BRCA	cis	rs1018697	1	rs10748830	MIMAT0022727	hsa-miR-1307-5p	3.7	0.000229	0.07	0.11	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394341~103394361:-
BRCA	cis	rs4713675	0.565	rs942640	MIMAT0022975	hsa-miR-3934-3p	-3.7	0.000229	-0.14	-0.11	Plateletcrit;	chr6:33718665	chr6:33698191~33698212:+
BRCA	cis	rs1355223	0.525	rs7129533	MIMAT0019776	hsa-miR-1343-3p	3.7	0.000231	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34850745	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.525	rs55796371	MIMAT0019776	hsa-miR-1343-3p	3.7	0.000231	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34851222	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.525	rs12280958	MIMAT0019776	hsa-miR-1343-3p	3.7	0.000231	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34851252	chr11:34941888~34941909:+
BRCA	cis	rs13256369	0.851	rs13267036	MIMAT0019728	hsa-miR-4660	3.69	0.000232	0.16	0.11	Obesity-related traits;	chr8:8709175	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.54	rs12542912	MIMAT0019728	hsa-miR-4660	-3.69	0.000234	-0.14	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9727686	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs17654621	MIMAT0000732	hsa-miR-378a-3p	-3.69	0.000237	-0.14	-0.11	Major depressive disorder;	chr5:149709271	chr5:149732867~149732888:+
BRCA	cis	rs73198271	0.813	rs17697237	MIMAT0019728	hsa-miR-4660	3.69	0.000238	0.15	0.11	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8758364	chr8:9048453~9048475:+
BRCA	cis	rs1355223	0.545	rs7123029	MIMAT0019776	hsa-miR-1343-3p	3.69	0.000239	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34853268	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.545	rs7111695	MIMAT0019776	hsa-miR-1343-3p	3.69	0.000239	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34853359	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.507	rs11032903	MIMAT0019776	hsa-miR-1343-3p	3.69	0.000239	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34854629	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.545	rs12278318	MIMAT0019776	hsa-miR-1343-3p	3.69	0.000239	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34854960	chr11:34941888~34941909:+
BRCA	cis	rs9527	0.521	rs12259163	MIMAT0005951	hsa-miR-1307-3p	3.69	0.000239	0.07	0.11	Arsenic metabolism;	chr10:103201720	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs75970938	MIMAT0005951	hsa-miR-1307-3p	-3.69	0.00024	-0.12	-0.11	Birth weight;	chr10:103033891	chr10:103394301~103394322:-
BRCA	cis	rs2400997	0.967	rs8008153	MIMAT0022861	hsa-miR-376c-5p	3.69	0.00024	0.11	0.11	Prostate cancer (SNP x SNP interaction);	chr14:101273343	chr14:101039694~101039714:+
BRCA	cis	rs189798	0.738	rs330908	MIMAT0019728	hsa-miR-4660	3.68	0.000242	0.15	0.11	Myopia (pathological);	chr8:9137656	chr8:9048453~9048475:+
BRCA	cis	rs2288884	0.634	rs74476955	MIMAT0000066	hsa-let-7e-5p	-3.68	0.000243	-0.17	-0.11	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:51997806	chr19:51692793~51692814:+
BRCA	cis	rs2288884	0.596	rs12459638	MIMAT0000066	hsa-let-7e-5p	-3.68	0.000243	-0.17	-0.11	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:51998549	chr19:51692793~51692814:+
BRCA	cis	rs9527	0.59	rs12785223	MIMAT0005951	hsa-miR-1307-3p	-3.68	0.000244	-0.07	-0.11	Arsenic metabolism;	chr10:103084254	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs7906754	MIMAT0005951	hsa-miR-1307-3p	3.68	0.000245	0.07	0.11	Arsenic metabolism;	chr10:103022800	chr10:103394301~103394322:-
BRCA	cis	rs2288884	0.541	rs7508746	MIMAT0000066	hsa-let-7e-5p	-3.68	0.000246	-0.17	-0.11	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:51990246	chr19:51692793~51692814:+
BRCA	cis	rs4713675	0.584	rs4711339	MIMAT0022975	hsa-miR-3934-3p	-3.68	0.000246	-0.14	-0.11	Plateletcrit;	chr6:33699422	chr6:33698191~33698212:+
BRCA	cis	rs6601327	0.606	rs4841204	MIMAT0019728	hsa-miR-4660	-3.68	0.000248	-0.14	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9725897	chr8:9048453~9048475:+
BRCA	cis	rs4237845	0.611	rs7298370	MIMAT0000082	hsa-miR-26a-5p	3.68	0.000248	0.08	0.11	Intelligence (multi-trait analysis);	chr12:57925114	chr12:57824658~57824679:-
BRCA	cis	rs4237845	0.611	rs7298370	MIMAT0000082_1	hsa-miR-26a-5p	3.68	0.000248	0.08	0.11	Intelligence (multi-trait analysis);	chr12:57925114	chr3:37969413~37969434:+
BRCA	cis	rs1355223	0.525	rs10836316	MIMAT0019776	hsa-miR-1343-3p	3.68	0.000248	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34852748	chr11:34941888~34941909:+
BRCA	cis	rs6601327	0.607	rs35316422	MIMAT0019728	hsa-miR-4660	-3.68	0.00025	-0.14	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9717619	chr8:9048453~9048475:+
BRCA	cis	rs13161895	0.877	rs13166286	MIMAT0004692	hsa-miR-340-5p	3.67	0.00025	0.17	0.11	LDL cholesterol;	chr5:180027656	chr5:180015361~180015382:-
BRCA	cis	rs12438945	0.565	rs12440505	MIMAT0003297	hsa-miR-628-3p	-3.67	0.000251	-0.17	-0.11	Glucose homeostasis traits;	chr15:54858604	chr15:55372954~55372974:-
BRCA	cis	rs7897654	0.61	rs10786731	MIMAT0005951	hsa-miR-1307-3p	3.67	0.000254	0.08	0.11	Schizophrenia;	chr10:102992024	chr10:103394301~103394322:-
BRCA	cis	rs2284932	0.556	rs6727168	MIMAT0016895	hsa-miR-2355-5p	-3.67	0.000255	-0.13	-0.11	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207124746	chr2:207110043~207110063:-
BRCA	cis	rs9527	0.59	rs10883839	MIMAT0005951	hsa-miR-1307-3p	3.67	0.000257	0.07	0.11	Arsenic metabolism;	chr10:103160584	chr10:103394301~103394322:-
BRCA	cis	rs12701220	0.503	rs12702024	MIMAT0000764	hsa-miR-339-5p	3.67	0.000257	0.12	0.11	Bronchopulmonary dysplasia;	chr7:1090184	chr7:1022990~1023012:-
BRCA	cis	rs17604090	0.878	rs10262227	MIMAT0004800	hsa-miR-550a-5p	3.67	0.000258	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29664457	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.878	rs10262227	MIMAT0004800_1	hsa-miR-550a-5p	3.67	0.000258	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29664457	chr7:32733002~32733024:+
BRCA	cis	rs6700896	0.5	rs10736403	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65674713	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.5	rs10749756	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65674828	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs1938500	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65675819	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs1938501	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65675901	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs1938502	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65675941	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs12567606	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65676201	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs12117858	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65676411	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs4655779	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65676847	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs11208708	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65676944	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs4655780	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677094	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.5	rs78263866	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677128	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs4655781	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677200	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs4655782	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677289	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs4655784	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677416	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs12023864	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677653	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs12038180	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65677766	chr1:65058477~65058498:-
BRCA	cis	rs11208691	0.513	rs55737039	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Lymphocyte percentage of white cells;	chr1:65677878	chr1:65058477~65058498:-
BRCA	cis	rs11208691	0.513	rs55973636	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Lymphocyte percentage of white cells;	chr1:65677883	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs12141410	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65678136	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs67787610	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65679469	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs12026918	MIMAT0004513	hsa-miR-101-5p	3.67	0.000259	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65680563	chr1:65058477~65058498:-
BRCA	cis	rs6700896	0.522	rs56964262	MIMAT0004513	hsa-miR-101-5p	3.66	0.000261	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65678055	chr1:65058477~65058498:-
BRCA	cis	rs35275482	0.646	rs7182438	MIMAT0011161	hsa-miR-2116-3p	3.66	0.000262	0.14	0.11	Gut microbiota (bacterial taxa);	chr15:59827793	chr15:59171192~59171212:-
BRCA	cis	rs7829975	0.508	rs4841006	MIMAT0019728	hsa-miR-4660	-3.66	0.000262	-0.14	-0.11	Mood instability;	chr8:8643964	chr8:9048453~9048475:+
BRCA	cis	rs56235845	0.694	rs9313758	MIMAT0005796	hsa-miR-1271-5p	-3.66	0.000267	-0.11	-0.11	Hematocrit;Hemoglobin concentration;	chr5:177346090	chr5:176367960~176367981:+
BRCA	cis	rs9527	0.59	rs11191547	MIMAT0005951	hsa-miR-1307-3p	3.66	0.000267	0.07	0.11	Arsenic metabolism;	chr10:103083391	chr10:103394301~103394322:-
BRCA	cis	rs4713675	0.584	rs3818527	MIMAT0018349	hsa-miR-3934-5p	3.66	0.000267	0.12	0.11	Plateletcrit;	chr6:33693258	chr6:33698152~33698173:+
BRCA	cis	rs7894407	0.856	rs7093667	MIMAT0022727	hsa-miR-1307-5p	-3.66	0.000268	-0.07	-0.11	White matter hyperintensity burden;	chr10:103320818	chr10:103394341~103394361:-
BRCA	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-3.65	0.00027	-0.13	-0.11	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
BRCA	cis	rs12197419	1	rs12197419	MIMAT0025851	hsa-miR-6720-3p	-3.65	0.000273	-0.13	-0.11	Monobrow thickness;	chr6:1708803	chr6:1390324~1390345:-
BRCA	cis	rs9527	0.615	rs4917991	MIMAT0005951	hsa-miR-1307-3p	3.65	0.000276	0.07	0.11	Arsenic metabolism;	chr10:103024076	chr10:103394301~103394322:-
BRCA	cis	rs11976180	0.569	rs12703565	MIMAT0027684	hsa-miR-6892-5p	-3.65	0.000276	-0.2	-0.11	Obesity-related traits;	chr7:144057308	chr7:143382686~143382706:+
BRCA	cis	rs17604090	0.816	rs10248839	MIMAT0004800	hsa-miR-550a-5p	3.65	0.000276	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29657637	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.816	rs10248839	MIMAT0004800_1	hsa-miR-550a-5p	3.65	0.000276	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29657637	chr7:32733002~32733024:+
BRCA	cis	rs1018697	1	rs7092051	MIMAT0022727	hsa-miR-1307-5p	3.65	0.00028	0.07	0.11	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394341~103394361:-
BRCA	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	3.64	0.000282	0.12	0.11	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
BRCA	cis	rs1018697	1	rs7092346	MIMAT0022727	hsa-miR-1307-5p	3.64	0.000286	0.07	0.11	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394341~103394361:-
BRCA	cis	rs7897654	0.651	rs12355897	MIMAT0005951	hsa-miR-1307-3p	3.64	0.000287	0.08	0.11	Schizophrenia;	chr10:102926900	chr10:103394301~103394322:-
BRCA	cis	rs7851726	1	rs4385527	MIMAT0019208	hsa-miR-3074-5p	-3.64	0.000288	-0.11	-0.11	Urinary albumin-to-creatinine ratio;	chr9:94886305	chr9:95086063~95086083:-
BRCA	cis	rs13256369	0.951	rs13270852	MIMAT0019728	hsa-miR-4660	3.64	0.000289	0.16	0.11	Obesity-related traits;	chr8:8709343	chr8:9048453~9048475:+
BRCA	cis	rs17604090	0.878	rs4457221	MIMAT0004800	hsa-miR-550a-5p	3.63	0.000294	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29662158	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.878	rs4457221	MIMAT0004800_1	hsa-miR-550a-5p	3.63	0.000294	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29662158	chr7:32733002~32733024:+
BRCA	cis	rs953492	0.831	rs2802723	MIMAT0019761	hsa-miR-4677-3p	-3.63	0.000295	-0.11	-0.11	Diastolic blood pressure;	chr1:243335010	chr1:243346225~243346246:+
BRCA	cis	rs13256369	0.95	rs13248096	MIMAT0019728	hsa-miR-4660	3.63	0.000295	0.15	0.11	Obesity-related traits;	chr8:8719966	chr8:9048453~9048475:+
BRCA	cis	rs250677	0.641	rs2915807	MIMAT0003249	hsa-miR-584-5p	3.63	0.000297	0.14	0.11	Breast cancer;	chr5:149071387	chr5:149062373~149062394:-
BRCA	cis	rs7829975	0.564	rs2921060	MIMAT0019728	hsa-miR-4660	-3.63	0.000298	-0.14	-0.11	Mood instability;	chr8:8460307	chr8:9048453~9048475:+
BRCA	cis	rs10949834	0.618	rs810551	MIMAT0003258	hsa-miR-590-5p	-3.63	0.000301	-0.08	-0.11	Verbal memory performance (residualized delayed recall change);	chr7:74077763	chr7:74191213~74191234:+
BRCA	cis	rs1018697	1	rs11191397	MIMAT0022727	hsa-miR-1307-5p	3.63	0.000302	0.07	0.11	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394341~103394361:-
BRCA	cis	rs61008539	0.821	rs10950789	MIMAT0004702	hsa-miR-339-3p	-3.62	0.000303	-0.1	-0.11	Perceived unattractiveness to mosquitoes;	chr7:857855	chr7:1022955~1022977:-
BRCA	cis	rs6717918	0.816	rs11901692	MIMAT0019935	hsa-miR-4777-3p	-3.62	0.000305	-0.14	-0.11	Height;	chr2:232285029	chr2:231362764~231362785:+
BRCA	cis	rs13256369	0.802	rs12681326	MIMAT0019728	hsa-miR-4660	3.62	0.000305	0.16	0.11	Obesity-related traits;	chr8:8708879	chr8:9048453~9048475:+
BRCA	cis	rs17604090	0.823	rs28415620	MIMAT0004800	hsa-miR-550a-5p	3.62	0.000307	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29661488	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.823	rs28415620	MIMAT0004800_1	hsa-miR-550a-5p	3.62	0.000307	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29661488	chr7:32733002~32733024:+
BRCA	cis	rs2400997	0.967	rs9707405	MIMAT0022923	hsa-miR-376b-5p	-3.62	0.000309	-0.11	-0.11	Prostate cancer (SNP x SNP interaction);	chr14:101276857	chr14:101040459~101040480:+
BRCA	cis	rs1018697	1	rs6584525	MIMAT0022727	hsa-miR-1307-5p	3.62	0.00031	0.07	0.11	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394341~103394361:-
BRCA	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.00031	-0.13	-0.11	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
BRCA	cis	rs12431410	0.536	rs2182139	MIMAT0022287	hsa-miR-5586-5p	-3.62	0.000311	-0.14	-0.11	Schizophrenia;	chr14:59682515	chr14:59646999~59647020:-
BRCA	cis	rs56235845	0.694	rs4976643	MIMAT0005796	hsa-miR-1271-5p	-3.62	0.000314	-0.11	-0.11	Hematocrit;Hemoglobin concentration;	chr5:177333226	chr5:176367960~176367981:+
BRCA	cis	rs74233809	1	rs11191505	MIMAT0005951	hsa-miR-1307-3p	-3.62	0.000314	-0.11	-0.11	Birth weight;	chr10:103007134	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-3.61	0.000316	-0.11	-0.11	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs7899622	MIMAT0005951	hsa-miR-1307-3p	3.61	0.000317	0.07	0.11	Arsenic metabolism;	chr10:102967576	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.579	rs12766187	MIMAT0005951	hsa-miR-1307-3p	3.61	0.000319	0.08	0.11	Schizophrenia;	chr10:103007117	chr10:103394301~103394322:-
BRCA	cis	rs61008539	0.893	rs4721502	MIMAT0004702	hsa-miR-339-3p	-3.61	0.000322	-0.1	-0.11	Perceived unattractiveness to mosquitoes;	chr7:822549	chr7:1022955~1022977:-
BRCA	cis	rs656319	0.638	rs670044	MIMAT0019728	hsa-miR-4660	3.61	0.000322	0.14	0.11	Myopia (pathological);	chr8:10035019	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs79082900	MIMAT0022727	hsa-miR-1307-5p	-3.61	0.000322	-0.11	-0.11	Birth weight;	chr10:103117545	chr10:103394341~103394361:-
BRCA	cis	rs2274459	1	rs3793080	MIMAT0018349	hsa-miR-3934-5p	-3.61	0.000326	-0.17	-0.11	Obesity (extreme);	chr6:33800026	chr6:33698152~33698173:+
BRCA	cis	rs12701220	0.553	rs34062359	MIMAT0000764	hsa-miR-339-5p	3.6	0.000327	0.12	0.11	Bronchopulmonary dysplasia;	chr7:1099440	chr7:1022990~1023012:-
BRCA	cis	rs56235845	0.694	rs6875461	MIMAT0005796	hsa-miR-1271-5p	3.6	0.00033	0.1	0.11	Hematocrit;Hemoglobin concentration;	chr5:177327664	chr5:176367960~176367981:+
BRCA	cis	rs4237845	0.611	rs4583019	MIMAT0000082	hsa-miR-26a-5p	3.6	0.00033	0.08	0.11	Intelligence (multi-trait analysis);	chr12:57922962	chr12:57824658~57824679:-
BRCA	cis	rs4237845	0.611	rs4583019	MIMAT0000082_1	hsa-miR-26a-5p	3.6	0.00033	0.08	0.11	Intelligence (multi-trait analysis);	chr12:57922962	chr3:37969413~37969434:+
BRCA	cis	rs61008539	0.853	rs10950611	MIMAT0004702	hsa-miR-339-3p	-3.6	0.000332	-0.1	-0.11	Perceived unattractiveness to mosquitoes;	chr7:821457	chr7:1022955~1022977:-
BRCA	cis	rs2274459	1	rs3806107	MIMAT0018349	hsa-miR-3934-5p	3.6	0.000332	0.17	0.11	Obesity (extreme);	chr6:33799636	chr6:33698152~33698173:+
BRCA	cis	rs10216189	0.785	rs4352753	MIMAT0004799	hsa-miR-589-5p	-3.6	0.000333	-0.11	-0.11	Relative hand skill in reading disability;	chr7:5487592	chr7:5495873~5495894:-
BRCA	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	3.6	0.000335	0.13	0.11	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
BRCA	cis	rs6681460	0.671	rs628655	MIMAT0014979	hsa-miR-3117-3p	3.6	0.000338	0.13	0.11	Presence of antiphospholipid antibodies;	chr1:66747890	chr1:66628485~66628505:+
BRCA	cis	rs7897654	0.61	rs11191516	MIMAT0005951	hsa-miR-1307-3p	3.6	0.000339	0.08	0.11	Schizophrenia;	chr10:103018115	chr10:103394301~103394322:-
BRCA	cis	rs13256369	1	rs10098234	MIMAT0019728	hsa-miR-4660	3.59	0.00034	0.15	0.11	Obesity-related traits;	chr8:8719182	chr8:9048453~9048475:+
BRCA	cis	rs4713675	0.565	rs4713670	MIMAT0018349	hsa-miR-3934-5p	3.59	0.000341	0.12	0.11	Plateletcrit;	chr6:33732105	chr6:33698152~33698173:+
BRCA	cis	rs9527	0.59	rs10509764	MIMAT0005951	hsa-miR-1307-3p	3.59	0.000342	0.07	0.11	Arsenic metabolism;	chr10:103016718	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs6584537	MIMAT0005951	hsa-miR-1307-3p	3.59	0.000342	0.07	0.11	Arsenic metabolism;	chr10:103018510	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.569	rs78193706	MIMAT0005951	hsa-miR-1307-3p	3.59	0.000342	0.07	0.11	Arsenic metabolism;	chr10:103020807	chr10:103394301~103394322:-
BRCA	cis	rs17604090	1	rs10272065	MIMAT0004800	hsa-miR-550a-5p	3.59	0.000343	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29654620	chr7:30289815~30289837:+
BRCA	cis	rs17604090	1	rs10272065	MIMAT0004800_1	hsa-miR-550a-5p	3.59	0.000343	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29654620	chr7:32733002~32733024:+
BRCA	cis	rs13256369	0.851	rs13271698	MIMAT0019728	hsa-miR-4660	3.59	0.000343	0.16	0.11	Obesity-related traits;	chr8:8710029	chr8:9048453~9048475:+
BRCA	cis	rs74233809	0.605	rs999867	MIMAT0022727	hsa-miR-1307-5p	-3.59	0.000346	-0.1	-0.11	Birth weight;	chr10:102744807	chr10:103394341~103394361:-
BRCA	cis	rs17604090	0.938	rs68072609	MIMAT0004800	hsa-miR-550a-5p	3.59	0.000348	0.17	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29642851	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs68072609	MIMAT0004800_1	hsa-miR-550a-5p	3.59	0.000348	0.17	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29642851	chr7:32733002~32733024:+
BRCA	cis	rs1239947	0.643	rs1239945	MIMAT0000068	hsa-miR-15a-5p	3.59	0.000348	0.09	0.11	Height;	chr13:50533621	chr13:50049167~50049188:-
BRCA	cis	rs17604090	0.646	rs75322793	MIMAT0004800	hsa-miR-550a-5p	3.59	0.000352	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29643560	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.646	rs75322793	MIMAT0004800_1	hsa-miR-550a-5p	3.59	0.000352	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29643560	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.877	rs68169519	MIMAT0004800	hsa-miR-550a-5p	3.59	0.000352	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645542	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.877	rs68169519	MIMAT0004800_1	hsa-miR-550a-5p	3.59	0.000352	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645542	chr7:32733002~32733024:+
BRCA	cis	rs9527	0.615	rs7917295	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000355	0.07	0.11	Arsenic metabolism;	chr10:102941430	chr10:103394301~103394322:-
BRCA	cis	rs56235845	0.694	rs11748912	MIMAT0005796	hsa-miR-1271-5p	-3.58	0.000355	-0.1	-0.11	Hematocrit;Hemoglobin concentration;	chr5:177338394	chr5:176367960~176367981:+
BRCA	cis	rs11037473	0.737	rs4755198	MIMAT0000242	hsa-miR-129-5p	3.58	0.000357	0.25	0.11	Birth length;	chr11:43551649	chr11:43581408~43581428:+
BRCA	cis	rs11037473	0.737	rs4755198	MIMAT0000242_1	hsa-miR-129-5p	3.58	0.000357	0.25	0.11	Birth length;	chr11:43551649	chr7:128207876~128207896:+
BRCA	cis	rs6681460	0.932	rs536410	MIMAT0014979	hsa-miR-3117-3p	-3.58	0.000358	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66725401	chr1:66628485~66628505:+
BRCA	cis	rs9527	0.59	rs11191553	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000359	0.07	0.11	Arsenic metabolism;	chr10:103091639	chr10:103394301~103394322:-
BRCA	cis	rs1355223	0.506	rs11032899	MIMAT0019776	hsa-miR-1343-3p	3.58	0.00036	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848687	chr11:34941888~34941909:+
BRCA	cis	rs9329221	0.617	rs483916	MIMAT0019728	hsa-miR-4660	-3.58	0.000361	-0.13	-0.11	Neuroticism;	chr8:9936091	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.651	rs12778673	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000361	0.08	0.11	Schizophrenia;	chr10:102965413	chr10:103394301~103394322:-
BRCA	cis	rs1018697	1	rs7911528	MIMAT0022727	hsa-miR-1307-5p	3.58	0.000362	0.07	0.11	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394341~103394361:-
BRCA	cis	rs4237845	0.715	rs4760340	MIMAT0000082	hsa-miR-26a-5p	3.58	0.000363	0.08	0.11	Intelligence (multi-trait analysis);	chr12:57881393	chr12:57824658~57824679:-
BRCA	cis	rs4237845	0.715	rs4760340	MIMAT0000082_1	hsa-miR-26a-5p	3.58	0.000363	0.08	0.11	Intelligence (multi-trait analysis);	chr12:57881393	chr3:37969413~37969434:+
BRCA	cis	rs12682352	0.652	rs1567398	MIMAT0019728	hsa-miR-4660	-3.58	0.000363	-0.13	-0.11	Neuroticism;	chr8:8869294	chr8:9048453~9048475:+
BRCA	cis	rs7897654	0.62	rs7073716	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000364	0.08	0.11	Schizophrenia;	chr10:102933604	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs7093461	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000364	0.08	0.11	Schizophrenia;	chr10:102933722	chr10:103394301~103394322:-
BRCA	cis	rs1018697	0.966	rs11191396	MIMAT0022727	hsa-miR-1307-5p	3.58	0.000364	0.06	0.11	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394341~103394361:-
BRCA	cis	rs7897654	0.61	rs34060850	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000365	0.08	0.11	Schizophrenia;	chr10:103004308	chr10:103394301~103394322:-
BRCA	cis	rs7897654	0.651	rs3897402	MIMAT0005951	hsa-miR-1307-3p	3.58	0.000365	0.08	0.11	Schizophrenia;	chr10:102945655	chr10:103394301~103394322:-
BRCA	cis	rs4711336	0.712	rs942641	MIMAT0022975	hsa-miR-3934-3p	-3.57	0.000367	-0.13	-0.11	Height;	chr6:33719230	chr6:33698191~33698212:+
BRCA	cis	rs7894407	0.856	rs10883855	MIMAT0022727	hsa-miR-1307-5p	-3.57	0.000369	-0.07	-0.11	White matter hyperintensity burden;	chr10:103332690	chr10:103394341~103394361:-
BRCA	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-3.57	0.000369	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
BRCA	cis	rs74233809	1	rs12219901	MIMAT0022727	hsa-miR-1307-5p	-3.57	0.000369	-0.11	-0.11	Birth weight;	chr10:103081210	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs10458729	MIMAT0022727	hsa-miR-1307-5p	-3.57	0.000369	-0.11	-0.11	Birth weight;	chr10:103081722	chr10:103394341~103394361:-
BRCA	cis	rs17604090	0.877	rs57253003	MIMAT0004800	hsa-miR-550a-5p	3.57	0.00037	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29646940	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.877	rs57253003	MIMAT0004800_1	hsa-miR-550a-5p	3.57	0.00037	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29646940	chr7:32733002~32733024:+
BRCA	cis	rs9527	0.569	rs10883801	MIMAT0005951	hsa-miR-1307-3p	3.57	0.000376	0.07	0.11	Arsenic metabolism;	chr10:102918130	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs11191515	MIMAT0005951	hsa-miR-1307-3p	-3.57	0.000378	-0.12	-0.11	Birth weight;	chr10:103016770	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs943037	MIMAT0022727	hsa-miR-1307-5p	-3.57	0.00038	-0.11	-0.11	Birth weight;	chr10:103076162	chr10:103394341~103394361:-
BRCA	cis	rs17604090	0.818	rs28390296	MIMAT0004800	hsa-miR-550a-5p	3.57	0.00038	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647475	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.818	rs28390296	MIMAT0004800_1	hsa-miR-550a-5p	3.57	0.00038	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647475	chr7:32733002~32733024:+
BRCA	cis	rs12744534	0.515	rs10919527	MIMAT0005885	hsa-miR-1295a	3.56	0.000386	0.17	0.11	Hip circumference adjusted for BMI;	chr1:170909593	chr1:171101738~171101758:-
BRCA	cis	rs9527	0.615	rs17725614	MIMAT0005951	hsa-miR-1307-3p	3.56	0.000387	0.07	0.11	Arsenic metabolism;	chr10:102925736	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.641	rs12155819	MIMAT0019728	hsa-miR-4660	-3.56	0.000388	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9715169	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.7	rs12114661	MIMAT0019728	hsa-miR-4660	-3.56	0.000388	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9715644	chr8:9048453~9048475:+
BRCA	cis	rs1355223	0.506	rs11032898	MIMAT0019776	hsa-miR-1343-3p	3.56	0.000388	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848564	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.506	rs1828299	MIMAT0019776	hsa-miR-1343-3p	3.56	0.000388	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848871	chr11:34941888~34941909:+
BRCA	cis	rs6601327	0.641	rs6601350	MIMAT0019728	hsa-miR-4660	-3.56	0.000388	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9716446	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.615	rs10883800	MIMAT0005951	hsa-miR-1307-3p	3.56	0.000389	0.07	0.11	Arsenic metabolism;	chr10:102911455	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs7073295	MIMAT0005951	hsa-miR-1307-3p	3.56	0.000389	0.07	0.11	Arsenic metabolism;	chr10:102912476	chr10:103394301~103394322:-
BRCA	cis	rs17428041	0.843	rs11784721	MIMAT0000510	hsa-miR-320a-3p	-3.56	0.000392	-0.16	-0.11	Neuropathic pain in type 2 diabetes;	chr8:21864963	chr8:22244975~22244996:-
BRCA	cis	rs13256369	1	rs10088439	MIMAT0019728	hsa-miR-4660	3.56	0.000392	0.15	0.11	Obesity-related traits;	chr8:8719189	chr8:9048453~9048475:+
BRCA	cis	rs4237845	1	rs4237845	MIMAT0000082	hsa-miR-26a-5p	-3.56	0.000395	-0.08	-0.11	Intelligence (multi-trait analysis);	chr12:57908653	chr12:57824658~57824679:-
BRCA	cis	rs4237845	1	rs4237845	MIMAT0000082_1	hsa-miR-26a-5p	-3.56	0.000395	-0.08	-0.11	Intelligence (multi-trait analysis);	chr12:57908653	chr3:37969413~37969434:+
BRCA	cis	rs9527	0.615	rs10883810	MIMAT0005951	hsa-miR-1307-3p	3.55	0.000396	0.07	0.11	Arsenic metabolism;	chr10:102967467	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs10883811	MIMAT0005951	hsa-miR-1307-3p	3.55	0.000396	0.07	0.11	Arsenic metabolism;	chr10:102967522	chr10:103394301~103394322:-
BRCA	cis	rs4841134	1	rs4841134	MIMAT0019728	hsa-miR-4660	3.55	0.000396	0.13	0.11	Age-related disease endophenotypes;	chr8:9329014	chr8:9048453~9048475:+
BRCA	cis	rs79387448	0.745	rs74560841	MIMAT0019926	hsa-miR-4772-5p	-3.55	0.000396	-0.18	-0.11	Gut microbiota (bacterial taxa);	chr2:102532751	chr2:102432300~102432321:+
BRCA	cis	rs17604090	0.938	rs73088374	MIMAT0004800	hsa-miR-550a-5p	3.55	0.000399	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29615203	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs73088374	MIMAT0004800_1	hsa-miR-550a-5p	3.55	0.000399	0.18	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29615203	chr7:32733002~32733024:+
BRCA	cis	rs2274459	0.556	rs35250767	MIMAT0018349	hsa-miR-3934-5p	3.55	0.000401	0.15	0.11	Obesity (extreme);	chr6:33718063	chr6:33698152~33698173:+
BRCA	cis	rs7226408	0.842	rs1609426	MIMAT0000262	hsa-miR-187-3p	3.55	0.000404	0.2	0.11	Obesity-related traits;	chr18:36765624	chr18:35904835~35904856:-
BRCA	cis	rs6537837	1	rs3768486	MIMAT0000227	hsa-miR-197-3p	-3.55	0.000404	-0.09	-0.11	Major depressive disorder;	chr1:109581349	chr1:109598940~109598961:+
BRCA	cis	rs10455248	0.77	rs4320322	MIMAT0000088	hsa-miR-30a-3p	3.55	0.000409	0.11	0.11	Cognitive performance;	chr6:71759041	chr6:71403554~71403575:-
BRCA	cis	rs17604090	0.877	rs28516764	MIMAT0004800	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645629	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.877	rs28516764	MIMAT0004800_1	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645629	chr7:32733002~32733024:+
BRCA	cis	rs17604090	1	rs28420551	MIMAT0004800	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645737	chr7:30289815~30289837:+
BRCA	cis	rs17604090	1	rs28420551	MIMAT0004800_1	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645737	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.938	rs28664977	MIMAT0004800	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645753	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs28664977	MIMAT0004800_1	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645753	chr7:32733002~32733024:+
BRCA	cis	rs4713675	0.584	rs7759668	MIMAT0022975	hsa-miR-3934-3p	3.54	0.000413	0.14	0.11	Plateletcrit;	chr6:33702629	chr6:33698191~33698212:+
BRCA	cis	rs11992186	0.505	rs7845203	MIMAT0019728	hsa-miR-4660	3.54	0.000413	0.13	0.11	Neuroticism;	chr8:8287918	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000413	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
BRCA	cis	rs2284367	0.505	rs2300182	MIMAT0019776	hsa-miR-1343-3p	3.54	0.000413	0.16	0.11	Blood protein levels;	chr11:34446301	chr11:34941888~34941909:+
BRCA	cis	rs17604090	1	rs73297441	MIMAT0004800	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29644747	chr7:30289815~30289837:+
BRCA	cis	rs17604090	1	rs73297441	MIMAT0004800_1	hsa-miR-550a-5p	3.54	0.000413	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29644747	chr7:32733002~32733024:+
BRCA	cis	rs7826238	0.502	rs10503377	MIMAT0019728	hsa-miR-4660	3.54	0.000413	0.15	0.11	Systolic blood pressure;	chr8:8520912	chr8:9048453~9048475:+
BRCA	cis	rs7617773	0.925	rs7374376	MIMAT0000440	hsa-miR-191-5p	-3.54	0.000414	-0.08	-0.11	Coronary artery disease;	chr3:48131197	chr3:49020672~49020694:-
BRCA	cis	rs13256369	1	rs9329165	MIMAT0019728	hsa-miR-4660	-3.54	0.000416	-0.15	-0.11	Obesity-related traits;	chr8:8719132	chr8:9048453~9048475:+
BRCA	cis	rs13256369	1	rs12550458	MIMAT0019728	hsa-miR-4660	3.54	0.000416	0.15	0.11	Obesity-related traits;	chr8:8710322	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs12220375	MIMAT0022727	hsa-miR-1307-5p	-3.54	0.000417	-0.11	-0.11	Birth weight;	chr10:103141734	chr10:103394341~103394361:-
BRCA	cis	rs17710780	0.803	rs17654705	MIMAT0000731	hsa-miR-378a-5p	-3.54	0.000417	-0.14	-0.11	Major depressive disorder;	chr5:149721453	chr5:149732829~149732850:+
BRCA	cis	rs11992186	0.597	rs77717027	MIMAT0019728	hsa-miR-4660	-3.54	0.000418	-0.13	-0.11	Neuroticism;	chr8:8734122	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs12412038	MIMAT0022727	hsa-miR-1307-5p	-3.54	0.000418	-0.11	-0.11	Birth weight;	chr10:103096405	chr10:103394341~103394361:-
BRCA	cis	rs13256369	0.901	rs12679831	MIMAT0019728	hsa-miR-4660	3.54	0.000421	0.15	0.11	Obesity-related traits;	chr8:8708901	chr8:9048453~9048475:+
BRCA	cis	rs13256369	0.901	rs12681327	MIMAT0019728	hsa-miR-4660	3.54	0.000421	0.15	0.11	Obesity-related traits;	chr8:8708904	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000423	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
BRCA	cis	rs74233809	0.748	rs10786736	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.000424	-0.1	-0.11	Birth weight;	chr10:103089359	chr10:103394301~103394322:-
BRCA	cis	rs10216189	0.967	rs4724700	MIMAT0004799	hsa-miR-589-5p	-3.53	0.000429	-0.11	-0.11	Relative hand skill in reading disability;	chr7:5487158	chr7:5495873~5495894:-
BRCA	cis	rs74233809	1	rs12412038	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.000431	-0.11	-0.11	Birth weight;	chr10:103096405	chr10:103394301~103394322:-
BRCA	cis	rs244731	0.959	rs7721671	MIMAT0005796	hsa-miR-1271-5p	3.53	0.000433	0.12	0.11	Urate levels in lean individuals;	chr5:177203983	chr5:176367960~176367981:+
BRCA	cis	rs9693857	0.553	rs10100760	MIMAT0019728	hsa-miR-4660	-3.53	0.000433	-0.13	-0.11	Systolic blood pressure;	chr8:9513049	chr8:9048453~9048475:+
BRCA	cis	rs13256369	1	rs883648	MIMAT0019728	hsa-miR-4660	3.53	0.000435	0.15	0.11	Obesity-related traits;	chr8:8712011	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs7074395	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.000435	-0.07	-0.11	Arsenic metabolism;	chr10:103085171	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs1556960	MIMAT0005951	hsa-miR-1307-3p	3.53	0.000435	0.07	0.11	Arsenic metabolism;	chr10:102966916	chr10:103394301~103394322:-
BRCA	cis	rs4713675	0.565	rs4713674	MIMAT0022975	hsa-miR-3934-3p	3.53	0.000436	0.13	0.11	Plateletcrit;	chr6:33740392	chr6:33698191~33698212:+
BRCA	cis	rs11037473	1	rs11037472	MIMAT0000242	hsa-miR-129-5p	-3.53	0.000437	-0.24	-0.11	Birth length;	chr11:43554216	chr11:43581408~43581428:+
BRCA	cis	rs11037473	1	rs11037472	MIMAT0000242_1	hsa-miR-129-5p	-3.53	0.000437	-0.24	-0.11	Birth length;	chr11:43554216	chr7:128207876~128207896:+
BRCA	cis	rs1018697	1	rs10786710	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000438	0.06	0.11	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394341~103394361:-
BRCA	cis	rs2921036	0.503	rs7817832	MIMAT0019728	hsa-miR-4660	3.53	0.000438	0.16	0.11	Neuroticism;	chr8:8523311	chr8:9048453~9048475:+
BRCA	cis	rs6537837	1	rs6537837	MIMAT0000227	hsa-miR-197-3p	-3.53	0.000439	-0.09	-0.11	Major depressive disorder;	chr1:109577110	chr1:109598940~109598961:+
BRCA	cis	rs10426930	0.607	rs858415	MIMAT0019880	hsa-miR-4746-5p	-3.53	0.000439	-0.14	-0.11	Monocyte percentage of white cells;	chr19:5055985	chr19:4445987~4446009:+
BRCA	cis	rs246180	0.521	rs30245	MIMAT0009199	hsa-miR-365a-5p	-3.53	0.000439	-0.13	-0.11	Male-pattern baldness;	chr16:14284185	chr16:14309300~14309322:+
BRCA	cis	rs11142387	0.566	rs4745008	MIMAT0000265	hsa-miR-204-5p	-3.53	0.00044	-0.1	-0.11	Body mass index (SNP x SNP interaction);Intelligence (multi-trait analysis);Body mass index;	chr9:70374916	chr9:70810031~70810052:-
BRCA	cis	rs6681460	0.932	rs665319	MIMAT0014979	hsa-miR-3117-3p	-3.52	0.000443	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66709805	chr1:66628485~66628505:+
BRCA	cis	rs13256369	1	rs9329166	MIMAT0019728	hsa-miR-4660	3.52	0.000444	0.15	0.11	Obesity-related traits;	chr8:8719145	chr8:9048453~9048475:+
BRCA	cis	rs9903692	0.954	rs8080662	MIMAT0000438	hsa-miR-152-3p	-3.52	0.000445	-0.1	-0.11	Pulse pressure;	chr17:48113457	chr17:48037174~48037194:-
BRCA	cis	rs4237845	0.611	rs10877036	MIMAT0000082	hsa-miR-26a-5p	-3.52	0.00045	-0.08	-0.11	Intelligence (multi-trait analysis);	chr12:57927867	chr12:57824658~57824679:-
BRCA	cis	rs4237845	0.611	rs10877036	MIMAT0000082_1	hsa-miR-26a-5p	-3.52	0.00045	-0.08	-0.11	Intelligence (multi-trait analysis);	chr12:57927867	chr3:37969413~37969434:+
BRCA	cis	rs13256369	1	rs12547721	MIMAT0019728	hsa-miR-4660	3.52	0.000452	0.15	0.11	Obesity-related traits;	chr8:8713161	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs10786741	MIMAT0005951	hsa-miR-1307-3p	3.52	0.000453	0.07	0.11	Arsenic metabolism;	chr10:103179425	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	3.52	0.000457	0.12	0.11	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
BRCA	cis	rs1950626	0.699	rs12896504	MIMAT0000754	hsa-miR-337-3p	3.51	0.000459	0.06	0.11	Pelvic organ prolapse (moderate/severe);	chr14:101001611	chr14:100874553~100874574:+
BRCA	cis	rs74233809	1	rs12411886	MIMAT0022727	hsa-miR-1307-5p	-3.51	0.000461	-0.11	-0.11	Birth weight;	chr10:102925542	chr10:103394341~103394361:-
BRCA	cis	rs7897654	0.651	rs7073179	MIMAT0005951	hsa-miR-1307-3p	3.51	0.000461	0.08	0.11	Schizophrenia;	chr10:102963334	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs11191555	MIMAT0022727	hsa-miR-1307-5p	-3.51	0.000465	-0.11	-0.11	Birth weight;	chr10:103097766	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs11191557	MIMAT0022727	hsa-miR-1307-5p	-3.51	0.000465	-0.11	-0.11	Birth weight;	chr10:103104857	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs11191558	MIMAT0022727	hsa-miR-1307-5p	-3.51	0.000465	-0.11	-0.11	Birth weight;	chr10:103104921	chr10:103394341~103394361:-
BRCA	cis	rs1950626	0.623	rs35947256	MIMAT0022698	hsa-miR-345-3p	-3.51	0.000469	-0.15	-0.11	Pelvic organ prolapse (moderate/severe);	chr14:100994029	chr14:100307912~100307933:+
BRCA	cis	rs1870653	0.516	rs28555162	MIMAT0003242	hsa-miR-577	3.51	0.000469	0.16	0.11	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114517408	chr4:114656774~114656794:+
BRCA	cis	rs13256369	0.76	rs7816171	MIMAT0019728	hsa-miR-4660	3.51	0.00047	0.15	0.11	Obesity-related traits;	chr8:8718325	chr8:9048453~9048475:+
BRCA	cis	rs13256369	0.76	rs7839473	MIMAT0019728	hsa-miR-4660	3.51	0.00047	0.15	0.11	Obesity-related traits;	chr8:8718326	chr8:9048453~9048475:+
BRCA	cis	rs6681460	0.898	rs1032635	MIMAT0014979	hsa-miR-3117-3p	3.51	0.000472	0.12	0.11	Presence of antiphospholipid antibodies;	chr1:66729501	chr1:66628485~66628505:+
BRCA	cis	rs513349	1	rs210146	MIMAT0022975	hsa-miR-3934-3p	-3.51	0.000474	-0.13	-0.11	Platelet count;	chr6:33581321	chr6:33698191~33698212:+
BRCA	cis	rs7897654	0.61	rs11191512	MIMAT0005951	hsa-miR-1307-3p	3.51	0.000476	0.08	0.11	Schizophrenia;	chr10:103012942	chr10:103394301~103394322:-
BRCA	cis	rs13256369	1	rs885000	MIMAT0019728	hsa-miR-4660	3.51	0.000476	0.15	0.11	Obesity-related traits;	chr8:8711365	chr8:9048453~9048475:+
BRCA	cis	rs513349	1	rs513349	MIMAT0022975	hsa-miR-3934-3p	-3.51	0.000476	-0.13	-0.11	Platelet count;	chr6:33573942	chr6:33698191~33698212:+
BRCA	cis	rs13256369	1	rs1109619	MIMAT0019728	hsa-miR-4660	3.5	0.000477	0.15	0.11	Obesity-related traits;	chr8:8714106	chr8:9048453~9048475:+
BRCA	cis	rs12701220	0.894	rs13224488	MIMAT0004702	hsa-miR-339-3p	3.5	0.000477	0.12	0.11	Bronchopulmonary dysplasia;	chr7:1012717	chr7:1022955~1022977:-
BRCA	cis	rs13390641	1	rs7566854	MIMAT0019926	hsa-miR-4772-5p	3.5	0.000477	0.16	0.11	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103386973	chr2:102432300~102432321:+
BRCA	cis	rs9527	0.59	rs10883820	MIMAT0005951	hsa-miR-1307-3p	-3.5	0.00048	-0.07	-0.11	Arsenic metabolism;	chr10:103004904	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs2066322	MIMAT0005951	hsa-miR-1307-3p	3.5	0.000481	0.07	0.11	Arsenic metabolism;	chr10:103149582	chr10:103394301~103394322:-
BRCA	cis	rs17867775	0.623	rs17864185	MIMAT0003260	hsa-miR-592	3.5	0.000488	0.27	0.11	Anti-saccade response;	chr7:127296934	chr7:127058148~127058169:-
BRCA	cis	rs9527	0.59	rs3861984	MIMAT0005951	hsa-miR-1307-3p	3.5	0.000488	0.07	0.11	Arsenic metabolism;	chr10:103157223	chr10:103394301~103394322:-
BRCA	cis	rs13256369	1	rs12545771	MIMAT0019728	hsa-miR-4660	3.5	0.00049	0.15	0.11	Obesity-related traits;	chr8:8710467	chr8:9048453~9048475:+
BRCA	cis	rs17604090	0.793	rs17136535	MIMAT0004800	hsa-miR-550a-5p	3.5	0.000491	0.15	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649542	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.793	rs17136535	MIMAT0004800_1	hsa-miR-550a-5p	3.5	0.000491	0.15	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649542	chr7:32733002~32733024:+
BRCA	cis	rs9527	0.59	rs10883843	MIMAT0005951	hsa-miR-1307-3p	3.5	0.000491	0.07	0.11	Arsenic metabolism;	chr10:103187736	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.568	rs12772775	MIMAT0005951	hsa-miR-1307-3p	3.5	0.000492	0.07	0.11	Arsenic metabolism;	chr10:102943242	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.641	rs4129360	MIMAT0019728	hsa-miR-4660	-3.5	0.000492	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9715774	chr8:9048453~9048475:+
BRCA	cis	rs1355223	0.506	rs1509660	MIMAT0019776	hsa-miR-1343-3p	3.5	0.000492	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34843470	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.506	rs1509659	MIMAT0019776	hsa-miR-1343-3p	3.5	0.000492	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34843586	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.506	rs11032894	MIMAT0019776	hsa-miR-1343-3p	3.5	0.000492	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34843997	chr11:34941888~34941909:+
BRCA	cis	rs1355223	0.506	rs7947848	MIMAT0019776	hsa-miR-1343-3p	3.5	0.000492	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34844673	chr11:34941888~34941909:+
BRCA	cis	rs9527	0.59	rs10509766	MIMAT0005951	hsa-miR-1307-3p	3.5	0.000494	0.07	0.11	Arsenic metabolism;	chr10:103166577	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs11191485	MIMAT0005951	hsa-miR-1307-3p	3.49	0.000495	0.07	0.11	Arsenic metabolism;	chr10:102970059	chr10:103394301~103394322:-
BRCA	cis	rs4851016	0.553	rs4851602	MIMAT0019926	hsa-miR-4772-5p	-3.49	0.000495	-0.11	-0.11	Blood protein levels;	chr2:102499846	chr2:102432300~102432321:+
BRCA	cis	rs9527	0.59	rs10883830	MIMAT0005951	hsa-miR-1307-3p	3.49	0.000496	0.07	0.11	Arsenic metabolism;	chr10:103091528	chr10:103394301~103394322:-
BRCA	cis	rs4851551	0.543	rs11887842	MIMAT0019926	hsa-miR-4772-5p	3.49	0.000496	0.19	0.11	Blood protein levels;	chr2:102223018	chr2:102432300~102432321:+
BRCA	cis	rs3749237	1	rs2291542	MIMAT0001343	hsa-miR-425-3p	3.49	0.000496	0.1	0.11	Resting heart rate;	chr3:49714152	chr3:49020159~49020180:-
BRCA	cis	rs2284367	0.505	rs4756146	MIMAT0019776	hsa-miR-1343-3p	-3.49	0.000498	-0.16	-0.11	Blood protein levels;	chr11:34442192	chr11:34941888~34941909:+
BRCA	cis	rs9527	0.64	rs35195396	MIMAT0005951	hsa-miR-1307-3p	3.49	0.000498	0.07	0.11	Arsenic metabolism;	chr10:103169013	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.614	rs11191589	MIMAT0005951	hsa-miR-1307-3p	3.49	0.000498	0.07	0.11	Arsenic metabolism;	chr10:103170625	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.59	rs3740386	MIMAT0005951	hsa-miR-1307-3p	3.49	0.000498	0.07	0.11	Arsenic metabolism;	chr10:103171294	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-3.49	0.000498	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
BRCA	cis	rs7226408	0.64	rs1968334	MIMAT0000262	hsa-miR-187-3p	3.49	0.000498	0.21	0.11	Obesity-related traits;	chr18:36763671	chr18:35904835~35904856:-
BRCA	cis	rs13256369	1	rs13267501	MIMAT0019728	hsa-miR-4660	3.49	5e-04	0.15	0.11	Obesity-related traits;	chr8:8716548	chr8:9048453~9048475:+
BRCA	cis	rs13256369	0.95	rs13270006	MIMAT0019728	hsa-miR-4660	3.49	5e-04	0.15	0.11	Obesity-related traits;	chr8:8716687	chr8:9048453~9048475:+
BRCA	cis	rs72482608	0.835	rs12044001	MIMAT0005885	hsa-miR-1295a	3.49	0.000501	0.13	0.11	Emphysema imaging phenotypes;	chr1:170778324	chr1:171101738~171101758:-
BRCA	cis	rs74233809	1	rs11191555	MIMAT0005951	hsa-miR-1307-3p	-3.49	0.000501	-0.11	-0.11	Birth weight;	chr10:103097766	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs11191557	MIMAT0005951	hsa-miR-1307-3p	-3.49	0.000501	-0.11	-0.11	Birth weight;	chr10:103104857	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs11191558	MIMAT0005951	hsa-miR-1307-3p	-3.49	0.000501	-0.11	-0.11	Birth weight;	chr10:103104921	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.878	rs4000281	MIMAT0004800	hsa-miR-550a-5p	3.49	0.000502	0.17	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29686671	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.878	rs4000281	MIMAT0004800_1	hsa-miR-550a-5p	3.49	0.000502	0.17	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29686671	chr7:32733002~32733024:+
BRCA	cis	rs72482608	0.865	rs10800541	MIMAT0005885	hsa-miR-1295a	3.49	0.000503	0.13	0.11	Emphysema imaging phenotypes;	chr1:170795766	chr1:171101738~171101758:-
BRCA	cis	rs4242434	0.927	rs13264187	MIMAT0000510	hsa-miR-320a-3p	-3.49	0.000503	-0.13	-0.11	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);	chr8:22648585	chr8:22244975~22244996:-
BRCA	cis	rs7226408	0.842	rs9958203	MIMAT0000262	hsa-miR-187-3p	3.49	0.000504	0.2	0.11	Obesity-related traits;	chr18:36768995	chr18:35904835~35904856:-
BRCA	cis	rs72482608	0.865	rs7523880	MIMAT0005885	hsa-miR-1295a	3.49	0.000505	0.13	0.11	Emphysema imaging phenotypes;	chr1:170800838	chr1:171101738~171101758:-
BRCA	cis	rs12701220	0.894	rs12701348	MIMAT0004702	hsa-miR-339-3p	3.49	0.000507	0.12	0.11	Bronchopulmonary dysplasia;	chr7:999821	chr7:1022955~1022977:-
BRCA	cis	rs2284367	0.505	rs7109778	MIMAT0019776	hsa-miR-1343-3p	-3.49	0.000507	-0.16	-0.11	Blood protein levels;	chr11:34460642	chr11:34941888~34941909:+
BRCA	cis	rs10455248	0.692	rs10085233	MIMAT0000088	hsa-miR-30a-3p	-3.49	0.000512	-0.11	-0.11	Cognitive performance;	chr6:71785925	chr6:71403554~71403575:-
BRCA	cis	rs10455248	0.728	rs4593328	MIMAT0000088	hsa-miR-30a-3p	3.48	0.000514	0.11	0.11	Cognitive performance;	chr6:71759094	chr6:71403554~71403575:-
BRCA	cis	rs2400997	0.967	rs9707405	MIMAT0022861	hsa-miR-376c-5p	-3.48	0.000516	-0.1	-0.11	Prostate cancer (SNP x SNP interaction);	chr14:101276857	chr14:101039694~101039714:+
BRCA	cis	rs10949834	0.504	rs150862	MIMAT0003258	hsa-miR-590-5p	3.48	0.000523	0.08	0.11	Verbal memory performance (residualized delayed recall change);	chr7:74109877	chr7:74191213~74191234:+
BRCA	cis	rs1018697	1	rs4919678	MIMAT0022727	hsa-miR-1307-5p	3.48	0.000526	0.06	0.11	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394341~103394361:-
BRCA	cis	rs74233809	0.901	rs12416331	MIMAT0005951	hsa-miR-1307-3p	-3.48	0.000526	-0.11	-0.11	Birth weight;	chr10:103169157	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.725	rs7667556	MIMAT0003242	hsa-miR-577	3.48	0.000526	0.1	0.11	Optic disc area;	chr4:114535359	chr4:114656774~114656794:+
BRCA	cis	rs1018697	0.966	rs10748832	MIMAT0022727	hsa-miR-1307-5p	3.48	0.000527	0.06	0.11	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394341~103394361:-
BRCA	cis	rs12701220	0.894	rs34712249	MIMAT0004702	hsa-miR-339-3p	3.48	0.000528	0.12	0.11	Bronchopulmonary dysplasia;	chr7:996998	chr7:1022955~1022977:-
BRCA	cis	rs250677	0.687	rs250674	MIMAT0003249	hsa-miR-584-5p	-3.48	0.00053	-0.12	-0.11	Breast cancer;	chr5:149059034	chr5:149062373~149062394:-
BRCA	cis	rs11118620	0.622	rs11118618	MIMAT0005948	hsa-miR-664a-5p	-3.47	0.000533	-0.13	-0.11	Heart failure;	chr1:220838204	chr1:220200586~220200609:-
BRCA	cis	rs12701220	0.894	rs12701406	MIMAT0004702	hsa-miR-339-3p	3.47	0.000533	0.12	0.11	Bronchopulmonary dysplasia;	chr7:1010647	chr7:1022955~1022977:-
BRCA	cis	rs4665809	0.627	rs1465720	MIMAT0026639	hsa-miR-1301-5p	-3.47	0.00054	-0.14	-0.11	Gut microbiome composition (summer);	chr2:26189769	chr2:25328689~25328707:-
BRCA	cis	rs56235845	0.694	rs11949401	MIMAT0005796	hsa-miR-1271-5p	-3.47	0.000543	-0.1	-0.11	Hematocrit;Hemoglobin concentration;	chr5:177338988	chr5:176367960~176367981:+
BRCA	cis	rs9527	0.615	rs36045108	MIMAT0005951	hsa-miR-1307-3p	3.47	0.000544	0.07	0.11	Arsenic metabolism;	chr10:102938172	chr10:103394301~103394322:-
BRCA	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-3.47	0.000544	-0.13	-0.11	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
BRCA	cis	rs12701220	0.894	rs12539012	MIMAT0004702	hsa-miR-339-3p	3.47	0.000545	0.12	0.11	Bronchopulmonary dysplasia;	chr7:1012497	chr7:1022955~1022977:-
BRCA	cis	rs17710780	0.803	rs72828366	MIMAT0000731	hsa-miR-378a-5p	-3.47	0.000545	-0.13	-0.11	Major depressive disorder;	chr5:149697605	chr5:149732829~149732850:+
BRCA	cis	rs250677	0.687	rs384979	MIMAT0003249	hsa-miR-584-5p	-3.47	0.000546	-0.12	-0.11	Breast cancer;	chr5:149079704	chr5:149062373~149062394:-
BRCA	cis	rs13256369	1	rs4840352	MIMAT0019728	hsa-miR-4660	3.47	0.000546	0.15	0.11	Obesity-related traits;	chr8:8715998	chr8:9048453~9048475:+
BRCA	cis	rs1018697	1	rs1018696	MIMAT0022727	hsa-miR-1307-5p	3.47	0.000548	0.06	0.11	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394341~103394361:-
BRCA	cis	rs6700896	0.5	rs12025906	MIMAT0004513	hsa-miR-101-5p	3.47	0.000549	0.13	0.11	Mean corpuscular hemoglobin;C-reactive protein;Mean corpuscular volume;	chr1:65635701	chr1:65058477~65058498:-
BRCA	cis	rs6163	0.54	rs11191385	MIMAT0005951	hsa-miR-1307-3p	3.47	0.00055	0.07	0.11	Waist circumference;Hip circumference;	chr10:102753292	chr10:103394301~103394322:-
BRCA	cis	rs13256369	0.901	rs13251887	MIMAT0019728	hsa-miR-4660	3.46	0.000553	0.15	0.11	Obesity-related traits;	chr8:8711168	chr8:9048453~9048475:+
BRCA	cis	rs12701220	0.894	rs10257744	MIMAT0004702	hsa-miR-339-3p	3.46	0.000553	0.12	0.11	Bronchopulmonary dysplasia;	chr7:1005976	chr7:1022955~1022977:-
BRCA	cis	rs11790994	1	rs11790994	MIMAT0019208	hsa-miR-3074-5p	-3.46	0.000555	-0.15	-0.11	Inattentive symptoms;	chr9:95666984	chr9:95086063~95086083:-
BRCA	cis	rs1355223	0.506	rs7131229	MIMAT0019776	hsa-miR-1343-3p	-3.46	0.000561	-0.11	-0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34847781	chr11:34941888~34941909:+
BRCA	cis	rs10021731	0.725	rs12503513	MIMAT0003242	hsa-miR-577	3.46	0.000562	0.1	0.11	Optic disc area;	chr4:114534996	chr4:114656774~114656794:+
BRCA	cis	rs17710780	0.803	rs17654872	MIMAT0000731	hsa-miR-378a-5p	-3.46	0.000564	-0.13	-0.11	Major depressive disorder;	chr5:149735588	chr5:149732829~149732850:+
BRCA	cis	rs13256369	1	rs4841016	MIMAT0019728	hsa-miR-4660	3.46	0.000564	0.15	0.11	Obesity-related traits;	chr8:8715051	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.586	rs6601340	MIMAT0019728	hsa-miR-4660	-3.46	0.000565	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9603805	chr8:9048453~9048475:+
BRCA	cis	rs6163	0.508	rs11191381	MIMAT0005951	hsa-miR-1307-3p	3.46	0.000567	0.07	0.11	Waist circumference;Hip circumference;	chr10:102733687	chr10:103394301~103394322:-
BRCA	cis	rs13256369	1	rs10095733	MIMAT0019728	hsa-miR-4660	3.46	0.000567	0.15	0.11	Obesity-related traits;	chr8:8717136	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.678	rs10106040	MIMAT0019728	hsa-miR-4660	3.46	0.000569	0.13	0.11	Multiple myeloma (hyperdiploidy);	chr8:9754903	chr8:9048453~9048475:+
BRCA	cis	rs7829975	0.535	rs4841005	MIMAT0019728	hsa-miR-4660	-3.46	0.00057	-0.13	-0.11	Mood instability;	chr8:8643720	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.615	rs2152915	MIMAT0005951	hsa-miR-1307-3p	3.45	0.000574	0.07	0.11	Arsenic metabolism;	chr10:102931975	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs3897401	MIMAT0005951	hsa-miR-1307-3p	3.45	0.000574	0.07	0.11	Arsenic metabolism;	chr10:102936622	chr10:103394301~103394322:-
BRCA	cis	rs13256369	1	rs873063	MIMAT0019728	hsa-miR-4660	3.45	0.000577	0.15	0.11	Obesity-related traits;	chr8:8714937	chr8:9048453~9048475:+
BRCA	cis	rs35275482	0.573	rs11071489	MIMAT0011161	hsa-miR-2116-3p	3.45	0.000578	0.13	0.11	Gut microbiota (bacterial taxa);	chr15:59828490	chr15:59171192~59171212:-
BRCA	cis	rs4919687	0.679	rs12762176	MIMAT0005951	hsa-miR-1307-3p	3.45	0.000578	0.07	0.11	Colorectal cancer;	chr10:102739475	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.518	rs13264850	MIMAT0019728	hsa-miR-4660	-3.45	0.000579	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9717821	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs2274339	MIMAT0005951	hsa-miR-1307-3p	3.45	0.000583	0.07	0.11	Arsenic metabolism;	chr10:103100296	chr10:103394301~103394322:-
BRCA	cis	rs250677	0.522	rs919730	MIMAT0003249	hsa-miR-584-5p	-3.45	0.000586	-0.13	-0.11	Breast cancer;	chr5:148972838	chr5:149062373~149062394:-
BRCA	cis	rs10455248	0.743	rs9446467	MIMAT0000088	hsa-miR-30a-3p	3.45	0.000591	0.11	0.11	Cognitive performance;	chr6:71756206	chr6:71403554~71403575:-
BRCA	cis	rs17604090	0.775	rs73090343	MIMAT0004800	hsa-miR-550a-5p	3.44	0.000598	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649152	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.775	rs73090343	MIMAT0004800_1	hsa-miR-550a-5p	3.44	0.000598	0.16	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649152	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.646	rs10258473	MIMAT0004800	hsa-miR-550a-5p	3.44	0.000599	0.15	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650823	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.646	rs10258473	MIMAT0004800_1	hsa-miR-550a-5p	3.44	0.000599	0.15	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650823	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.938	rs10241566	MIMAT0004800	hsa-miR-550a-5p	3.44	6e-04	0.15	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650563	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs10241566	MIMAT0004800_1	hsa-miR-550a-5p	3.44	6e-04	0.15	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650563	chr7:32733002~32733024:+
BRCA	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-3.44	0.000603	-0.12	-0.11	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
BRCA	cis	rs17710780	0.803	rs72828357	MIMAT0000731	hsa-miR-378a-5p	-3.44	0.000603	-0.13	-0.11	Major depressive disorder;	chr5:149693110	chr5:149732829~149732850:+
BRCA	cis	rs9527	0.59	rs11191513	MIMAT0005951	hsa-miR-1307-3p	3.44	0.000605	0.07	0.11	Arsenic metabolism;	chr10:103013227	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.701	rs60930239	MIMAT0004800	hsa-miR-550a-5p	3.44	0.000605	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29648928	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.701	rs60930239	MIMAT0004800_1	hsa-miR-550a-5p	3.44	0.000605	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29648928	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.793	rs66956566	MIMAT0004800	hsa-miR-550a-5p	3.44	0.000605	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649086	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.793	rs66956566	MIMAT0004800_1	hsa-miR-550a-5p	3.44	0.000605	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649086	chr7:32733002~32733024:+
BRCA	cis	rs2921073	0.605	rs2976933	MIMAT0019728	hsa-miR-4660	3.44	0.000608	0.13	0.11	Parkinson's disease;	chr8:8397365	chr8:9048453~9048475:+
BRCA	cis	rs6601327	0.641	rs10102170	MIMAT0019728	hsa-miR-4660	3.44	0.000609	0.13	0.11	Multiple myeloma (hyperdiploidy);	chr8:9753960	chr8:9048453~9048475:+
BRCA	cis	rs1355223	0.506	rs6484738	MIMAT0019776	hsa-miR-1343-3p	3.44	0.000614	0.11	0.11	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34839311	chr11:34941888~34941909:+
BRCA	cis	rs250677	0.522	rs56309414	MIMAT0003249	hsa-miR-584-5p	3.44	0.000614	0.13	0.11	Breast cancer;	chr5:148996463	chr5:149062373~149062394:-
BRCA	cis	rs74233809	1	rs12411886	MIMAT0005951	hsa-miR-1307-3p	-3.43	0.000619	-0.11	-0.11	Birth weight;	chr10:102925542	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.793	rs73687726	MIMAT0004800	hsa-miR-550a-5p	3.43	0.000626	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649157	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.793	rs73687726	MIMAT0004800_1	hsa-miR-550a-5p	3.43	0.000626	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649157	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.793	rs17150665	MIMAT0004800	hsa-miR-550a-5p	3.43	0.000626	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649244	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.793	rs17150665	MIMAT0004800_1	hsa-miR-550a-5p	3.43	0.000626	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649244	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.793	rs17150667	MIMAT0004800	hsa-miR-550a-5p	3.43	0.000626	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649722	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.793	rs17150667	MIMAT0004800_1	hsa-miR-550a-5p	3.43	0.000626	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29649722	chr7:32733002~32733024:+
BRCA	cis	rs35275482	0.646	rs12595753	MIMAT0011161	hsa-miR-2116-3p	-3.43	0.000626	-0.14	-0.11	Gut microbiota (bacterial taxa);	chr15:59813449	chr15:59171192~59171212:-
BRCA	cis	rs9882792	0.711	rs7633358	MIMAT0004987	hsa-miR-944	-3.43	0.000627	-0.17	-0.11	Breast cancer;	chr3:190085082	chr3:189829975~189829996:+
BRCA	cis	rs225190	0.69	rs9903536	MIMAT0022833	hsa-miR-365b-5p	3.43	0.000628	0.12	0.11	Pancreatic cancer;	chr17:32551730	chr17:31575439~31575460:+
BRCA	cis	rs17604090	1	rs28591682	MIMAT0004800	hsa-miR-550a-5p	3.43	0.00063	0.17	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651195	chr7:30289815~30289837:+
BRCA	cis	rs17604090	1	rs28591682	MIMAT0004800_1	hsa-miR-550a-5p	3.43	0.00063	0.17	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29651195	chr7:32733002~32733024:+
BRCA	cis	rs1420098	0.505	rs1921622	MIMAT0019926	hsa-miR-4772-5p	-3.43	0.000631	-0.1	-0.11	Inflammatory bowel disease;	chr2:102349607	chr2:102432300~102432321:+
BRCA	cis	rs7851726	0.932	rs7853195	MIMAT0019208	hsa-miR-3074-5p	3.43	0.000631	0.1	0.11	Urinary albumin-to-creatinine ratio;	chr9:94923016	chr9:95086063~95086083:-
BRCA	cis	rs13256369	1	rs7004438	MIMAT0019728	hsa-miR-4660	3.43	0.000631	0.15	0.11	Obesity-related traits;	chr8:8716869	chr8:9048453~9048475:+
BRCA	cis	rs1018697	0.966	rs1953930	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000634	0.06	0.11	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394341~103394361:-
BRCA	cis	rs1018697	1	rs2150928	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000638	0.06	0.11	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs12219901	MIMAT0005951	hsa-miR-1307-3p	-3.43	0.000638	-0.1	-0.11	Birth weight;	chr10:103081210	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs10458729	MIMAT0005951	hsa-miR-1307-3p	-3.43	0.000638	-0.1	-0.11	Birth weight;	chr10:103081722	chr10:103394301~103394322:-
BRCA	cis	rs56235845	0.694	rs6860069	MIMAT0005796	hsa-miR-1271-5p	-3.42	0.00064	-0.1	-0.11	Hematocrit;Hemoglobin concentration;	chr5:177328840	chr5:176367960~176367981:+
BRCA	cis	rs35275482	0.573	rs34835177	MIMAT0011161	hsa-miR-2116-3p	3.42	0.000644	0.13	0.11	Gut microbiota (bacterial taxa);	chr15:59828911	chr15:59171192~59171212:-
BRCA	cis	rs13161895	0.877	rs13179406	MIMAT0004692	hsa-miR-340-5p	3.42	0.000645	0.16	0.11	LDL cholesterol;	chr5:180026077	chr5:180015361~180015382:-
BRCA	cis	rs10949834	0.529	rs150861	MIMAT0003258	hsa-miR-590-5p	3.42	0.000646	0.08	0.11	Verbal memory performance (residualized delayed recall change);	chr7:74110571	chr7:74191213~74191234:+
BRCA	cis	rs17710780	0.803	rs56073703	MIMAT0000731	hsa-miR-378a-5p	-3.42	0.000647	-0.14	-0.11	Major depressive disorder;	chr5:149705665	chr5:149732829~149732850:+
BRCA	cis	rs17710780	0.803	rs4705083	MIMAT0000731	hsa-miR-378a-5p	-3.42	0.000647	-0.14	-0.11	Major depressive disorder;	chr5:149705876	chr5:149732829~149732850:+
BRCA	cis	rs9693857	0.52	rs4841163	MIMAT0019728	hsa-miR-4660	3.42	0.000648	0.14	0.11	Systolic blood pressure;	chr8:9508668	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs7912517	MIMAT0005951	hsa-miR-1307-3p	3.42	0.000648	0.07	0.11	Arsenic metabolism;	chr10:103145772	chr10:103394301~103394322:-
BRCA	cis	rs35275482	0.573	rs11071488	MIMAT0011161	hsa-miR-2116-3p	3.42	0.000649	0.13	0.11	Gut microbiota (bacterial taxa);	chr15:59828189	chr15:59171192~59171212:-
BRCA	cis	rs4713675	0.584	rs9394163	MIMAT0022975	hsa-miR-3934-3p	-3.42	0.000649	-0.13	-0.11	Plateletcrit;	chr6:33714637	chr6:33698191~33698212:+
BRCA	cis	rs72482608	0.826	rs10919475	MIMAT0005885	hsa-miR-1295a	3.42	0.000649	0.13	0.11	Emphysema imaging phenotypes;	chr1:170802165	chr1:171101738~171101758:-
BRCA	cis	rs74233809	1	rs12217501	MIMAT0005951	hsa-miR-1307-3p	-3.42	0.00065	-0.11	-0.11	Birth weight;	chr10:103092132	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.775	rs10225523	MIMAT0004800	hsa-miR-550a-5p	3.42	0.000651	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650119	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.775	rs10225523	MIMAT0004800_1	hsa-miR-550a-5p	3.42	0.000651	0.14	0.11	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650119	chr7:32733002~32733024:+
BRCA	cis	rs74233809	1	rs1060240	MIMAT0022727	hsa-miR-1307-5p	-3.42	0.000651	-0.1	-0.11	Birth weight;	chr10:103123580	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs10883835	MIMAT0022727	hsa-miR-1307-5p	-3.42	0.000651	-0.1	-0.11	Birth weight;	chr10:103124451	chr10:103394341~103394361:-
BRCA	cis	rs250677	0.687	rs36043	MIMAT0003249	hsa-miR-584-5p	3.42	0.000654	0.12	0.11	Breast cancer;	chr5:149061420	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.522	rs891920	MIMAT0003249	hsa-miR-584-5p	3.42	0.000655	0.12	0.11	Breast cancer;	chr5:148989855	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.559	rs17109198	MIMAT0003249	hsa-miR-584-5p	3.42	0.000655	0.12	0.11	Breast cancer;	chr5:148990149	chr5:149062373~149062394:-
BRCA	cis	rs9527	0.615	rs10883804	MIMAT0005951	hsa-miR-1307-3p	3.42	0.000655	0.07	0.11	Arsenic metabolism;	chr10:102946763	chr10:103394301~103394322:-
BRCA	cis	rs10426930	0.752	rs56249413	MIMAT0019880	hsa-miR-4746-5p	3.42	0.000662	0.14	0.11	Monocyte percentage of white cells;	chr19:5036719	chr19:4445987~4446009:+
BRCA	cis	rs13161895	0.877	rs71613436	MIMAT0004692	hsa-miR-340-5p	3.41	0.000668	0.16	0.11	LDL cholesterol;	chr5:180031009	chr5:180015361~180015382:-
BRCA	cis	rs74233809	1	rs9633712	MIMAT0022727	hsa-miR-1307-5p	-3.41	0.00067	-0.1	-0.11	Birth weight;	chr10:103114004	chr10:103394341~103394361:-
BRCA	cis	rs74233809	0.786	rs11191564	MIMAT0022727	hsa-miR-1307-5p	-3.41	0.00067	-0.1	-0.11	Birth weight;	chr10:103118786	chr10:103394341~103394361:-
BRCA	cis	rs1018697	0.966	rs10748831	MIMAT0022727	hsa-miR-1307-5p	3.41	0.000672	0.06	0.11	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394341~103394361:-
BRCA	cis	rs13256369	1	rs873064	MIMAT0019728	hsa-miR-4660	3.41	0.000675	0.15	0.11	Obesity-related traits;	chr8:8714870	chr8:9048453~9048475:+
BRCA	cis	rs1018697	0.518	rs2482506	MIMAT0005951	hsa-miR-1307-3p	-3.41	0.000678	-0.07	-0.11	Colorectal adenoma (advanced);	chr10:102803986	chr10:103394301~103394322:-
BRCA	cis	rs1950626	0.743	rs1956734	MIMAT0002890	hsa-miR-299-5p	-3.41	0.000678	-0.11	-0.11	Pelvic organ prolapse (moderate/severe);	chr14:100933493	chr14:101023800~101023821:+
BRCA	cis	rs7929679	1	rs7929789	MIMAT0019776	hsa-miR-1343-3p	3.41	0.000678	0.1	0.11	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34784301	chr11:34941888~34941909:+
BRCA	cis	rs7929679	1	rs7929679	MIMAT0019776	hsa-miR-1343-3p	3.41	0.000678	0.1	0.11	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34784302	chr11:34941888~34941909:+
BRCA	cis	rs7829975	0.846	rs7005216	MIMAT0019728	hsa-miR-4660	-3.41	0.000679	-0.12	-0.11	Mood instability;	chr8:8689600	chr8:9048453~9048475:+
BRCA	cis	rs13256369	1	rs13282915	MIMAT0019728	hsa-miR-4660	3.41	0.000681	0.14	0.11	Obesity-related traits;	chr8:8713381	chr8:9048453~9048475:+
BRCA	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	3.41	0.000683	0.07	0.11	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
BRCA	cis	rs6601327	0.641	rs7462070	MIMAT0019728	hsa-miR-4660	-3.41	0.000684	-0.13	-0.11	Multiple myeloma (hyperdiploidy);	chr8:9713854	chr8:9048453~9048475:+
BRCA	cis	rs4921799	0.574	rs7465275	MIMAT0015020	hsa-miR-548v	-3.41	0.000685	-0.12	-0.11	Lung cancer;Adenocarcinoma;	chr8:17648676	chr8:17681588~17681609:-
BRCA	cis	rs11976180	0.517	rs6949375	MIMAT0027684	hsa-miR-6892-5p	-3.4	0.000687	-0.19	-0.11	Obesity-related traits;	chr7:144076758	chr7:143382686~143382706:+
BRCA	cis	rs2031532	0.569	rs7326345	MIMAT0017990	hsa-miR-3613-5p	3.4	0.000691	0.09	0.11	Cardiac hypertrophy;	chr13:49493307	chr13:49996465~49996486:-
BRCA	cis	rs17710780	0.803	rs1001778	MIMAT0000731	hsa-miR-378a-5p	-3.4	0.000694	-0.13	-0.11	Major depressive disorder;	chr5:149695209	chr5:149732829~149732850:+
BRCA	cis	rs17710780	0.803	rs62380631	MIMAT0000731	hsa-miR-378a-5p	-3.4	0.000694	-0.14	-0.11	Major depressive disorder;	chr5:149702913	chr5:149732829~149732850:+
BRCA	cis	rs1795240	0.818	rs4916390	MIMAT0005885	hsa-miR-1295a	3.4	0.000701	0.12	0.11	Lentiform nucleus volume;	chr1:171128422	chr1:171101738~171101758:-
BRCA	cis	rs4665809	0.567	rs12999875	MIMAT0026639	hsa-miR-1301-5p	3.4	0.000702	0.14	0.11	Gut microbiome composition (summer);	chr2:26191978	chr2:25328689~25328707:-
BRCA	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-3.4	0.000708	-0.09	-0.11	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
BRCA	cis	rs6681460	0.932	rs2483705	MIMAT0014979	hsa-miR-3117-3p	3.4	0.000709	0.12	0.11	Presence of antiphospholipid antibodies;	chr1:66725497	chr1:66628485~66628505:+
BRCA	cis	rs9903692	0.954	rs6847	MIMAT0000438	hsa-miR-152-3p	-3.39	0.000714	-0.09	-0.1	Pulse pressure;	chr17:48070445	chr17:48037174~48037194:-
BRCA	cis	rs13256369	1	rs4840351	MIMAT0019728	hsa-miR-4660	3.39	0.000714	0.14	0.1	Obesity-related traits;	chr8:8715638	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.725	rs4833457	MIMAT0003242	hsa-miR-577	3.39	0.000723	0.1	0.1	Optic disc area;	chr4:114490891	chr4:114656774~114656794:+
BRCA	cis	rs7147503	1	rs12431682	MIMAT0003163	hsa-miR-539-5p	-3.39	0.000728	-0.07	-0.1	Corneal astigmatism;	chr14:101073662	chr14:101047329~101047350:+
BRCA	cis	rs7851726	0.932	rs10821415	MIMAT0019208	hsa-miR-3074-5p	3.39	0.000732	0.1	0.1	Urinary albumin-to-creatinine ratio;	chr9:94951177	chr9:95086063~95086083:-
BRCA	cis	rs1018697	1	rs7909612	MIMAT0022727	hsa-miR-1307-5p	3.39	0.000733	0.06	0.1	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394341~103394361:-
BRCA	cis	rs4713675	0.565	rs4713670	MIMAT0022975	hsa-miR-3934-3p	3.39	0.000733	0.13	0.1	Plateletcrit;	chr6:33732105	chr6:33698191~33698212:+
BRCA	cis	rs9527	0.615	rs7096452	MIMAT0005951	hsa-miR-1307-3p	3.39	0.000734	0.06	0.1	Arsenic metabolism;	chr10:102976806	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs7080462	MIMAT0005951	hsa-miR-1307-3p	3.39	0.000734	0.06	0.1	Arsenic metabolism;	chr10:102976942	chr10:103394301~103394322:-
BRCA	cis	rs7226408	0.842	rs11662247	MIMAT0000262	hsa-miR-187-3p	3.39	0.000734	0.2	0.1	Obesity-related traits;	chr18:36768547	chr18:35904835~35904856:-
BRCA	cis	rs12431410	0.536	rs10148598	MIMAT0022287	hsa-miR-5586-5p	3.39	0.000735	0.13	0.1	Schizophrenia;	chr14:59680941	chr14:59646999~59647020:-
BRCA	cis	rs13390641	0.908	rs17028817	MIMAT0019926	hsa-miR-4772-5p	-3.39	0.000736	-0.17	-0.1	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103404129	chr2:102432300~102432321:+
BRCA	cis	rs250677	0.522	rs12520924	MIMAT0003249	hsa-miR-584-5p	-3.39	0.000738	-0.13	-0.1	Breast cancer;	chr5:148969586	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.687	rs36048	MIMAT0003249	hsa-miR-584-5p	3.38	0.00074	0.12	0.1	Breast cancer;	chr5:149062150	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.687	rs40522	MIMAT0003249	hsa-miR-584-5p	3.38	0.00074	0.12	0.1	Breast cancer;	chr5:149062732	chr5:149062373~149062394:-
BRCA	cis	rs2574975	0.679	rs2842107	MIMAT0003273	hsa-miR-605-5p	-3.38	0.000742	-0.13	-0.1	Response to amphetamines;	chr10:50371725	chr10:51299588~51299610:+
BRCA	cis	rs13256369	1	rs10103769	MIMAT0019728	hsa-miR-4660	3.38	0.000743	0.14	0.1	Obesity-related traits;	chr8:8715526	chr8:9048453~9048475:+
BRCA	cis	rs17604090	0.793	rs10241305	MIMAT0004800	hsa-miR-550a-5p	3.38	0.000746	0.14	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650313	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.793	rs10241305	MIMAT0004800_1	hsa-miR-550a-5p	3.38	0.000746	0.14	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650313	chr7:32733002~32733024:+
BRCA	cis	rs9527	0.59	rs7089680	MIMAT0005951	hsa-miR-1307-3p	-3.38	0.000751	-0.06	-0.1	Arsenic metabolism;	chr10:103042314	chr10:103394301~103394322:-
BRCA	cis	rs1882496	0.839	rs7971806	MIMAT0018197	hsa-miR-3922-3p	3.38	0.000751	0.12	0.1	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr12:104490132	chr12:104591694~104591715:+
BRCA	cis	rs13256369	1	rs13271966	MIMAT0019728	hsa-miR-4660	3.38	0.000753	0.14	0.1	Obesity-related traits;	chr8:8717962	chr8:9048453~9048475:+
BRCA	cis	rs10021731	0.725	rs12641633	MIMAT0003242	hsa-miR-577	3.38	0.000754	0.1	0.1	Optic disc area;	chr4:114488186	chr4:114656774~114656794:+
BRCA	cis	rs4665809	0.59	rs1049987	MIMAT0026639	hsa-miR-1301-5p	3.38	0.000755	0.14	0.1	Gut microbiome composition (summer);	chr2:26190948	chr2:25328689~25328707:-
BRCA	cis	rs4711336	1	rs2229642	MIMAT0018349	hsa-miR-3934-5p	-3.38	0.000757	-0.12	-0.1	Height;	chr6:33691695	chr6:33698152~33698173:+
BRCA	cis	rs9527	0.59	rs7898770	MIMAT0005951	hsa-miR-1307-3p	-3.38	0.000761	-0.06	-0.1	Arsenic metabolism;	chr10:102996879	chr10:103394301~103394322:-
BRCA	cis	rs13256369	0.95	rs12548792	MIMAT0019728	hsa-miR-4660	3.38	0.000761	0.15	0.1	Obesity-related traits;	chr8:8710521	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs12413046	MIMAT0022727	hsa-miR-1307-5p	-3.37	0.00077	-0.1	-0.1	Birth weight;	chr10:103111447	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs10883832	MIMAT0022727	hsa-miR-1307-5p	-3.37	0.00077	-0.1	-0.1	Birth weight;	chr10:103111522	chr10:103394341~103394361:-
BRCA	cis	rs11708245	0.5	rs9858678	MIMAT0015003	hsa-miR-3136-5p	-3.37	0.00077	-0.12	-0.1	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr3:68719339	chr3:69049004~69049026:-
BRCA	cis	rs349114	0.51	rs9556760	MIMAT0015045	hsa-miR-3170	-3.37	0.000771	-0.1	-0.1	Obesity-related traits;	chr13:97601122	chr13:98208533~98208554:+
BRCA	cis	rs11622263	1	rs11622263	MIMAT0000737	hsa-miR-382-5p	-3.37	0.000772	-0.08	-0.1	Peripheral arterial disease (traffic-related air pollution interaction);	chr14:100814324	chr14:101054316~101054337:+
BRCA	cis	rs13390641	1	rs67891378	MIMAT0019926	hsa-miR-4772-5p	-3.37	0.000774	-0.17	-0.1	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103389051	chr2:102432300~102432321:+
BRCA	cis	rs2284367	0.505	rs2076556	MIMAT0019776	hsa-miR-1343-3p	-3.37	0.000775	-0.15	-0.1	Blood protein levels;	chr11:34451875	chr11:34941888~34941909:+
BRCA	cis	rs250677	0.522	rs4562031	MIMAT0003249	hsa-miR-584-5p	-3.37	0.000776	-0.12	-0.1	Breast cancer;	chr5:148988888	chr5:149062373~149062394:-
BRCA	cis	rs7851726	0.932	rs4744411	MIMAT0019208	hsa-miR-3074-5p	3.37	0.000776	0.1	0.1	Urinary albumin-to-creatinine ratio;	chr9:94926763	chr9:95086063~95086083:-
BRCA	cis	rs7851726	1	rs7851726	MIMAT0019208	hsa-miR-3074-5p	-3.37	0.000782	-0.1	-0.1	Urinary albumin-to-creatinine ratio;	chr9:94741703	chr9:95086063~95086083:-
BRCA	cis	rs12701220	0.725	rs13242971	MIMAT0004702	hsa-miR-339-3p	3.37	0.000782	0.12	0.1	Bronchopulmonary dysplasia;	chr7:1015879	chr7:1022955~1022977:-
BRCA	cis	rs9527	0.64	rs7089061	MIMAT0005951	hsa-miR-1307-3p	3.37	0.000782	0.06	0.1	Arsenic metabolism;	chr10:102963258	chr10:103394301~103394322:-
BRCA	cis	rs9527	0.615	rs7089065	MIMAT0005951	hsa-miR-1307-3p	3.37	0.000782	0.06	0.1	Arsenic metabolism;	chr10:102963265	chr10:103394301~103394322:-
BRCA	cis	rs250677	0.687	rs185155	MIMAT0003249	hsa-miR-584-5p	3.37	0.000783	0.12	0.1	Breast cancer;	chr5:149076330	chr5:149062373~149062394:-
BRCA	cis	rs4790312	0.513	rs9912609	MIMAT0000426	hsa-miR-132-3p	3.37	0.000784	0.11	0.1	Left atrial antero-posterior diameter;	chr17:2064326	chr17:2049929~2049950:-
BRCA	cis	rs9527	0.59	rs1935323	MIMAT0005951	hsa-miR-1307-3p	3.37	0.000784	0.07	0.1	Arsenic metabolism;	chr10:103117278	chr10:103394301~103394322:-
BRCA	cis	rs10216189	0.785	rs4623325	MIMAT0004799	hsa-miR-589-5p	3.37	0.000787	0.1	0.1	Relative hand skill in reading disability;	chr7:5487176	chr7:5495873~5495894:-
BRCA	cis	rs10455248	0.692	rs6908973	MIMAT0000088	hsa-miR-30a-3p	-3.37	0.00079	-0.11	-0.1	Cognitive performance;	chr6:71782308	chr6:71403554~71403575:-
BRCA	cis	rs2031532	0.544	rs35980977	MIMAT0017990	hsa-miR-3613-5p	3.37	0.000791	0.09	0.1	Cardiac hypertrophy;	chr13:49483800	chr13:49996465~49996486:-
BRCA	cis	rs6864727	1	rs2097865	MIMAT0004911	hsa-miR-874-3p	-3.37	0.000792	-0.1	-0.1	Atrial fibrillation;	chr5:137909378	chr5:137647582~137647603:-
BRCA	cis	rs12701220	0.655	rs9638973	MIMAT0000764	hsa-miR-339-5p	3.37	0.000792	0.1	0.1	Bronchopulmonary dysplasia;	chr7:1094042	chr7:1022990~1023012:-
BRCA	cis	rs2574975	0.679	rs2255720	MIMAT0003273	hsa-miR-605-5p	3.37	0.000793	0.13	0.1	Response to amphetamines;	chr10:50373226	chr10:51299588~51299610:+
BRCA	cis	rs4851551	0.867	rs3917330	MIMAT0019926	hsa-miR-4772-5p	3.36	0.000796	0.19	0.1	Blood protein levels;	chr2:102179965	chr2:102432300~102432321:+
BRCA	cis	rs4851551	0.867	rs3917331	MIMAT0019926	hsa-miR-4772-5p	3.36	0.000796	0.19	0.1	Blood protein levels;	chr2:102179966	chr2:102432300~102432321:+
BRCA	cis	rs1882496	0.84	rs3902812	MIMAT0018197	hsa-miR-3922-3p	3.36	8e-04	0.12	0.1	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr12:104481660	chr12:104591694~104591715:+
BRCA	cis	rs7851726	0.934	rs368138	MIMAT0019208	hsa-miR-3074-5p	-3.36	0.000806	-0.1	-0.1	Urinary albumin-to-creatinine ratio;	chr9:94761301	chr9:95086063~95086083:-
BRCA	cis	rs7897654	0.59	rs7092593	MIMAT0005951	hsa-miR-1307-3p	3.36	0.00081	0.08	0.1	Schizophrenia;	chr10:102976594	chr10:103394301~103394322:-
BRCA	cis	rs12701220	0.847	rs10272002	MIMAT0004702	hsa-miR-339-3p	3.36	0.00081	0.12	0.1	Bronchopulmonary dysplasia;	chr7:1007979	chr7:1022955~1022977:-
BRCA	cis	rs17604090	0.938	rs115369413	MIMAT0004800	hsa-miR-550a-5p	3.36	0.000813	0.15	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645424	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs115369413	MIMAT0004800_1	hsa-miR-550a-5p	3.36	0.000813	0.15	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29645424	chr7:32733002~32733024:+
BRCA	cis	rs7929679	0.846	rs7933927	MIMAT0019776	hsa-miR-1343-3p	3.36	0.000813	0.1	0.1	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34778252	chr11:34941888~34941909:+
BRCA	cis	rs9527	0.569	rs10786730	MIMAT0005951	hsa-miR-1307-3p	3.36	0.000815	0.06	0.1	Arsenic metabolism;	chr10:102964443	chr10:103394301~103394322:-
BRCA	cis	rs13256369	0.755	rs12680167	MIMAT0019728	hsa-miR-4660	3.36	0.000816	0.14	0.1	Obesity-related traits;	chr8:8704957	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs11191472	MIMAT0005951	hsa-miR-1307-3p	-3.36	0.000816	-0.11	-0.1	Birth weight;	chr10:102947259	chr10:103394301~103394322:-
BRCA	cis	rs2284367	0.505	rs72923163	MIMAT0019776	hsa-miR-1343-3p	-3.36	0.000818	-0.16	-0.1	Blood protein levels;	chr11:34477055	chr11:34941888~34941909:+
BRCA	cis	rs1239947	0.643	rs1239945	MIMAT0000069	hsa-miR-16-5p	3.35	0.000823	0.06	0.1	Height;	chr13:50533621	chr13:50049027~50049048:-
BRCA	cis	rs1239947	0.643	rs1239945	MIMAT0000069_1	hsa-miR-16-5p	3.35	0.000823	0.06	0.1	Height;	chr13:50533621	chr3:160404754~160404775:+
BRCA	cis	rs4711336	0.935	rs3818525	MIMAT0018349	hsa-miR-3934-5p	-3.35	0.000823	-0.11	-0.1	Height;	chr6:33693002	chr6:33698152~33698173:+
BRCA	cis	rs2868985	1	rs2868985	MIMAT0000274	hsa-miR-217-5p	3.35	0.000827	0.15	0.1	Schizophrenia;	chr2:55964335	chr2:55983020~55983042:-
BRCA	cis	rs12701220	0.894	rs8591	MIMAT0004702	hsa-miR-339-3p	3.35	0.000828	0.11	0.1	Bronchopulmonary dysplasia;	chr7:997163	chr7:1022955~1022977:-
BRCA	cis	rs74233809	1	rs11191453	MIMAT0022727	hsa-miR-1307-5p	-3.35	0.000832	-0.1	-0.1	Birth weight;	chr10:102900095	chr10:103394341~103394361:-
BRCA	cis	rs6864727	1	rs6864727	MIMAT0004911	hsa-miR-874-3p	3.35	0.000833	0.09	0.1	Atrial fibrillation;	chr5:137912251	chr5:137647582~137647603:-
BRCA	cis	rs9527	0.615	rs11191489	MIMAT0005951	hsa-miR-1307-3p	3.35	0.000836	0.06	0.1	Arsenic metabolism;	chr10:102980811	chr10:103394301~103394322:-
BRCA	cis	rs10021731	0.725	rs2126026	MIMAT0003242	hsa-miR-577	-3.35	0.000836	-0.09	-0.1	Optic disc area;	chr4:114533531	chr4:114656774~114656794:+
BRCA	cis	rs2274459	0.841	rs12661400	MIMAT0018349	hsa-miR-3934-5p	3.35	0.000836	0.16	0.1	Obesity (extreme);	chr6:33728700	chr6:33698152~33698173:+
BRCA	cis	rs6537837	1	rs2301229	MIMAT0000227	hsa-miR-197-3p	-3.35	0.000841	-0.09	-0.1	Major depressive disorder;	chr1:109594056	chr1:109598940~109598961:+
BRCA	cis	rs6537837	1	rs3525	MIMAT0000227	hsa-miR-197-3p	-3.35	0.000841	-0.09	-0.1	Major depressive disorder;	chr1:109594224	chr1:109598940~109598961:+
BRCA	cis	rs6601327	0.575	rs6994574	MIMAT0019728	hsa-miR-4660	-3.35	0.000842	-0.13	-0.1	Multiple myeloma (hyperdiploidy);	chr8:9720745	chr8:9048453~9048475:+
BRCA	cis	rs35275482	0.646	rs11633484	MIMAT0011161	hsa-miR-2116-3p	3.35	0.000842	0.13	0.1	Gut microbiota (bacterial taxa);	chr15:59827113	chr15:59171192~59171212:-
BRCA	cis	rs9693857	0.52	rs10107887	MIMAT0019728	hsa-miR-4660	3.35	0.000843	0.14	0.1	Systolic blood pressure;	chr8:9507154	chr8:9048453~9048475:+
BRCA	cis	rs4711336	1	rs2296742	MIMAT0018349	hsa-miR-3934-5p	-3.35	0.000846	-0.11	-0.1	Height;	chr6:33692016	chr6:33698152~33698173:+
BRCA	cis	rs4711336	1	rs4711337	MIMAT0018349	hsa-miR-3934-5p	-3.35	0.000846	-0.11	-0.1	Height;	chr6:33692210	chr6:33698152~33698173:+
BRCA	cis	rs732716	0.889	rs62129355	MIMAT0019880	hsa-miR-4746-5p	3.35	0.000847	0.14	0.1	Mean corpuscular volume;	chr19:4397037	chr19:4445987~4446009:+
BRCA	cis	rs74233809	1	rs79993475	MIMAT0022727	hsa-miR-1307-5p	-3.35	0.000848	-0.1	-0.1	Birth weight;	chr10:103141274	chr10:103394341~103394361:-
BRCA	cis	rs6537837	0.701	rs12021920	MIMAT0000227	hsa-miR-197-3p	-3.35	0.00085	-0.1	-0.1	Major depressive disorder;	chr1:109604665	chr1:109598940~109598961:+
BRCA	cis	rs7226408	0.79	rs55935783	MIMAT0000262	hsa-miR-187-3p	3.35	0.00085	0.2	0.1	Obesity-related traits;	chr18:36766157	chr18:35904835~35904856:-
BRCA	cis	rs2274459	0.778	rs2281917	MIMAT0022975	hsa-miR-3934-3p	3.35	0.000852	0.16	0.1	Obesity (extreme);	chr6:33687951	chr6:33698191~33698212:+
BRCA	cis	rs74233809	1	rs3781285	MIMAT0022727	hsa-miR-1307-5p	-3.35	0.000852	-0.11	-0.1	Birth weight;	chr10:103065908	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.659	rs28564476	MIMAT0003242	hsa-miR-577	-3.35	0.000852	-0.09	-0.1	Optic disc area;	chr4:114484592	chr4:114656774~114656794:+
BRCA	cis	rs74233809	1	rs11191575	MIMAT0022727	hsa-miR-1307-5p	-3.34	0.000857	-0.1	-0.1	Birth weight;	chr10:103138580	chr10:103394341~103394361:-
BRCA	cis	rs8060686	0.516	rs7193701	MIMAT0000752	hsa-miR-328-3p	3.34	0.000859	0.07	0.1	Metabolic syndrome;HDL cholesterol;	chr16:68151257	chr16:67202327~67202348:-
BRCA	cis	rs74233809	1	rs11191548	MIMAT0005951	hsa-miR-1307-3p	3.34	0.000861	0.1	0.1	Birth weight;	chr10:103086421	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.938	rs28457783	MIMAT0004800	hsa-miR-550a-5p	3.34	0.000863	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647442	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.938	rs28457783	MIMAT0004800_1	hsa-miR-550a-5p	3.34	0.000863	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647442	chr7:32733002~32733024:+
BRCA	cis	rs17604090	0.818	rs73090342	MIMAT0004800	hsa-miR-550a-5p	3.34	0.000863	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647924	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.818	rs73090342	MIMAT0004800_1	hsa-miR-550a-5p	3.34	0.000863	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647924	chr7:32733002~32733024:+
BRCA	cis	rs440932	1	rs365309	MIMAT0019728	hsa-miR-4660	-3.34	0.000864	-0.14	-0.1	High light scatter reticulocyte percentage of red cells;	chr8:9169430	chr8:9048453~9048475:+
BRCA	cis	rs17710780	0.803	rs10515631	MIMAT0000731	hsa-miR-378a-5p	-3.34	0.000873	-0.12	-0.1	Major depressive disorder;	chr5:149723097	chr5:149732829~149732850:+
BRCA	cis	rs6681460	0.932	rs659291	MIMAT0014979	hsa-miR-3117-3p	-3.34	0.000875	-0.12	-0.1	Presence of antiphospholipid antibodies;	chr1:66715063	chr1:66628485~66628505:+
BRCA	cis	rs73198271	0.74	rs10105920	MIMAT0019728	hsa-miR-4660	3.34	0.000879	0.13	0.1	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8791227	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs79668541	MIMAT0022727	hsa-miR-1307-5p	-3.34	0.000879	-0.11	-0.1	Birth weight;	chr10:103034147	chr10:103394341~103394361:-
BRCA	cis	rs4711336	1	rs2229642	MIMAT0022975	hsa-miR-3934-3p	-3.34	0.00088	-0.12	-0.1	Height;	chr6:33691695	chr6:33698191~33698212:+
BRCA	cis	rs6437061	0.74	rs2679163	MIMAT0019935	hsa-miR-4777-3p	-3.34	0.000882	-0.12	-0.1	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI in non-smokers;	chr2:231951527	chr2:231362764~231362785:+
BRCA	cis	rs730566	1	rs4858819	MIMAT0000440	hsa-miR-191-5p	-3.34	0.000883	-0.09	-0.1	Prion diseases;	chr3:48436678	chr3:49020672~49020694:-
BRCA	cis	rs2274459	0.841	rs13204162	MIMAT0018349	hsa-miR-3934-5p	3.33	0.000885	0.16	0.1	Obesity (extreme);	chr6:33728354	chr6:33698152~33698173:+
BRCA	cis	rs2031532	0.587	rs2038638	MIMAT0017990	hsa-miR-3613-5p	3.33	0.000886	0.09	0.1	Cardiac hypertrophy;	chr13:49474839	chr13:49996465~49996486:-
BRCA	cis	rs74233809	0.901	rs12416331	MIMAT0022727	hsa-miR-1307-5p	-3.33	0.000887	-0.1	-0.1	Birth weight;	chr10:103169157	chr10:103394341~103394361:-
BRCA	cis	rs4841134	0.625	rs12235038	MIMAT0019728	hsa-miR-4660	-3.33	0.000888	-0.12	-0.1	Age-related disease endophenotypes;	chr8:9379893	chr8:9048453~9048475:+
BRCA	cis	rs250677	0.687	rs41181	MIMAT0003249	hsa-miR-584-5p	-3.33	0.00089	-0.12	-0.1	Breast cancer;	chr5:149064694	chr5:149062373~149062394:-
BRCA	cis	rs2031532	0.544	rs3764089	MIMAT0017990	hsa-miR-3613-5p	3.33	0.00089	0.09	0.1	Cardiac hypertrophy;	chr13:49489102	chr13:49996465~49996486:-
BRCA	cis	rs7617773	0.963	rs12494304	MIMAT0000440	hsa-miR-191-5p	-3.33	0.000893	-0.07	-0.1	Coronary artery disease;	chr3:48136539	chr3:49020672~49020694:-
BRCA	cis	rs13390641	1	rs12616040	MIMAT0019926	hsa-miR-4772-5p	-3.33	0.000896	-0.17	-0.1	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103384805	chr2:102432300~102432321:+
BRCA	cis	rs7123876	0.587	rs11602616	MIMAT0000250	hsa-miR-139-5p	-3.33	0.000896	-0.11	-0.1	Body mass index;	chr11:72653033	chr11:72615102~72615124:-
BRCA	cis	rs74233809	1	rs75970938	MIMAT0022727	hsa-miR-1307-5p	-3.33	0.000896	-0.11	-0.1	Birth weight;	chr10:103033891	chr10:103394341~103394361:-
BRCA	cis	rs7226408	0.842	rs62083201	MIMAT0000262	hsa-miR-187-3p	3.33	0.000896	0.2	0.1	Obesity-related traits;	chr18:36767873	chr18:35904835~35904856:-
BRCA	cis	rs10021731	0.725	rs13103327	MIMAT0003242	hsa-miR-577	3.33	0.000899	0.1	0.1	Optic disc area;	chr4:114532551	chr4:114656774~114656794:+
BRCA	cis	rs1355223	0.506	rs7130774	MIMAT0019776	hsa-miR-1343-3p	3.33	0.000901	0.1	0.1	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34847720	chr11:34941888~34941909:+
BRCA	cis	rs6601327	0.613	rs10094989	MIMAT0019728	hsa-miR-4660	3.33	0.000901	0.13	0.1	Multiple myeloma (hyperdiploidy);	chr8:9754499	chr8:9048453~9048475:+
BRCA	cis	rs13256369	0.951	rs13259955	MIMAT0019728	hsa-miR-4660	3.33	0.000905	0.14	0.1	Obesity-related traits;	chr8:8708375	chr8:9048453~9048475:+
BRCA	cis	rs1882496	0.84	rs3902813	MIMAT0018197	hsa-miR-3922-3p	3.33	0.000905	0.12	0.1	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr12:104481702	chr12:104591694~104591715:+
BRCA	cis	rs4237845	0.761	rs11172378	MIMAT0000082	hsa-miR-26a-5p	3.33	0.000907	0.08	0.1	Intelligence (multi-trait analysis);	chr12:57904378	chr12:57824658~57824679:-
BRCA	cis	rs4237845	0.761	rs11172378	MIMAT0000082_1	hsa-miR-26a-5p	3.33	0.000907	0.08	0.1	Intelligence (multi-trait analysis);	chr12:57904378	chr3:37969413~37969434:+
BRCA	cis	rs250677	0.522	rs4431331	MIMAT0003249	hsa-miR-584-5p	3.33	0.000908	0.12	0.1	Breast cancer;	chr5:148974011	chr5:149062373~149062394:-
BRCA	cis	rs4711336	0.967	rs4713658	MIMAT0022975	hsa-miR-3934-3p	-3.33	0.00091	-0.12	-0.1	Height;	chr6:33699340	chr6:33698191~33698212:+
BRCA	cis	rs7617773	0.963	rs12493256	MIMAT0000440	hsa-miR-191-5p	-3.33	0.000912	-0.07	-0.1	Coronary artery disease;	chr3:48135257	chr3:49020672~49020694:-
BRCA	cis	rs2400997	1	rs2400997	MIMAT0022923	hsa-miR-376b-5p	-3.33	0.000914	-0.1	-0.1	Prostate cancer (SNP x SNP interaction);	chr14:101260770	chr14:101040459~101040480:+
BRCA	cis	rs7851726	0.865	rs2584806	MIMAT0019208	hsa-miR-3074-5p	-3.32	0.000917	-0.1	-0.1	Urinary albumin-to-creatinine ratio;	chr9:94766996	chr9:95086063~95086083:-
BRCA	cis	rs250677	0.687	rs2963484	MIMAT0003249	hsa-miR-584-5p	3.32	0.00092	0.12	0.1	Breast cancer;	chr5:149071564	chr5:149062373~149062394:-
BRCA	cis	rs10021731	0.725	rs72676244	MIMAT0003242	hsa-miR-577	3.32	0.000923	0.09	0.1	Optic disc area;	chr4:114479168	chr4:114656774~114656794:+
BRCA	cis	rs12204590	0.821	rs11242678	MIMAT0025851	hsa-miR-6720-3p	3.32	0.000925	0.12	0.1	Stroke;	chr6:1336945	chr6:1390324~1390345:-
BRCA	cis	rs74233809	1	rs77860422	MIMAT0005951	hsa-miR-1307-3p	-3.32	0.000932	-0.1	-0.1	Birth weight;	chr10:102988252	chr10:103394301~103394322:-
BRCA	cis	rs250677	0.617	rs166106	MIMAT0003249	hsa-miR-584-5p	3.32	0.000932	0.12	0.1	Breast cancer;	chr5:149067498	chr5:149062373~149062394:-
BRCA	cis	rs2031532	0.565	rs11619265	MIMAT0017990	hsa-miR-3613-5p	3.32	0.000938	0.09	0.1	Cardiac hypertrophy;	chr13:49483497	chr13:49996465~49996486:-
BRCA	cis	rs13256369	1	rs4841017	MIMAT0019728	hsa-miR-4660	3.32	0.000941	0.14	0.1	Obesity-related traits;	chr8:8719583	chr8:9048453~9048475:+
BRCA	cis	rs6961102	1	rs896156	MIMAT0004560	hsa-miR-183-3p	3.32	0.000946	0.19	0.1	Platelet distribution width;	chr7:129574577	chr7:129774928~129774949:-
BRCA	cis	rs7026071	1	rs7026071	MIMAT0019208	hsa-miR-3074-5p	-3.32	0.000948	-0.1	-0.1	Atrial fibrillation;	chr9:94730238	chr9:95086063~95086083:-
BRCA	cis	rs1014286	0.706	rs10202404	MIMAT0019926	hsa-miR-4772-5p	-3.31	0.000953	-0.1	-0.1	Serum protein levels (sST2);	chr2:102560955	chr2:102432300~102432321:+
BRCA	cis	rs4665809	0.652	rs2241739	MIMAT0026639	hsa-miR-1301-5p	-3.31	0.000953	-0.12	-0.1	Gut microbiome composition (summer);	chr2:26189025	chr2:25328689~25328707:-
BRCA	cis	rs74233809	1	rs12219027	MIMAT0022727	hsa-miR-1307-5p	-3.31	0.000955	-0.1	-0.1	Birth weight;	chr10:103051446	chr10:103394341~103394361:-
BRCA	cis	rs9990333	1	rs9990333	MIMAT0003235	hsa-miR-570-3p	-3.31	0.000958	-0.11	-0.1	Iron status biomarkers (transferrin levels);Iron status biomarkers (transferrin saturation);	chr3:196100334	chr3:195699460~195699481:+
BRCA	cis	rs13256369	1	rs12550762	MIMAT0019728	hsa-miR-4660	3.31	0.000958	0.14	0.1	Obesity-related traits;	chr8:8719025	chr8:9048453~9048475:+
BRCA	cis	rs35275482	0.573	rs1036514	MIMAT0011161	hsa-miR-2116-3p	3.31	0.000959	0.13	0.1	Gut microbiota (bacterial taxa);	chr15:59829633	chr15:59171192~59171212:-
BRCA	cis	rs2274459	1	rs2296749	MIMAT0018349	hsa-miR-3934-5p	3.31	0.000968	0.16	0.1	Obesity (extreme);	chr6:33795350	chr6:33698152~33698173:+
BRCA	cis	rs7851726	1	rs183066	MIMAT0019208	hsa-miR-3074-5p	-3.31	0.000968	-0.1	-0.1	Urinary albumin-to-creatinine ratio;	chr9:94755150	chr9:95086063~95086083:-
BRCA	cis	rs6961102	1	rs7805465	MIMAT0000259	hsa-miR-182-5p	3.31	0.000969	0.16	0.1	Platelet distribution width;	chr7:129608797	chr7:129770447~129770470:-
BRCA	cis	rs3749237	0.964	rs10865959	MIMAT0001343	hsa-miR-425-3p	3.31	0.000969	0.1	0.1	Resting heart rate;	chr3:49853569	chr3:49020159~49020180:-
BRCA	cis	rs250677	0.687	rs250673	MIMAT0003249	hsa-miR-584-5p	3.31	0.000973	0.12	0.1	Breast cancer;	chr5:149066235	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.687	rs250672	MIMAT0003249	hsa-miR-584-5p	3.31	0.000973	0.12	0.1	Breast cancer;	chr5:149066547	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.687	rs250671	MIMAT0003249	hsa-miR-584-5p	3.31	0.000973	0.12	0.1	Breast cancer;	chr5:149066960	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.652	rs250670	MIMAT0003249	hsa-miR-584-5p	3.31	0.000973	0.12	0.1	Breast cancer;	chr5:149067083	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.687	rs168750	MIMAT0003249	hsa-miR-584-5p	3.31	0.000973	0.12	0.1	Breast cancer;	chr5:149067193	chr5:149062373~149062394:-
BRCA	cis	rs74233809	1	rs11191543	MIMAT0022727	hsa-miR-1307-5p	-3.31	0.000975	-0.1	-0.1	Birth weight;	chr10:103064630	chr10:103394341~103394361:-
BRCA	cis	rs111803315	1	rs73301712	MIMAT0022287	hsa-miR-5586-5p	3.31	0.000978	0.19	0.1	Schizophrenia;	chr14:59431527	chr14:59646999~59647020:-
BRCA	cis	rs4711336	1	rs2296742	MIMAT0022975	hsa-miR-3934-3p	-3.31	0.000978	-0.12	-0.1	Height;	chr6:33692016	chr6:33698191~33698212:+
BRCA	cis	rs4711336	1	rs4711337	MIMAT0022975	hsa-miR-3934-3p	-3.31	0.000978	-0.12	-0.1	Height;	chr6:33692210	chr6:33698191~33698212:+
BRCA	cis	rs7929679	0.846	rs2136509	MIMAT0019776	hsa-miR-1343-3p	3.31	0.000981	0.1	0.1	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34775257	chr11:34941888~34941909:+
BRCA	cis	rs7929679	0.846	rs7116210	MIMAT0019776	hsa-miR-1343-3p	3.31	0.000981	0.1	0.1	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34775808	chr11:34941888~34941909:+
BRCA	cis	rs72482608	0.865	rs10919471	MIMAT0005885	hsa-miR-1295a	3.31	0.000981	0.13	0.1	Emphysema imaging phenotypes;	chr1:170794412	chr1:171101738~171101758:-
BRCA	cis	rs10455248	0.669	rs1576239	MIMAT0000088	hsa-miR-30a-3p	-3.31	0.000981	-0.1	-0.1	Cognitive performance;	chr6:71777521	chr6:71403554~71403575:-
BRCA	cis	rs250677	0.522	rs17109208	MIMAT0003249	hsa-miR-584-5p	3.3	0.000998	0.12	0.1	Breast cancer;	chr5:148998912	chr5:149062373~149062394:-
BRCA	cis	rs11603691	0.551	rs10792086	MIMAT0004593	hsa-miR-130a-5p	3.3	0.001	0.14	0.1	Low high density lipoprotein cholesterol levels;	chr11:57315422	chr11:57641212~57641233:+
BRCA	cis	rs6601327	0.606	rs7006985	MIMAT0019728	hsa-miR-4660	-3.3	0.001	-0.13	-0.1	Multiple myeloma (hyperdiploidy);	chr8:9706927	chr8:9048453~9048475:+
BRCA	cis	rs74233809	1	rs12221193	MIMAT0022727	hsa-miR-1307-5p	-3.3	0.001	-0.1	-0.1	Birth weight;	chr10:102905510	chr10:103394341~103394361:-
BRCA	cis	rs74233809	1	rs77180047	MIMAT0022727	hsa-miR-1307-5p	-3.3	0.001	-0.1	-0.1	Birth weight;	chr10:102907000	chr10:103394341~103394361:-
BRCA	cis	rs10455248	0.692	rs9342877	MIMAT0000088	hsa-miR-30a-3p	3.3	0.00101	0.11	0.1	Cognitive performance;	chr6:71782914	chr6:71403554~71403575:-
BRCA	cis	rs74233809	1	rs12219027	MIMAT0005951	hsa-miR-1307-3p	-3.3	0.00101	-0.1	-0.1	Birth weight;	chr10:103051446	chr10:103394301~103394322:-
BRCA	cis	rs730566	1	rs730566	MIMAT0000440	hsa-miR-191-5p	-3.3	0.00101	-0.08	-0.1	Prion diseases;	chr3:48445644	chr3:49020672~49020694:-
BRCA	cis	rs74233809	1	rs12413046	MIMAT0005951	hsa-miR-1307-3p	-3.3	0.00101	-0.1	-0.1	Birth weight;	chr10:103111447	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs10883832	MIMAT0005951	hsa-miR-1307-3p	-3.3	0.00101	-0.1	-0.1	Birth weight;	chr10:103111522	chr10:103394301~103394322:-
BRCA	cis	rs17604090	0.536	rs112165062	MIMAT0004800	hsa-miR-550a-5p	3.3	0.00101	0.14	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647976	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.536	rs112165062	MIMAT0004800_1	hsa-miR-550a-5p	3.3	0.00101	0.14	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29647976	chr7:32733002~32733024:+
BRCA	cis	rs17710780	0.803	rs11749341	MIMAT0000731	hsa-miR-378a-5p	-3.3	0.00101	-0.12	-0.1	Major depressive disorder;	chr5:149723346	chr5:149732829~149732850:+
BRCA	cis	rs17710780	0.803	rs62382267	MIMAT0000731	hsa-miR-378a-5p	-3.3	0.00101	-0.12	-0.1	Major depressive disorder;	chr5:149723764	chr5:149732829~149732850:+
BRCA	cis	rs6864727	1	rs2349556	MIMAT0004911	hsa-miR-874-3p	-3.3	0.00102	-0.09	-0.1	Atrial fibrillation;	chr5:137913032	chr5:137647582~137647603:-
BRCA	cis	rs250677	0.522	rs2895837	MIMAT0003249	hsa-miR-584-5p	-3.29	0.00102	-0.12	-0.1	Breast cancer;	chr5:148977972	chr5:149062373~149062394:-
BRCA	cis	rs13161895	1	rs35973843	MIMAT0004692	hsa-miR-340-5p	3.29	0.00103	0.13	0.1	LDL cholesterol;	chr5:180039502	chr5:180015361~180015382:-
BRCA	cis	rs13161895	1	rs35135297	MIMAT0004692	hsa-miR-340-5p	3.29	0.00103	0.13	0.1	LDL cholesterol;	chr5:180042532	chr5:180015361~180015382:-
BRCA	cis	rs13161895	1	rs13161895	MIMAT0004692	hsa-miR-340-5p	3.29	0.00103	0.13	0.1	LDL cholesterol;	chr5:180044201	chr5:180015361~180015382:-
BRCA	cis	rs13161895	1	rs12656814	MIMAT0004692	hsa-miR-340-5p	3.29	0.00103	0.13	0.1	LDL cholesterol;	chr5:180044556	chr5:180015361~180015382:-
BRCA	cis	rs13161895	1	rs4700853	MIMAT0004692	hsa-miR-340-5p	3.29	0.00103	0.13	0.1	LDL cholesterol;	chr5:180046328	chr5:180015361~180015382:-
BRCA	cis	rs13161895	1	rs34674199	MIMAT0004692	hsa-miR-340-5p	3.29	0.00103	0.13	0.1	LDL cholesterol;	chr5:180046900	chr5:180015361~180015382:-
BRCA	cis	rs4711336	1	rs3818523	MIMAT0018349	hsa-miR-3934-5p	-3.29	0.00103	-0.11	-0.1	Height;	chr6:33692594	chr6:33698152~33698173:+
BRCA	cis	rs16869212	1	rs16869212	MIMAT0004951	hsa-miR-887-3p	3.29	0.00104	0.17	0.1	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:16881981	chr5:15935229~15935250:+
BRCA	cis	rs12545912	0.774	rs4841173	MIMAT0019728	hsa-miR-4660	3.29	0.00104	0.14	0.1	Multiple myeloma (hyperdiploidy);	chr8:9578546	chr8:9048453~9048475:+
BRCA	cis	rs35275482	0.646	rs2414647	MIMAT0011161	hsa-miR-2116-3p	3.29	0.00105	0.13	0.1	Gut microbiota (bacterial taxa);	chr15:59813535	chr15:59171192~59171212:-
BRCA	cis	rs250677	0.687	rs250664	MIMAT0003249	hsa-miR-584-5p	3.29	0.00105	0.12	0.1	Breast cancer;	chr5:149074260	chr5:149062373~149062394:-
BRCA	cis	rs250677	0.687	rs250666	MIMAT0003249	hsa-miR-584-5p	3.29	0.00105	0.12	0.1	Breast cancer;	chr5:149075059	chr5:149062373~149062394:-
BRCA	cis	rs17604090	1	rs17603986	MIMAT0004800	hsa-miR-550a-5p	3.29	0.00105	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650873	chr7:30289815~30289837:+
BRCA	cis	rs17604090	1	rs17603986	MIMAT0004800_1	hsa-miR-550a-5p	3.29	0.00105	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29650873	chr7:32733002~32733024:+
BRCA	cis	rs6681460	0.932	rs524114	MIMAT0014979	hsa-miR-3117-3p	3.29	0.00105	0.11	0.1	Presence of antiphospholipid antibodies;	chr1:66722652	chr1:66628485~66628505:+
BRCA	cis	rs11172055	0.54	rs9919772	MIMAT0004681	hsa-miR-26a-2-3p	3.29	0.00105	0.11	0.1	Migraine;	chr12:56866243	chr12:57824620~57824641:-
BRCA	cis	rs4711336	0.967	rs4711338	MIMAT0022975	hsa-miR-3934-3p	-3.29	0.00105	-0.12	-0.1	Height;	chr6:33692411	chr6:33698191~33698212:+
BRCA	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	3.28	0.00105	0.06	0.1	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
BRCA	cis	rs917793	1	rs2908282	MIMAT0027577	hsa-miR-6837-3p	-3.28	0.00106	-0.16	-0.1	Fasting plasma glucose;	chr7:44209229	chr7:44051807~44051829:+
BRCA	cis	rs73198271	0.586	rs3789850	MIMAT0019728	hsa-miR-4660	-3.28	0.00106	-0.13	-0.1	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8829335	chr8:9048453~9048475:+
BRCA	cis	rs2574975	0.679	rs2842109	MIMAT0003273	hsa-miR-605-5p	3.28	0.00106	0.12	0.1	Response to amphetamines;	chr10:50373378	chr10:51299588~51299610:+
BRCA	cis	rs7929679	0.875	rs1396887	MIMAT0019776	hsa-miR-1343-3p	3.28	0.00106	0.1	0.1	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34773891	chr11:34941888~34941909:+
BRCA	cis	rs259842	0.8	rs1383413	MIMAT0005909	hsa-miR-1258	3.28	0.00106	0.11	0.1	Blood protein levels;	chr2:179852906	chr2:179860845~179860865:-
BRCA	cis	rs74233809	1	rs11191543	MIMAT0005951	hsa-miR-1307-3p	-3.28	0.00106	-0.1	-0.1	Birth weight;	chr10:103064630	chr10:103394301~103394322:-
BRCA	cis	rs35847492	1	rs35847492	MIMAT0019728	hsa-miR-4660	3.28	0.00106	0.13	0.1	Neuroticism;	chr8:9418515	chr8:9048453~9048475:+
BRCA	cis	rs7929679	0.777	rs1396888	MIMAT0019776	hsa-miR-1343-3p	3.28	0.00107	0.1	0.1	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34772885	chr11:34941888~34941909:+
BRCA	cis	rs1014286	0.706	rs10171438	MIMAT0019926	hsa-miR-4772-5p	-3.28	0.00107	-0.1	-0.1	Serum protein levels (sST2);	chr2:102558917	chr2:102432300~102432321:+
BRCA	cis	rs1018697	1	rs7896903	MIMAT0022727	hsa-miR-1307-5p	3.28	0.00107	0.06	0.1	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394341~103394361:-
BRCA	cis	rs7929679	0.777	rs1396889	MIMAT0019776	hsa-miR-1343-3p	3.28	0.00107	0.1	0.1	Chronic obstructive pulmonary disease-related biomarkers;Lung disease severity in cystic fibrosis;	chr11:34772751	chr11:34941888~34941909:+
BRCA	cis	rs74233809	1	rs11191531	MIMAT0005951	hsa-miR-1307-3p	-3.28	0.00107	-0.1	-0.1	Birth weight;	chr10:103047141	chr10:103394301~103394322:-
BRCA	cis	rs6681460	1	rs7532173	MIMAT0014979	hsa-miR-3117-3p	-3.28	0.00107	-0.12	-0.1	Presence of antiphospholipid antibodies;	chr1:66620428	chr1:66628485~66628505:+
BRCA	cis	rs909848	0.524	rs2050065	MIMAT0000456	hsa-miR-186-5p	3.28	0.00108	0.08	0.1	IgG glycosylation;	chr1:71044736	chr1:71067681~71067702:-
BRCA	cis	rs6681460	0.8	rs485543	MIMAT0014979	hsa-miR-3117-3p	3.28	0.00108	0.11	0.1	Presence of antiphospholipid antibodies;	chr1:66728689	chr1:66628485~66628505:+
BRCA	cis	rs2031532	0.569	rs6561526	MIMAT0017990	hsa-miR-3613-5p	3.28	0.00108	0.09	0.1	Cardiac hypertrophy;	chr13:49492388	chr13:49996465~49996486:-
BRCA	cis	rs250677	0.522	rs3763022	MIMAT0003249	hsa-miR-584-5p	3.28	0.00108	0.11	0.1	Breast cancer;	chr5:149001515	chr5:149062373~149062394:-
BRCA	cis	rs17710780	0.614	rs115403966	MIMAT0000731	hsa-miR-378a-5p	-3.28	0.00108	-0.13	-0.1	Major depressive disorder;	chr5:149698057	chr5:149732829~149732850:+
BRCA	cis	rs1870653	0.516	rs6852269	MIMAT0003242	hsa-miR-577	3.28	0.00108	0.15	0.1	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);	chr4:114481622	chr4:114656774~114656794:+
BRCA	cis	rs250677	0.522	rs1432801	MIMAT0003249	hsa-miR-584-5p	3.28	0.00108	0.12	0.1	Breast cancer;	chr5:149011416	chr5:149062373~149062394:-
BRCA	cis	rs10784762	1	rs10784762	MIMAT0018187	hsa-miR-3913-5p	-3.28	0.00108	-0.12	-0.1	QRS duration;	chr12:69130143	chr12:69584780~69584801:-
BRCA	cis	rs10784762	1	rs10784762	MIMAT0018187_1	hsa-miR-3913-5p	-3.28	0.00108	-0.12	-0.1	QRS duration;	chr12:69130143	chr12:69584744~69584765:+
BRCA	cis	rs4711336	0.935	rs3818525	MIMAT0022975	hsa-miR-3934-3p	-3.28	0.00108	-0.12	-0.1	Height;	chr6:33693002	chr6:33698191~33698212:+
BRCA	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	3.28	0.00108	0.08	0.1	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
BRCA	cis	rs10426930	0.547	rs2054519	MIMAT0019880	hsa-miR-4746-5p	-3.28	0.00109	-0.13	-0.1	Monocyte percentage of white cells;	chr19:5059349	chr19:4445987~4446009:+
BRCA	cis	rs72482608	0.865	rs10919476	MIMAT0005885	hsa-miR-1295a	3.27	0.0011	0.12	0.1	Emphysema imaging phenotypes;	chr1:170802794	chr1:171101738~171101758:-
BRCA	cis	rs74233809	1	rs11191505	MIMAT0022727	hsa-miR-1307-5p	-3.27	0.0011	-0.1	-0.1	Birth weight;	chr10:103007134	chr10:103394341~103394361:-
BRCA	cis	rs10021731	0.725	rs13103303	MIMAT0003242	hsa-miR-577	3.27	0.0011	0.09	0.1	Optic disc area;	chr4:114532477	chr4:114656774~114656794:+
BRCA	cis	rs74233809	1	rs11191499	MIMAT0022727	hsa-miR-1307-5p	-3.27	0.0011	-0.1	-0.1	Birth weight;	chr10:103004514	chr10:103394341~103394361:-
BRCA	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-3.27	0.0011	-0.08	-0.1	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
BRCA	cis	rs17710780	0.803	rs17710942	MIMAT0000731	hsa-miR-378a-5p	-3.27	0.0011	-0.13	-0.1	Major depressive disorder;	chr5:149699521	chr5:149732829~149732850:+
BRCA	cis	rs9527	0.615	rs9733635	MIMAT0005951	hsa-miR-1307-3p	3.27	0.0011	0.06	0.1	Arsenic metabolism;	chr10:102952183	chr10:103394301~103394322:-
BRCA	cis	rs74233809	1	rs79237883	MIMAT0022727	hsa-miR-1307-5p	-3.27	0.0011	-0.1	-0.1	Birth weight;	chr10:103181189	chr10:103394341~103394361:-
BRCA	cis	rs9882792	0.6	rs34975672	MIMAT0004987	hsa-miR-944	-3.27	0.00111	-0.17	-0.1	Breast cancer;	chr3:190084959	chr3:189829975~189829996:+
BRCA	cis	rs74233809	1	rs76752100	MIMAT0022727	hsa-miR-1307-5p	-3.27	0.00111	-0.1	-0.1	Birth weight;	chr10:103034329	chr10:103394341~103394361:-
BRCA	cis	rs10949834	0.517	rs810536	MIMAT0003258	hsa-miR-590-5p	3.27	0.00111	0.07	0.1	Verbal memory performance (residualized delayed recall change);	chr7:74089903	chr7:74191213~74191234:+
BRCA	cis	rs13256369	0.951	rs13260947	MIMAT0019728	hsa-miR-4660	3.27	0.00111	0.14	0.1	Obesity-related traits;	chr8:8708373	chr8:9048453~9048475:+
BRCA	cis	rs593982	0.92	rs4930298	MIMAT0004543	hsa-miR-192-3p	3.27	0.00111	0.22	0.1	Atopic dermatitis;	chr11:65680637	chr11:64891159~64891180:-
BRCA	cis	rs4665809	0.652	rs10779956	MIMAT0026639	hsa-miR-1301-5p	-3.27	0.00112	-0.13	-0.1	Gut microbiome composition (summer);	chr2:26183116	chr2:25328689~25328707:-
BRCA	cis	rs3617	0.573	rs9860296	MIMAT0000414	hsa-let-7g-5p	-3.27	0.00112	-0.08	-0.1	Autism spectrum disorder or schizophrenia;Red blood cell count;	chr3:52879765	chr3:52268336~52268357:-
BRCA	cis	rs7215564	0.818	rs901063	MIMAT0004701	hsa-miR-338-5p	3.27	0.00113	0.2	0.1	Myopia (pathological);	chr17:80621896	chr17:81125923~81125944:-
BRCA	cis	rs732716	0.889	rs11666856	MIMAT0019880	hsa-miR-4746-5p	3.27	0.00113	0.14	0.1	Mean corpuscular volume;	chr19:4437453	chr19:4445987~4446009:+
BRCA	cis	rs2574975	0.708	rs2574981	MIMAT0003273	hsa-miR-605-5p	3.27	0.00113	0.12	0.1	Response to amphetamines;	chr10:50371808	chr10:51299588~51299610:+
BRCA	cis	rs10949834	0.652	rs2269082	MIMAT0004801	hsa-miR-590-3p	-3.26	0.00113	-0.1	-0.1	Verbal memory performance (residualized delayed recall change);	chr7:74105545	chr7:74191253~74191273:+
BRCA	cis	rs6601327	0.635	rs10099122	MIMAT0019728	hsa-miR-4660	-3.26	0.00115	-0.13	-0.1	Multiple myeloma (hyperdiploidy);	chr8:9710493	chr8:9048453~9048475:+
BRCA	cis	rs10426930	0.607	rs858423	MIMAT0019880	hsa-miR-4746-5p	-3.26	0.00115	-0.13	-0.1	Monocyte percentage of white cells;	chr19:5048363	chr19:4445987~4446009:+
BRCA	cis	rs17710780	0.554	rs55650980	MIMAT0000732	hsa-miR-378a-3p	-3.26	0.00115	-0.13	-0.1	Major depressive disorder;	chr5:149803269	chr5:149732867~149732888:+
BRCA	cis	rs10021731	0.691	rs2126027	MIMAT0003242	hsa-miR-577	-3.26	0.00115	-0.09	-0.1	Optic disc area;	chr4:114533510	chr4:114656774~114656794:+
BRCA	cis	rs9882792	0.63	rs9834642	MIMAT0004987	hsa-miR-944	3.26	0.00115	0.14	0.1	Breast cancer;	chr3:190017478	chr3:189829975~189829996:+
BRCA	cis	rs13256369	0.802	rs11249888	MIMAT0019728	hsa-miR-4660	3.26	0.00115	0.14	0.1	Obesity-related traits;	chr8:8707424	chr8:9048453~9048475:+
BRCA	cis	rs13256369	0.851	rs11249889	MIMAT0019728	hsa-miR-4660	3.26	0.00115	0.14	0.1	Obesity-related traits;	chr8:8707482	chr8:9048453~9048475:+
BRCA	cis	rs9902453	0.78	rs3115093	MIMAT0001631	hsa-miR-451a	-3.26	0.00116	-0.11	-0.1	Coffee consumption (cups per day);	chr17:29712737	chr17:28861403~28861424:-
BRCA	cis	rs72482608	0.835	rs7527200	MIMAT0005885	hsa-miR-1295a	3.26	0.00116	0.12	0.1	Emphysema imaging phenotypes;	chr1:170771949	chr1:171101738~171101758:-
BRCA	cis	rs4711336	0.967	rs4711338	MIMAT0018349	hsa-miR-3934-5p	-3.26	0.00116	-0.11	-0.1	Height;	chr6:33692411	chr6:33698152~33698173:+
BRCA	cis	rs74233809	1	rs11191580	MIMAT0005951	hsa-miR-1307-3p	3.26	0.00116	0.1	0.1	Birth weight;	chr10:103146454	chr10:103394301~103394322:-
BRCA	cis	rs250677	0.522	rs6872701	MIMAT0003249	hsa-miR-584-5p	-3.26	0.00116	-0.12	-0.1	Breast cancer;	chr5:148979523	chr5:149062373~149062394:-
BRCA	cis	rs2274459	1	rs66670017	MIMAT0018349	hsa-miR-3934-5p	3.26	0.00116	0.16	0.1	Obesity (extreme);	chr6:33795786	chr6:33698152~33698173:+
BRCA	cis	rs6681460	0.8	rs481681	MIMAT0014979	hsa-miR-3117-3p	3.26	0.00117	0.11	0.1	Presence of antiphospholipid antibodies;	chr1:66728695	chr1:66628485~66628505:+
BRCA	cis	rs12460587	0.587	rs10415150	MIMAT0000443	hsa-miR-125a-5p	-3.25	0.00118	-0.08	-0.1	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52101372	chr19:51693268~51693291:+
BRCA	cis	rs7617773	0.78	rs71323396	MIMAT0011159	hsa-miR-2115-3p	3.25	0.00118	0.12	0.1	Coronary artery disease;	chr3:48333244	chr3:48316381~48316402:-
BRCA	cis	rs4665809	0.59	rs1122972	MIMAT0026639	hsa-miR-1301-5p	-3.25	0.00118	-0.13	-0.1	Gut microbiome composition (summer);	chr2:26195919	chr2:25328689~25328707:-
BRCA	cis	rs4665809	0.59	rs2289019	MIMAT0026639	hsa-miR-1301-5p	-3.25	0.00118	-0.13	-0.1	Gut microbiome composition (summer);	chr2:26197940	chr2:25328689~25328707:-
BRCA	cis	rs485497	1	rs485497	MIMAT0004518	hsa-miR-16-2-3p	3.25	0.00118	0.08	0.1	Sjögren's syndrome;	chr3:160001345	chr3:160404797~160404818:+
BRCA	cis	rs4711336	1	rs3818523	MIMAT0022975	hsa-miR-3934-3p	-3.25	0.00118	-0.12	-0.1	Height;	chr6:33692594	chr6:33698191~33698212:+
BRCA	cis	rs17604090	0.887	rs850013	MIMAT0004800	hsa-miR-550a-5p	3.25	0.00118	0.14	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29626914	chr7:30289815~30289837:+
BRCA	cis	rs17604090	0.887	rs850013	MIMAT0004800_1	hsa-miR-550a-5p	3.25	0.00118	0.14	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29626914	chr7:32733002~32733024:+
BRCA	cis	rs17604090	1	rs17661938	MIMAT0004800	hsa-miR-550a-5p	3.25	0.00119	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29653762	chr7:30289815~30289837:+
BRCA	cis	rs17604090	1	rs17661938	MIMAT0004800_1	hsa-miR-550a-5p	3.25	0.00119	0.16	0.1	Facial emotion recognition;Facial emotion recognition (sad faces);	chr7:29653762	chr7:32733002~32733024:+
BRCA	cis	rs513349	0.964	rs210141	MIMAT0022975	hsa-miR-3934-3p	-3.25	0.00119	-0.12	-0.1	Platelet count;	chr6:33579048	chr6:33698191~33698212:+
BRCA	cis	rs10021731	0.725	rs6850121	MIMAT0003242	hsa-miR-577	-3.25	0.00119	-0.09	-0.1	Optic disc area;	chr4:114484294	chr4:114656774~114656794:+
BRCA	cis	rs7617773	0.963	rs6766754	MIMAT0000440	hsa-miR-191-5p	-3.25	0.00119	-0.07	-0.1	Coronary artery disease;	chr3:48141099	chr3:49020672~49020694:-
BRCA	cis	rs7617773	0.832	rs6775114	MIMAT0000440	hsa-miR-191-5p	-3.25	0.00119	-0.07	-0.1	Coronary artery disease;	chr3:48141130	chr3:49020672~49020694:-
BRCA	cis	rs13256369	0.802	rs13255789	MIMAT0019728	hsa-miR-4660	3.25	0.0012	0.14	0.1	Obesity-related traits;	chr8:8705281	chr8:9048453~9048475:+
BRCA	cis	rs9527	0.59	rs12355120	MIMAT0005951	hsa-miR-1307-3p	3.25	0.0012	0.06	0.1	Arsenic metabolism;	chr10:103092409	chr10:103394301~103394322:-
BRCA	trans	rs2122469	0.655	rs17603934	MIMAT0000510	hsa-miR-320a-3p	7.95	4.84e-15	0.39	0.24	Serum tamsulosin hydrochloride concentration;	chr8:20718833	chr8:22244975~22244996:-
BRCA	trans	rs2122469	0.655	rs17603934	MIMAT0005792	hsa-miR-320b	6.65	4.64e-11	0.33	0.2	Serum tamsulosin hydrochloride concentration;	chr8:20718833	chr1:116671787~116671808:+
BRCA	trans	rs2122469	0.655	rs17603934	MIMAT0005792_1	hsa-miR-320b	6.65	4.64e-11	0.33	0.2	Serum tamsulosin hydrochloride concentration;	chr8:20718833	chr1:224257049~224257070:-
BRCA	trans	rs911263	0.561	rs2064912	MIMAT0000067	hsa-let-7f-5p	6.25	6.17e-10	0.17	0.19	Primary biliary cholangitis;	chr14:68340415	chr9:94176353~94176374:+
BRCA	trans	rs911263	0.561	rs2064912	MIMAT0000067_1	hsa-let-7f-5p	6.25	6.17e-10	0.17	0.19	Primary biliary cholangitis;	chr14:68340415	chrX:53557246~53557267:-
BRCA	trans	rs9644568	0.599	rs12679834	MIMAT0005792	hsa-miR-320b	6.18	9.19e-10	0.27	0.19	Hypertriglyceridemia;HDL cholesterol;	chr8:19962922	chr1:116671787~116671808:+
BRCA	trans	rs9644568	0.599	rs12679834	MIMAT0005792_1	hsa-miR-320b	6.18	9.19e-10	0.27	0.19	Hypertriglyceridemia;HDL cholesterol;	chr8:19962922	chr1:224257049~224257070:-
BRCA	trans	rs703108	0.731	rs7898954	MIMAT0000435	hsa-miR-143-3p	-6.16	1.02e-09	-0.14	-0.19	Monocyte percentage of white cells;	chr10:22034717	chr5:149428978~149428998:+
BRCA	trans	rs2066940	0.54	rs2045562	MIMAT0005792	hsa-miR-320b	6.04	2.14e-09	0.22	0.18	Sitting height ratio;	chr8:21350726	chr1:116671787~116671808:+
BRCA	trans	rs2066940	0.54	rs2045562	MIMAT0005792_1	hsa-miR-320b	6.04	2.14e-09	0.22	0.18	Sitting height ratio;	chr8:21350726	chr1:224257049~224257070:-
BRCA	trans	rs7189233	0.955	rs8054299	MIMAT0027684	hsa-miR-6892-5p	6.01	2.52e-09	0.24	0.18	Intelligence (multi-trait analysis);	chr16:53464743	chr7:143382686~143382706:+
BRCA	trans	rs7227892	0.659	rs9959212	MIMAT0004809	hsa-miR-628-5p	-5.99	2.84e-09	-0.14	-0.18	Migraine with aura;	chr18:48816071	chr15:55372991~55373012:-
BRCA	trans	rs12499371	1	rs12499371	MIMAT0005797	hsa-miR-1301-3p	5.93	4.01e-09	0.14	0.18	Superior frontal gyrus grey matter volume;	chr4:26509667	chr2:25328651~25328674:-
BRCA	trans	rs2963482	0.507	rs4704942	MIMAT0000759	hsa-miR-148b-3p	5.91	4.63e-09	0.14	0.18	Nonsyndromic cleft lip with or without cleft palate;	chr5:158466352	chr12:54337278~54337299:+
BRCA	trans	rs7840128	0.661	rs7830364	MIMAT0000510	hsa-miR-320a-3p	-5.87	5.84e-09	-0.42	-0.18	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr8:3824501	chr8:22244975~22244996:-
BRCA	trans	rs703108	0.731	rs7898954	MIMAT0000067	hsa-let-7f-5p	-5.79	9.27e-09	-0.18	-0.18	Monocyte percentage of white cells;	chr10:22034717	chr9:94176353~94176374:+
BRCA	trans	rs703108	0.731	rs7898954	MIMAT0000067_1	hsa-let-7f-5p	-5.79	9.27e-09	-0.18	-0.18	Monocyte percentage of white cells;	chr10:22034717	chrX:53557246~53557267:-
BRCA	trans	rs9644568	0.599	rs12679834	MIMAT0000510	hsa-miR-320a-3p	5.78	9.88e-09	0.25	0.18	Hypertriglyceridemia;HDL cholesterol;	chr8:19962922	chr8:22244975~22244996:-
BRCA	trans	rs71435601	0.739	rs1800481	MIMAT0004589	hsa-miR-30b-3p	5.74	1.25e-08	0.27	0.18	Cholesterol, total;	chr2:21044338	chr8:134800532~134800553:-
BRCA	trans	rs747334	0.846	rs4933629	MIMAT0019746	hsa-miR-4668-3p	5.71	1.45e-08	0.2	0.17	Fibroblast growth factor basic levels;	chr10:90959448	chr9:111932147~111932169:+
BRCA	trans	rs1426063	0.614	rs17266308	MIMAT0000753	hsa-miR-342-3p	5.64	2.24e-08	0.29	0.17	QT interval;	chr4:75137695	chr14:100109715~100109737:+
BRCA	trans	rs71435601	0.782	rs531819	MIMAT0004589	hsa-miR-30b-3p	5.63	2.29e-08	0.27	0.17	Cholesterol, total;	chr2:21040767	chr8:134800532~134800553:-
BRCA	trans	rs13153459	1	rs10054457	MIMAT0000435	hsa-miR-143-3p	-5.61	2.58e-08	-0.14	-0.17	Parkinson's disease;	chr5:44575931	chr5:149428978~149428998:+
BRCA	trans	rs12499371	1	rs13115937	MIMAT0005797	hsa-miR-1301-3p	-5.55	3.6e-08	-0.14	-0.17	Superior frontal gyrus grey matter volume;	chr4:26510394	chr2:25328651~25328674:-
BRCA	trans	rs12499371	1	rs1027149	MIMAT0005797	hsa-miR-1301-3p	-5.53	3.99e-08	-0.14	-0.17	Superior frontal gyrus grey matter volume;	chr4:26512099	chr2:25328651~25328674:-
BRCA	trans	rs12499371	1	rs34977909	MIMAT0005797	hsa-miR-1301-3p	-5.52	4.21e-08	-0.14	-0.17	Superior frontal gyrus grey matter volume;	chr4:26511026	chr2:25328651~25328674:-
BRCA	trans	rs12499371	1	rs1027150	MIMAT0005797	hsa-miR-1301-3p	5.5	4.85e-08	0.13	0.17	Superior frontal gyrus grey matter volume;	chr4:26512095	chr2:25328651~25328674:-
BRCA	trans	rs1569175	0.655	rs4672567	MIMAT0002874	hsa-miR-503-5p	5.46	5.88e-08	0.35	0.17	Response to treatment for acute lymphoblastic leukemia;	chr2:199847015	chrX:134546371~134546393:-
BRCA	trans	rs6479527	0.806	rs1316814	MIMAT0004499	hsa-miR-26a-1-3p	5.45	6.35e-08	0.15	0.17	Esophageal adenocarcinoma;	chr9:93980436	chr3:37969452~37969473:+
BRCA	trans	rs12499371	1	rs1027148	MIMAT0005797	hsa-miR-1301-3p	-5.44	6.68e-08	-0.13	-0.17	Superior frontal gyrus grey matter volume;	chr4:26512675	chr2:25328651~25328674:-
BRCA	trans	rs473892	1	rs473892	MIMAT0001340	hsa-miR-423-3p	-5.42	7.38e-08	-0.13	-0.17	Forced expiratory volume in 1 second (occupational environmental exposures interaction);	chr6:137629910	chr17:30117131~30117153:+
BRCA	trans	rs12499371	1	rs6811280	MIMAT0005797	hsa-miR-1301-3p	5.41	7.72e-08	0.13	0.17	Superior frontal gyrus grey matter volume;	chr4:26508831	chr2:25328651~25328674:-
BRCA	trans	rs10955961	0.692	rs2305604	MIMAT0004570	hsa-miR-223-5p	-5.41	8.03e-08	-0.15	-0.17	Parasitemia in Tripanosoma cruzi seropositivity;	chr8:120247604	chrX:66018895~66018916:+
BRCA	trans	rs17023900	0.867	rs76557883	MIMAT0005923	hsa-miR-1269a	5.39	8.84e-08	0.36	0.17	Prostate cancer;	chr3:87124612	chr4:66276890~66276911:+
BRCA	trans	rs703108	0.731	rs7898954	MIMAT0000062	hsa-let-7a-5p	-5.39	8.87e-08	-0.15	-0.17	Monocyte percentage of white cells;	chr10:22034717	chr11:122146568~122146589:-
BRCA	trans	rs703108	0.731	rs7898954	MIMAT0000062_1	hsa-let-7a-5p	-5.39	8.87e-08	-0.15	-0.17	Monocyte percentage of white cells;	chr10:22034717	chr22:46112752~46112773:+
BRCA	trans	rs703108	0.731	rs7898954	MIMAT0000062_2	hsa-let-7a-5p	-5.39	8.87e-08	-0.15	-0.17	Monocyte percentage of white cells;	chr10:22034717	chr9:94175962~94175983:+